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Living systems contain enormous potential to solve many pressing engineering 
problems, including the production of usable energy, the synthesis and degradation of a 
variety of materials, and the treatment of disease.  Metabolic engineering, as one 
approach to harness this potential, treats the behavior of a living system as the combined 
product of multiple interacting modules, each of which can be tuned to maximize 
performance.  However, the scarcity of techniques for predictive or high-throughput 
engineering design of these modules, especially in eukaryotes, contributes to long strain 
development times and high research cost.  In this work, we develop several new tools to 
expand our capabilities for predictive design and high-throughput engineering in yeast.  
At the transcriptional level, we develop a method which, for the first time, enables 
predictive strengthening endogenous yeast promoters and also the de novo design of 
strong synthetic promoters.  At the translational level, we show that it is possible to 
exploit the context resulting from the arrangement of DNA parts in order to predictably 
increase or decrease gene expression.  We also develop a powerful new approach for 
directed evolution of enzymes in yeast, termed in vivo continuous evolution, which 
enables the creation of library sizes orders of magnitude larger than can be obtained with 
 ix
the current state of the art using significantly less labor.  Finally, we harness the 
programmatic inhibitory potential of RNA interference to optimize and demonstrate a 
system for rapid strain engineering with minimal genomic editing.  Taken together, this 
work provides new techniques which enable a significant reduction in the development 
time of new yeast strains and informs future development of new tools for metabolic 
engineering. 
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Chapter 1: Introduction 
Living systems exhibit many useful phenotypes, including the synthesis of a wide 
variety of compounds (1), the extraction of energy from diverse substrates (2), and the 
degradation of toxins (3).  In many cases, the capabilities and potential of living things to 
solve important problems have no equal in man-made, nonliving systems.  Therefore, 
there has been significant interest in developing a greater understanding of the 
mechanisms by which organisms achieve these interesting behaviors as well as in 
designing modified organisms that exhibit improved functionality.  As one way to meet 
this objective, metabolic engineering aims to develop novel phenotypes by applying 
engineering strategies and formalizations to living systems.  These efforts have played a 
pivotal role in the development of strains which convert renewable substrates into high 
quantities of useful compounds (4-8) and which exhibit synthetic behaviors (9-12).  
Metabolic engineering treats organisms at multiple layers of complexity, each of which 
coordinately determine the behavior of the cell.  These layers can be at the basic level of 
regulation of transcription or translation, but they can also represent more complicated 
systems, such as enzymatic activity or even networks of interacting proteins (Figure 1-1).  
A deep understanding and the ability to engineer of each of these layers is critical to the 
development of living systems which effectively solve humanity’s problems.  Here, 
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factors and RNA polymerase.  These transcription factors tend to dictate the amount of 
RNA produced as well as its timing in relation to environmental cues and cellular 
processes.  Many transcription factors have known DNA binding sites, prompting the 
development of several databases linking sequence motifs to transcription factors in 
several organisms (14-18).  These databases enable engineers to create novel promoters 
by combining transcription factor binding sites in a modular fashion.  Indeed, Blazeck, et 
al. developed a series of synthetic hybrid promoters by successively adding upstream 
activating sequences to a core promoter region, and it was shown that the effect of 
subsequent additional upstream activating sequences is well-described by a cooperative 
hill function (19-21).  Further, Amit, et al. developed a predictive model for the behavior 
of bacterial promoters through a statistical thermodynamics approach (22).  In this study, 
every potential state of the promoter (transcription factors bound/unbound, enhancer 
proteins in proximity to the RNA polymerase, etc.) was assigned a weight corresponding 
to its free energy to compute a partition function and the Boltzmann distribution was used 
to compute the fraction of promoters in an active state.  For this model, higher active 
fractions corresponded to more active promoters.  In addition to work demonstrating the 
importance of the transcription factors themselves, previous studies have also 
demonstrated both the importance of chromatin structure in regulating the accessibility of 
transcription factor binding sites (23) as well as the capacity to alter transcription rates by 
modifying nucleosome binding sequences (24).  These rational approaches, coupled with 
part-mining from natural systems (25) as well as diversification of native promoters 
through mutagenesis (26,27) have given researchers a large toolkit for developing new 
promoters, although well-characterized promoters of low strength have not yet been 
developed, and de novo design of promoters remains a challenge in eukaryotes.  For 
model systems such as E. coli, formalizations have been developed which enable 
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researchers to measure and characterize promoters in a standardized fashion, leading to 
the development of online repositories of standard parts (28). Therefore, there are 
currently multiple avenues which a metabolic engineer can pursue in order to enable 
desired levels of transcript production, yet more work is needed to in order to develop 
large libraries of promoters which span the full range of gene expression in yeast.     
1.2 ENGINEERING CELLULAR BEHAVIOR AT THE TRANSLATIONAL LEVEL 
In order to realize the promise of synthetic biology, researchers are constructing 
ever more complex genetic architectures.   In these constructs, multiple DNA parts are 
assembled in order to achieve a desired outcome.  As important as the gene products and 
their associated regulatory machinery are in these engineered systems, method by which 
these DNA parts are assembled into a functional construct is equally so.  In particular, 
issues such as mRNA structure and construct homology can greatly impact the yield and 
functionality of synthetic constructs through effects at the translational level, thus 
prompting metabolic engineers to develop methods which mitigate or exploit these 
effects.   
1.2.1 Regulating Translation through RNA Structure 
RNAs often undergo intra- and intermolecular hybridization reactions to form 
structures which may inhibit or enhance gene expression through interference with the 
ribosome.  In contrast to the complex DNA-protein and protein-protein interactions 
which determine promoter activity, these RNA structures are formed through nucleic acid 
hybridization, which has a mature modeling framework.  Within this framework, it is 
necessary to enumerate nearly all possible secondary structures and their energies by 
making use of the well-known free energies of hybridization between nucleotides (29).  
This set of states may then be used to compute a partition function, enabling the 
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calculation of the most probable free energy structures and ensemble free energies.   
Several software packages enable prediction of DNA and RNA secondary structure as 
well as sequence design to achieve a user-defined secondary structure (30,31).  However, 
these programs limit treatment of pseudoknotted structures to short nucleic acids due to 
the computational complexity of enumerating all structures for nucleotides above 100 bp 
in length.  Nevertheless, these thermodynamic models can enable the design of nucleic 
acids with defined secondary structures, which may be used to occlude ribosome binding 
sites, impede ribosome scanning, or respond to the presence of small molecules in 
solution.    
In addition, a myriad of RNA-based regulators have been developed (32).  In 
particular, Isaacs, et al. (33) developed “riboregulators” which enable post-transcriptional 
tuning of gene expression through competitive binding to a ribosome binding site (RBS)-
occluding stemloop.  In this study, prediction tools such as mfold (34) enabled the design 
of riboregulators with stable secondary structures.  By varying the concentration of a 
small trans-activating RNA, the expression of a gene encoded by the bound transcript 
could be modulated independently of promoter strength.  Ribosome binding site 
occlusion by mRNA secondary structure represents a simple way to modulate gene 
expression.  In fact, several groups have leveraged RNA structure prediction tools to 
develop programs which can design ribosome binding sites which are occluded by 
secondary structure to a prescribed extent, enabling a user-defined control of translation 
(35,36) in prokaryotes.  However, gene expression modulation by mRNA secondary 
structure is not limited to this kingdom.  As eukaryotic translation initiation is dependent 
upon ribosomal “scanning” along the 5’ untranslated region (5’UTR) for the start codon, 
any secondary structure in this region will pose a barrier to gene expression.  Thus, the 
same thermodynamic RNA structure prediction tools may be used in eukaryotes to design 
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cloning elements present in the 5’UTR to minimize this inhibitory secondary structure 
(37).  
 In addition to tuning levels of gene expression in a static sense, RNA structure 
may be used to regulate gene expression in response to the presence of compounds 
present inside the cell through RNA sensors called aptamers.  These TNAs are capable of 
precisely binding a small molecule and subsequently undergoing a conformational 
change to elicit a corresponding change in the actuation domain of this RNA structure.  
These structures can regulate gene expression in response to a single input (38), or may 
perform Boolean logic operations on multiple inputs (39,40).  Finally, thermodynamic 
models of RNA folding have been integrated with kinetic models of transcription and 
translation to develop prokaryotic promoters with defined dynamic behaviors (41).  
Although these kinetic models require extensive experimentation to fit unknown 
parameters, they enable design of promoters with time-dependent behaviors and are 
reminiscent of the models used to describe and predict the behavior of gene regulatory 
networks.  Collectively, these strategies enable researchers to tune gene expression 
through modulation of translation rate. 
1.2.2 Streamlining Eukaryotic Translation through the use of 2A peptides 
2A peptides are 22 amino acid “self-cleaving” sequences discovered in 
picornaviruses which enable the production of physically separated protein products from 
genes which are encoded in the same open reading frame (42), thus enabling co-
regulation of several gene products without the necessity for the addition of promoter and 
terminator sequences between each gene.  The defining feature of a 2A site is a proline-
glycine-proline sequence at the polypeptide cleavage site.  This unique peptide sequence 
induces stalling of the translating ribosome during the synthesis of the glycyl-prolyl 
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peptide bond, presumably due to steric hindrance.  This allows hydrolysis of the nascent 
polypeptide chain at the glycine-proline junction, releasing the first protein product and 
enabling the ribosome to continue translating the second (43).   These sites have been 
used for engineering applications in mammalian cells and in plants (but interestingly, not 
in prokaryotes) (42), but reports of its use for biotechnological objectives in yeast are 
sparse (44).   
1.2.3 Development of Polycistronic Expression Cassettes in Eukaryotes through 
Internal Ribosome Entry Sites 
Internal ribosome entry sites (IRESs) are cis-encoded elements which direct 
ribosome binding to the interior of a polycistronic transcript.  These elements can be 
derived from RNA viruses which infect mammalian hosts and enable translation of viral 
RNAs in a cap-independent fashion (45), or they can be derived from endogenous 
mRNAs which enable translation in a cap-independent manner, which is thought to be a 
mechanism to maintain protein production during stress (46).  It is hypothesized that the 
ability to direct eukaryotic translation machinery to the interior of an mRNA is dependent 
on the unique secondary structure that an internal ribosome entry site adopts.  In 
particular, it has been shown that viral IRESs adopt structures that resemble the canonical 
tRNA cloverleaf structure (as is the case with the encephalomyocarditis virus (47-49)) or 
even pseudoknotted structures that resemble the anticodon loop of a tRNA bound to its 
cognate mRNA substrate (as is the case for IRESs derived from the dicistroviridae family 
(50)).  However, the sequence, structural, or mechanistic determinants of IRES function 
have yet to be definitively elucidated.   
Nevertheless, the unique ability of an internal ribosome entry site to enable 
translation of a polycistronic mRNA in eukaryotes has spurred interest in its use as a tool 
for biotechnology.  In mammalian cells, high-level production of a gene product is often 
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enabled by the use of a polycistronic expression cassette consisting of the gene of interest 
in tandem with a selection marker.  In this scheme, culture in selective media permits 
only the growth of those cells which express the selection marker, and hence, the gene of 
interest.  In addition, the ability of IRESs to initiate translation at an uncapped mRNA has 
enabled researchers to use dedicated bacterial RNA polymerases (such as T7) to 
transcribe a gene of interest in a non-prokaryotic host (51).  Although bacterial RNA 
polymerases do not produce capped RNAs, the presence of an IRES enables translation to 
occur.  Not only does this system enable high transcript production, but it is also 
orthogonally regulated, thus minimizing inhibition from the cell’s native machinery.  For 
metabolic engineering applications, the use of IRES elements to express a synthetic 
pathway would enable pathway components to be co-regulated in a facile manner, thus 
reducing waste associated with functionally redundant DNA as well as reducing the risk 
of homologous recombination-associated construct instability.  Furthermore, the variable 
efficiency of IRES elements would enable tunable expression of each component of a 
synthetic pathway while each maintaining the same induction or repression responses.  
Therefore, there has been much interest in the development of an IRES for S. cerevisiae, 
as this organism is a platform for industrial biotechnology yet its potential to utilize 
known internal ribosome entry sites remains underdeveloped (52).  Additionally, 
although several publications have reported the identification of internal ribosome entry 
sites which function (at least to a small extent) in yeast (53), these sites have not been 
utilized in a metabolic engineering context.   
1.3 ENGINEERING PROTEINS 
The properties of enzymatic machinery are of fundamental importance to the 
overall efficiency and economics of a bioprocess.  Although maximum productivity can 
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be greatly enhanced through optimization of the quantity and timing of gene expression 
and the availability of substrate, yield of product per substrate consumed is a major factor 
driving cost, and increases to yield come through optimizing the properties of the 
biocatalyst.  Catalytic rate, substrate promiscuity, product specificity, and cofactor 
requirements are of critical importance to the design of any catalyst, and enzymes are no 
exception.    Hence, the development of tools for facile, rational enzyme engineering is an 
area of intense research (54-56).  Several packages exist to assist in predicting the effects 
of small changes to an existing protein structure, the most famous of which is ROSETTA 
(57) which has found wide use suggesting potential routes for enzyme engineering (58-
60).  In addition, Fold-It is a user-friendly program for protein structure optimization, and 
also leverages humans’ ability to recognize patterns by crowd-sourcing difficult folding 
problems (61). This approach has succeeded in determining increasing the Diels-Alderase 
activity of an enzyme (62).  Despite the relative dearth of predictive models, several 
groups have reported outstanding successes in rationally re-engineering enzymes for 
novel functions and also developing enzymes de novo.  Milestones include developing 
novel ligand-binding capabilities (63) and expanded activity on non-native substrates (64) 
through docking simulations, novel enzyme function through engineering a catalytic site 
to stabilize a highly divergent transition state complex (65,66), and completely novel 
enzymes by stabilizing metal ions on an artificial scaffold (67).  It is hoped that increases 
in computational power will soon enable routine design of novel, specific, and active 
biocatalysts.   
Although techniques for ab initio modeling (61,68), as well as semi-rational 
procedures such as site-directed mutagenesis (69-72) and domain shuffling (73-75) have 
seen outstanding success in the development of proteins with improved functionality, 
these techniques require detailed structural information.   Additionally, accurate de novo 
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prediction of enzyme function requires exquisitely precise molecular modeling (and thus 
computational prowess outside the grasp of most synthetic biology labs), so enzymes are 
commonly engineered through “nonrational” procedures such as directed evolution (76).  
Classical directed evolution relying on error-prone PCR has seen remarkable successes in 
yielding improvements to enzymes (77), transcription factors (78), and regulatory 
elements (79).  In addition, several techniques for in vivo library generation have been 
developed, most notably Phage-Assisted Continuous Evolution (PACE).  PACE (80) 
exploits the high reproductive capacity of M13 phage to introduce mutations in a plasmid 
enabling pIII production in E. coli.  This technique requires the use of a constant-flow 
bioreactor to apply selective pressure to the phage, and is generally limited to the 
evolution of biological parts which activate transcription.  In addition, this technique is 
not applicable to the evolution of parts which specifically function in eukaryotic systems. 
Therefore, there is significant interest in developing a system for continuous evolution 
which avoids these shortcomings.  
1.4 ENGINEERING METABOLIC NETWORKS 
Metabolism represents the concerted effort of thousands of enzymes to synthesize 
thousands of molecules from substrates such as small, simple sugars and large, complex 
polypeptides.  This highly complex, interconnected network is responsible for the diverse 
chemistries enabled by microbial catalysts.  However, these networks contain thousands 
of enzymes whose behavior is often not fully characterized.  Thus, synthetic biologists 
face significant challenges when predicting perturbations to microbial metabolism with 
the goal of increasing bioprocess productivity.  As a result, several modeling frameworks 
have been developed to aid in the design of engineered metabolic networks, differing 
mainly in the level of detail they provide.  Stoichiometric models tabulate all the 
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chemical reactions possible in metabolism, thermodynamic models contain information 
regarding the feasibility of each reaction, and kinetic models contain rate information for 
each enzyme.  Models for a variety of organisms have been curated using portions of 
each of these frameworks, and several automated tools have been developed to aid in the 
construction and utilization of these models.  
1.4.1 Models of Metabolism 
Models of metabolism are essentially systematic enumerations of all metabolic 
reactions, detailing the ratios with which metabolites react to form products.  At their 
heart is a large matrix which details the potential sources and sinks of each metabolite.  
Together with the flux through each metabolic pathway, this matrix is used to determine 
the change over time of the concentrations of each metabolite.  In general, this framework 
results in a system of coupled differential equations for the concentrations of each 
metabolite.  The distinguishing features of each modeling framework detailed below are 
the assumptions used to simplify and solve this often severely underdetermined system of 
equations. 
1.4.1.1 Stoichiometric Models 
Most studies employing stoichiometric models assume metabolism is at steady 
state, that is, the concentration of each metabolite does not change. Constraints on the 
permissible values of the flux through each reaction may also be specified.  This results 
in a set of algebraic equations and inequalities which restricts the metabolic fluxes that 
may be observed.  However, since the number of reactions in a model greatly exceeds the 
number of metabolites, these assumptions do not specify a unique flux profile.  Thus, 
additional assumptions must be made to determine the state of the cell.  Usually, these 
assumptions take the form of an objective function and optimization algorithms may be 
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used to solve for metabolic fluxes.  Several of these objective functions have seen wide 
use, including the constraint that cell growth must be maximized (81) and the constraint 
that deviation of metabolic flux from some “base case” is minimized (82).  The latter 
objective function is frequently used to analyze engineered strains by assuming their 
metabolic flux profile is similar to that of the parent strain (usually calculated by 
assuming maximization of growth).  These objective functions are sufficient to define a 
unique metabolic state, including growth rate and flux through every pathway (83).  
1.4.1.2 Thermodynamic Models 
Models incorporating thermodynamics are similar to the stoichiometric models 
mentioned above, except that the free energy of each reaction is constrained to be 
negative (84,85).  These free energies may be estimated for every reaction in the cell 
using the method of group contributions (86).  This added constraint reduces the space of 
feasible fluxes and eliminates flux distributions which violate the laws of 
thermodynamics, such as internal flux cycles.  The energy associated with moving solutes 
up a concentration gradient through a membrane is also considered in this analysis. 
Feasible flux distributions may be computed using linear optimization and the objective 
functions mentioned above.  These modeling structures help further refine the solution 
space of this underdetermined system.   
1.4.1.3 Kinetic Models 
The most accurate description and prediction of cellular metabolism must include 
rate laws for each reaction in the organism.  Inclusion of these rate laws transforms the 
algebraic system treated above into a system of coupled differential equations.  It is also 
expected that these kinetic models will include the dynamic effects of regulatory proteins, 
which is not accounted for in either the stoichiometric or thermodynamic modeling 
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framework.  Manual characterization of the kinetics associated with each metabolic 
component initially seems like a daunting task.  However, several techniques currently 
exist to experimentally determine metabolic fluxes in the cell, enabling estimates of 
kinetic parameters to be developed.  Metabolic flux analysis using radioactive tracer 
compounds is the most commonly used method to estimate intracellular fluxes and 
several algorithms to compute the resulting flux distribution have been developed (87-
89).  MASS (mass-action stoichiometric simulation) uses this metabolomics data to 
create estimates of rate constants (90), and similar techniques have been used to make 
estimates in yeast (91) and in mammalian cells (92).  Estimates of these kinetic 
parameters will enable the classical technique of metabolic control analysis to be used on 
a genome scale (93,94) in addition to more detailed simulations of the temporal behavior 
of engineered cells (95). 
1.4.2 Curated Models 
The first models of metabolism were stoichiometric in nature and were created for 
common laboratory species such as E. coli (96) and S. cerevisiae (97) among other 
organisms (98,99) though literature search and manual annotation.  Recently, metabolic 
models have been automatically generated and updated for many other organisms based 
on genome sequences and through analysis of reaction thermodynamics.  Current models 
for E. coli take into account the thermodynamics of each reaction (100),  and 
stoichiometric models of other model organisms such as S. cerevisiae (101) are nearing 
completion.  For organisms which do not have a metabolic model, a collection of 
software packages have been developed to automate stoichiometric network 
reconstruction based on genomic data (102,103).  In addition, these pathways can be 
refined by comparing in silico growth phenotypes to those determined experimentally 
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and adding or deleting the necessary reactions (104).  These networks have, until 
recently, been curated in an ad hoc manner throughout the biological literature.  As a 
consequence, the Systems Biology Markup Language (SBML) has been developed to 
describe metabolic networks in a standardized and machine-readable format (105).  
1.4.3 Optimization of Metabolism 
The utility of a metabolic model to a metabolic engineer lies in its capacity to 
enable the design of heterologous metabolism.  Several algorithms and software packages 
have been developed which automate the process of strain design using the models 
mentioned above.  Flux balance analysis enables the calculation of metabolic fluxes at 
equilibrium given either a stoichiometric or thermodynamic model.  Thus, identifying 
promising engineering targets simply involves making perturbations to the host genome 
in silico and iteratively performing flux balance analysis until a specified production goal 
is achieved.  Exhaustive search methods have been used to identify promising knockouts 
improving lycopene production in E. coli (106) and formic acid production in S. 
cerevisiae (107).  A linear optimization approach to identifying promising knockouts 
(108) has been used to improve lactic acid (109) and 2,3-butaendiol titers (110).  In 
addition, pathway databases such as MetaCyc (111,112), KEGG (113), BRENDA  (114), 
and BiGG (115) have been used to suggest heterologous enzymes enabling improved 3-
hydroxypropionate (116) and 1,4-butanediol production (117).  Methods incorporating 
concepts from retrosynthesis have also been developed to assemble heterologous 
pathways (118-120).  
Several user-friendly software packages exist to automate the process of searching 
for interesting metabolic perturbations.  The well-known COBRA toolbox is an add-on to 
the MATLAB computing environment which performs flux balance analysis and 
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knockout identification (121,122).  OptGene (123) utilizes a genetic algorithm to identify 
promising knockouts and has been used successfully to improve the production of 
vanillin (124) and cubebol (125).  The Biomet toolbox automates heterologous pathway 
assembly by interfacing with databases of reactions (126) and CycSim (127) is a web-
based tool that performs simple flux calculations in a user-friendly environment.  Finally, 
suggested metabolic changes may be easily visualized on the metabolic network with 
tools such as iPATH2 (128) and GLAMM (129).  Progress has moved rapidly in this area 
of metabolic modeling and has recently been demonstrated to be a potent approach for 
designing synthetic metabolic systems. 
1.4.4 Engineering Metabolic Networks in a High-Throughput Manner 
Applications in both synthetic biology and metabolic engineering often rely upon 
the ability to either partially or completely remove the activity of a gene product in order 
to provide living systems with the optimal catalytic repertoire to meet a certain goal.  
Thus, knockdown and knockout strategies which have been informed by the rational 
approaches mentioned above have been instrumental in rewiring microbial systems for 
the production of a wide variety of chemicals.  However, it is often the case that the 
phenotype of interest is not directly linked to metabolism, and is rather a complex 
phenotype such as tolerance.  These phenotypes are very difficult to model in silico, 
necessitating genome-wide screening in vivo (6,130-132).  Among possible host 
organisms, yeasts have gained traction as a highly attractive system for the bioproduction 
of fuels and chemicals (133).  However, current methods for elimination or reduction of 
endogenous gene activity in yeast remain laborious and necessitate highly sequential 
workflows in spite of the need to test (often many) different gene knockdown/out 
strategies.  Strain choice can also significantly influence the yield and productivity of 
 16
industrial bioprocesses, but a priori strain selection is not always feasible (8).  Therefore, 
although parallel processing of multiple yeast strains during the design-build-test cycle is 
highly desirable, the high cost associated with each genome modification limit the 
amount of possible parallelization.  Furthermore, if a superior wild-type strain is 
identified late during process optimization, it may be extremely costly and difficult to 
transfer genomic modifications to the new strain using the same linearized workflow.  
Thus, there is a strong need for a synthetic methodology to quickly and cheaply introduce 
gene knockdown/outs into multiple strains of yeast in order to rapidly prototype within 
the design-build-test cycle. 
Recent reports have demonstrated the use of small regulatory RNAs as a means 
for rapid, facile knockdowns in the bacterial system Escherichia coli (134).  In higher 
eukaryotic systems, RNA interference (RNAi) is used to systematically target and reduce 
mRNA levels through the action of the RNA-induced silencing complex on double 
stranded RNA (135).  Specifically, double stranded RNA (dsRNA) is cleaved by Dicer to 
form small guide RNAs, which are then used by Argonaute to recognize and degrade the 
corresponding mRNA in a programmatic manner (Figure 1-2).  A major advantage of 
RNAi is that it is highly portable and only requires the requisite machinery (i.e. 
Argonaute, Dicer, and dsRNA) to be expressed– no genome engineering is explicitly 
required.  Furthermore, the targeting dsRNA can be generated without prior knowledge 
of a host’s genome using existing cDNA library techniques.  RNAi thus enables rapid 
strain prototyping through synthetic import of this machinery into novel host strains.  As 
a result, RNAi has been widely used for targeted loss-of-function studies and metabolic 
engineering in a wide variety of eukaryotic organisms (136-140).  Despite its utility, a 
functional RNAi pathway is endogenously absent from common yeast hosts such as S. 









































s (4-8).  In o
ed which en
gies inform





ogy to a target













e and Dicer 
 metabolic n
nce 
 gene is degrad


















 by the hig
at produce 
mitation, to
ing and 2) 
 In this wor
g yeast at t
ively achiev










k, I will dem
he level of 
e these goal























Chapter 2: Model-Based Design of Synthetic Yeast Promoters via 
Tuning of Nucleosome Architecture 
2.1 INTRODUCTION 
Synthetic biology design is ultimately constrained by our capacity to specify 
function of synthetic parts at the DNA sequence level.  This capacity would redirect the 
field away from relying on a “parts-off-the-shelf” strategy and toward an approach 
marked by pure, synthetic design and customizable specification.  Toward this end, great 
strides have been made to enable model-based design of cellular behavior (142) and to 
allow for rational design of small sequences (such as ribosome binding sites, transcription 
factors and enhancers) (13,19,20,22,33,35,143).  Yet, pure de novo design of full 
promoters, one of the most fundamental components in synthetic circuits, remains 
difficult, especially in eukaryotic model organisms like yeast.  Traditional approaches 
spanning the last decade of promoter engineering efforts (13) rely upon part-mining 
(144), mutagenesis strategies (26,27,145), and/or chimeric design (19,20) to identify 
promoter variants.    
In contrast, here we present the first approach for DNA-level specification of 
promoter activity based on predicted nucleosome affinity.    Based on previous studies 
demonstrating the importance of nucleosome occupancy on promoter activity (23,24), our 
overall hypothesis is that promoter activity can be predicted and controlled based on 
nucleosome architecture (Figure 2-1).  To test this hypothesis, we made use of a 
previously-developed hidden Markov model to de novo predict nucleosome occupancy 
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by a single base pair were computationally generated and the candidate with the smallest 
cumulative affinity score was used as an input for the next round.  Importantly, this 
optimization was bounded by the sequence-based requirement to avoid the destruction or 
creation of well-known transcription factor binding sites (147,148) (see Appendix B.1).  
A greedy algorithm was chosen for computational convenience rather than for exhaustive 
nucleosome occupancy optimization.  Moreover, we have validated this choice by finding 
that optimizing over all pairs of nucleotide substitutions in each round resulted in 
promoters with only slightly lower predicted nucleosome affinity although at a 
substantially increased computational cost (700 sec per mutation vs. 218,000 sec per pair 
of mutations in the case of CYC1) (Figure 2-3).  Thus, the greedy algorithm is well-
suited for the rapid identification of designer promoter sequences.  Since each round of 
the greedy algorithm evaluated all candidates differing by single base pair changes (a 
space on the order of 103 for each promoter tested), and because our design cycle 
consisted of 50-100 rounds, this proof-of-concept demonstration corresponds to sequence 
space searches of upwards of 105 in a facile manner.  The scope of this sequence space 
for the first round of the CYC1 promoter optimization is depicted in Figure 2-4.  This 
initial search illustrates hot-spots in sequence space that result in lower cumulative 
nucleosome affinity scores.  For example, in Figure 2-4A, there are a series of variants 
clustered near the -100 base-pair position that show decreased cumulative nucleosome 
affinity scores when mutated to T, and higher scores when mutated to G or C.  
Furthermore, it should be noted there are examples where changing a particular 
nucleotide to an A or T does not result in the lowest predicted score for that position even 
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Using this approach, we successfully defined promoter sequences that 
experimentally increased the strength of four different native yeast promoters (CYC1, 
HIS5, HXT7, and TEF1) that natively span an order of magnitude in expression level 
(Figure 2-5A, see Figure 2-6 for a comparison of wild-type promoter strengths and 
predicted nucleosome affinity profiles).  In each of these cases, we used our approach to 
computationally redesign sequences for higher strength promoter variants by choosing 
the products of select rounds of optimization to synthesize, and then experimentally 
demonstrating improved transcriptional activity in a plasmid-based system.  Furthermore, 
using the CYC1 promoter as a test case, we showed that a variety of expression levels can 
be generated by synthesizing the products of varying rounds of optimization, with 
CYC1v1 the product of an early round and CYC1v3 the product of a late round (see 
Appendix Table A1-1 for full promoter sequences). The greatest improvement in 
strength over wild-type for all of the redesigned promoters was 3.2-fold, exhibited by the 
CYC1v3 promoter, which is the result of the 30th round of optimization.  Subsequent 
measurement of transcript level using quantitative PCR confirmed that the redesigned 
promoters increased transcriptional expression over each corresponding wild-type 
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Specifically, alternative contexts can be used to test the importance of the predicted 
mutation to potentiate nucleosome architecture rearrangements independent of upstream 
and downstream DNA segments.  Differences in the genetic contexts that surround the 
promoter, either due to the promoter’s location in the genome or due to the particular 
gene being expressed, could result in changes to the local chromosomal architecture and 
could therefore influence the final expression level of the promoter.  This phenomenon of 
genetic loci-dependent expression is well-documented for the yeast genome (149).   
First, the CYC1 series of re-designed promoters was evaluated with an alternative 
reporter gene.  In this case, the yECitrine gene used in our previous experiments was 
replaced with a beta-galactosidase gene from E. coli (LacZ).  Beta-galactosidase activity 
was detected and the relative increase in expression level using this reporter was similar 
to that from the yECitrine constructs (Figure 2-9A).  In this case, the CYC1v3 had a 3.8 

























































m the CYC1 p
inescent assay
 expression lev
 of the BY474
trine with the 
 basis for the 
 deviation from
ries of re-d
 plasmid.  I
oter varian
us in the ge
g flow cyto








el from the C





n this case, 











)  Relative ex
3 gene integra






re 2-9B).  
e same as f
ld-change i


















































was due to the move from the plasmid to the genome or due to the URA3 marker gene 
integrated upstream of the promoter, a set of plasmids containing the URA3 marker gene 
were also assayed for yECitrine expression (Figure 2-9C).  Interestingly, the fold-change 
in expression level for these constructs was intermediate between the original plasmid 
constructs and the integrated constructs, with the highest increase being 5.9-fold for 
CYC1v3.  It is therefore likely that both the addition of the marker gene and the 
integration of the cassette resulted in local repositioning of nucelosomes that changed the 
final ultimate nucleosome architecture of the expression cassette.  Regardless, the re-
designed promoters consistently increased expression level, indicating that these rational 
mutations are able to potentiate a decrease in the nucleosome occupancy of yeast 
promoters in a variety of genetic contexts, thereby increasing expression level in a 
general manner.   
2.2.3 Design and creation of synthetic yeast promoters 
As a second proof-of-concept, we sought to demonstrate that a model-guided 
approach can be used to create de novo promoters for synthetic biology without requiring 
the use of a native promoter as a scaffold.  Previous attempts to create synthetic S. 
cerevisiae promoters usually relied upon hybrids of multiple promoter parts (20), 
synthetic zinc finger transcription factor binding sites inserted into a scaffold of a native 
promoter (143,150), the use of synthetic TALE transcription factors (151), or random 
libraries and screening (152).  A purely synthetic, de novo designed promoter created 
merely upon the arrangement of desired transcription factors has not been previously 
demonstrated.  Specifically, our goal in this proof-of-concept was to demonstrate that, 
even without information related to promoter architecture rules, it is possible to 
computationally specify active promoter sequences.  To use our design and search 
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strategy to create such a synthetic promoter, we specified two arrangements as initial lead 
scaffolds for the promoter design.  To do so, we utilized common glycolytic transcription 
factor binding sites embedded in random spacer sequences as the lead designs for our 
algorithm (Figure 2-10A, see Table 2-1 for comparison to native promoters).  This 
approach resulted in two synthetic base scaffolds: Psynth1, and a shorter version Psynth2, 
which were both used as inputs to our nucleosome affinity minimization techniqueThree 
synthetic promoters were designed for Psynth1 and Psynth2: one version from the sixth 
round of optimization, a second version from the 50th or 30th round, and a third version 
from the 98th or 59th round, respectively.  As a result, a total search space of 105 was 
evaluated over the entire design cycle for each base scaffold.  The result was six DNA-
specified promoters that were subsequently characterized.  All six designs were found to 
be active promoters in vivo (Figure 2-10B) that span nearly a 20-fold dynamic range with 
most of them being similar or higher in strength to the CYC1 promoter—a promoter 
representative of the mean expression level of native yeast promoters (153).  The power 
of our affinity minimization technique to increase promoter activity is especially evident 
in the case of Psynth1.  Psynth1v1  is only marginally higher in expression than the 
negative control, whereas Psynth1v2 is 3.5-fold higher and approaches the strength of 
CYC1.  Psynth1v3 is nearly 20-fold higher than Psynth1v1 and is on par with the strength 
of a commonly used promoter, the HXT7 promoter.  Moreover, the substantial 
transcriptional capacity of this purely synthetic promoter places it in the 6th percentile of 
expression when compared to endogenous yeast promoters (153).  Furthermore, it should 
be noted that each of these synthetic promoters is quite distinct on a sequence level from 
native S. cerevisiae promoters.  In fact, the most significant homology consisted of a 39 
base-pair sequence surrounding the TATA box of Psynth1 (E-value =0.48).  Thus, our 
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TDH3 2 1 1 41 93 309 38 27 31 
FBA1 3 1 0 11 105 255 42 N/A N/A 
TPI1 2 0 1 31 140 167 40 N/A N/A 
ADH1 2 1 0 39 82 207 N/A N/A N/A 
PGK1 2 1 1 42 104 279 17 24 88 
CDC19 5 1 1 29 163 64 47 12 170 
TDH2 4 0 1 33 93 170 45 N/A N/A 
GPM1 2 1 0 11 128 196 16 37 N/A 
Average 2.75 0.75 0.625 29.6 113.5 205.9 35 25 96.3 
Minimum 2 0 0 11 82 64 16 12 31 
                    
Psynth1 2 1 1 41 100 200 40 24 30 
Psynth2 2 1 1 41 80 65 40 24 30 
Table 2-1: Glycolytic promoter architecture and design of Psynth1 and Psynth2. 
The positions and lengths between various transcription factors in a collection of yeast glycolytic promoters 
were catalogued in order to design Psynth1 and Psynth2.  All lengths refer to the distance in basepairs 
between the start of each binding site.  Column Descriptions: 1. Number of Gcr1p binding sites.  2.  
Number of Rap1p binding sites.  3.  Number of Reb1p binding sites. 4. 5’ UTR length.  5.  Length between 
TATA box and transcription start site. 6. Length between Gcr1p binding site and TATA box.  7.   Length 
between two Gcr1p binding sites when they occur in close proximity to a Rap1p or Reb1p binding site.  
Values of N/A mean that the sites did not occur in a pair.  A value of 40 bp was chosen for the synthetic 
promoters because PGK1 and GPM1 were identified as outliers in this category.  8.  Length between Rap1p 
binding site and Gcr1p binding site when they occur in close proximity to each other.  Values of N/A mean 
that the sites did not occur close together or there was no Rap1p binding site.  9.  Length between Rap1p 
and Reb1p binding sites.  Values of N/A mean that the promoter did not have both a Rap1p site and a 
Reb1p site.  The minimum distance was chosen in this category because the three values had a large 
distribution and some of the promoters that lack a Reb1p binding site have an Abf1 binding site in a similar 
position. 
2.3 DISCUSSION 
Taken together, these results present the first DNA-level specification of promoter 
strength for yeast promoters based on a nucleosome architecture model.  We have 
demonstrated the potential of this approach for (1) the re-design of endogenous promoter 
scaffolds and (2) the design of de novo synthetic promoters.   
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Specifically, native yeast promoters were redesigned into highly homologous 
sequences with promoter strengths up to 16-fold higher than their wild-type sequences.  
For each of the four promoter case studies, we improved activity by first interrogating 
~105 promoter variants in silico (103 candidates were queried per round when searching 
over all possible single base pair changes, and 106 could be queried per round when 
searching over doubles, see Figure 2-3) then characterizing the products of selected 
rounds of the greedy algorithm in vivo.  For the case of the CYC1 promoter, we chose the 
products of three different rounds of optimization to synthesize.  This approach stands in 
stark contrast to the generation of large mutagenic libraries followed by screening.  The 
extent of expression level increase did not always correlate with the absolute number of 
base pairs changed, as increases obtained in TEF1v1 required only five rounds of 
optimization (see Appendix Table A1-1 for full sequences).  However, the utility of the 
greedy algorithm to sequentially identify increasingly optimal sequences was upheld for 
each case tested.  Regardless, each of the redesigned promoters required multiple rounds 
(i.e. basepair changes) to significantly increase expression, underscoring that these 
specific high-strength-potentiating combinations would be undetectable in random 
mutant libraries. Additionally, we confirmed that these improvements were indeed due to 
decreased nucleosome occupancy in the case of the CYC1v3 promoter.  Finally, we 
showed that these rationally designed promoters consistently display increased 
expression in a variety of genetic contexts, demonstrating that these directed changes are 
able to potentiate a decrease in nucleosome occupancy despite variation in the 
surrounding chromosomal architecture. 
Further, we created several fully synthetic yeast promoters which attain a variety 
of strengths and have minimal homology to any native sequence.  The base promoter 
scaffolds for these synthetic promoters were only very loosely based on the native 
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glycolytic promoters in yeast, demonstrating that close homology to native promoters 
may not be necessary for synthetic eukaryotic promoters.  Given this surprising result, the 
range of synthetic promoter design possibilities is unbounded by traditional promoter 
architecture design rules inferred from native promoter structures.  Furthermore, one of 
our synthetic promoters, Psynth1v3, is on par with a commonly used promoter for 
metabolic engineering purposes, the HXT7 promoter, and resides among the top six 
percent of native yeast promoters in regards to strength (153).   
This work confirms that nucleosome occupancy is an important, causative factor 
limiting the strength of native yeast promoters and is likely an evolutionary mechanism 
for controlling transcriptional strength (154).   This method significantly advances the 
state-of-the-art in a field currently entrained in mutation and chimeric library construction 
by enabling the predictable specification of synthetic parts in single design-build-test 
cycles rather than by the generation of large libraries.  Thus, this method opens the door 
to the rational design and creation of synthetic eukaryotic promoters as well as expands 
our capacity for pure synthetic biology design. 
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Chapter 3: Fine-Tuning Transcriptional Control through Weak 
Promoters 
3.1 INTRODUCTION 
In order to efficiently direct metabolism towards the production of a desired 
product, synthetic and endogenous cellular machinery must be expressed at precise levels 
to ensure maximal productivity while minimizing metabolic waste.  Although well-
characterized libraries of strong promoters have been curated and developed (25-27), 
there remains a need for promoters which exhibit weak levels of expression (i.e. of a 
strength lower than the promoter driving CYC1, which is of average strength in the yeast 
transcriptome (153)).  For example, it is often the case that endogenous biosynthetic 
machinery competes with the pathway of interest for metabolite flux.  In these cases, it is 
often desirable to knock out the competing pathway.  However, if the competing pathway 
is essential to cell growth, its expression must be optimally downregulated so as to 
balance the needs of cell growth with productivity.  As a second example, graded 
expression of a dominant mutant has been shown to yield more detailed information 
regarding gene function than knockout alone (155).  In this application, weak promoters 
must be used to span the full range of dominant mutant expression.  A common strategy 
to develop weakened promoters is through random mutagenesis of a promoter template 
followed by screening to identify altered variants.  This strategy has been effective at 
creating an attenuated library of the strong TEF1 promoter in yeast (26,27).  Here we use 
random mutagenesis followed by screening in order to develop well-characterized 
variants of the CYC1 promoter (an average-strength promoter in yeast (153)) which 
exhibit very low levels of expression. 
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3.2 RESULTS 
3.2.1 Screening Methodology 
In order to identify pCYC1 variants of weak activity, pCYC1 mutant libraries 
were used to drive the expression of URA3p.  Mutants of low but nonzero activity could 
then be isolated through exposure to media containing sublethal amounts of 5-fluoro-
orotic acid (5-FOA) and low concentrations of uracil.  In this scheme, mutants which are 
too strong will result in cell lethality due to the presence of 5-FOA, while mutants which 
are not strong enough will also prevent cell growth by failing to compensate for the low 
levels of uracil.  To identify optimal 5-FOA/uracil ratios for maximal enrichment of 
promoters weaker than pCYC1, wild-type pCYC1, pNUP57 (40% activity relative to 
pCYC1), and pTFC1 (30% activity relative to pCYC1) promoters were separately used to 
drive URA3 expression and growth rates were measured at 30 different selective 
conditions (0-0.4 g/L 5-FOA and 0-5 mg/L uracil).  Those conditions which yielded the 
largest growth advantage of pNUP57 and pTFC1 were found to be 0.75 mg/L uracil and 
0.2 g/L 5-FOA (Table 3-1).  Therefore, pCYC1 mutant libraries were plated on media 
containing 0.3, 0.4, and 0.5 g/L 5-FOA and 0.75 mg/L uracil, and large colonies were 
picked to identify weaker variants of pCYC1.  In total, 30 colonies were picked and 
sequenced.  To reduce the possibility of false positives, those promoters which had 
mutated to form a start codon in the 5’UTR were discarded.  The remaining promoters 




TFC1 growth advantage    
(h-1) 
5-FOA (g/L) 
0 0.5 0.1 0.2 0.4 
Uracil (mg/L) 
0 -0.02726 0.013311 0.032763 0.037059 0 
0.25 -0.01602 0.020889 0.025389 0.027616 0 
0.5 -0.01546 0.01205 0.035186 0.03247 0 
0.75 -0.01254 0.014216 0.024039 0.039503 0 
1 -0.0045 0.025246 0.035632 0.028183 0.007384
5 0.008656 0.012585 0.031115 0.036332 0 
50 
 
NUP57 growth advantage 
(h-1) 
5-FOA (g/L) 
0 0.05 0.1 0.2 0.4
Uracil (mg/L) 
0 -0.0102 0.028138 0.03775 0.032935 0 
0.25 0.014061 0.027226 0.030414 0.017106 0 
0.5 -0.00746 0.024193 0.037623 0.002495 0 
0.75 0.003338 0.018786 0.030508 0.045039 0.00695 
1 -0.00358 0.034552 0.033212 0.028546 0 
5 0.008614 0.01098 0.02649 0.032768 0 
50         
Table 3-1: Growth advantage of weak promoters in 5-FOA/uracil screen 
pCYC1, pTFC1, and pNUP57 were used to drive the expression of URA3p in BY4741.  Yeast cells 
expressing each cassette were grown in varying concentrations of 5-FOA and uracil in order to determine 
the best conditions to use to select pCYC1 mutants of reduced strength. 
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3.2.2 Characterization of Isolated Mutants 
Promoter variants identified above were then used to drive the expression of 
yECitrine (a yeast codon-optimized yellow fluorescent protein) in a high copy vector.  As 
a control, a vector was also constructed which did not contain a promoter.  These 
constructs were then analyzed via flow cytometry (Figure 3-1).  Excitingly, the pCYC1 
variants spanned a wide range of gene expression, indicating that the URA3/5-FOA 
screen is well-suited for the identification of weak-expression constructs.  Interestingly, 
however, it was also observed that many of the constructs enabled a lower expression of 
YFP than a construct lacking a promoter.  This implied that in this context, these 
promoters acted more like terminators and enabled cell survival during screening by 
reducing the ability of upstream transcriptional noise to activate expression.   




























During this work, we were largely successful at developing promoter variants 
which enabled a wide range of expression in our screening construct.  This demonstrated 
that random mutagenesis followed by screening using 5-FOA and uracil is an efficient 
method to develop attenuated promoter variants.  However, it was observed that several 
promoters identified by this work would be better characterized as terminators, as 
illustrated by their ability to reduce the baseline level of gene expression enabled by the 
expression vector we were using.  Surprisingly, this baseline level of gene expression was 
rather high: 30% the strength of pCYC1.  This baseline expression was also significantly 
higher than yeast’s autofluorescence, implying that this limitation was not related to 
instrument sensitivity, but rather represented an innate level of noise and context 
dependence in biological systems.  One of several conclusions may be drawn from this 
result.  Firstly, if the level of background we observed with our expression vector is 
characteristic of that found in the genome, then many promoters for lowly-expressed 
genes may contain sequences which function as insulators in order to enable more precise 
levels of gene expression.  Alternatively, if the expression vector we used enabled an 
unusually high level of background expression, then it may not be suitable for the 
assembly and implementation of phenotypes dependent on very low levels of gene 
expression.  As a final possibility, if level of transcriptional noise inherent to the yeast 
genome varies by genomic location, then the regulatory machinery controlling lowly-
expressed genes may function in a context-dependent manner and may perform 
differently when implemented in a synthetic construct.  Taken together, these results 
emphasize the importance of context during the design of low-expression synthetic 
constructs and demonstrate the need for the development of synthetic insulators to ensure 
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Chapter 4: Tuning Translational Efficiency in the Context of 
Multicloning Sites 
4.1 INTRODUCTION 
Expression vectors with pre-defined multiple cloning sites (MCSs) are among the 
most common tools employed in molecular biology and genetics.  These vectors have 
enabled the facile expression and cloning of recombinant genes and have recently 
ushered in the era of synthetic biology (156).  The flexibility of restriction enzyme sites 
in MCSs facilitate easy cloning of genes of interest for diverse applications from genetic 
analysis to creation of biofuels-producing strains.  Common improvements to vectors 
containing MCSs are focused at controlling transcript levels (via promoter 
replacement/engineering (79), transcription machinery engineering (78), or copy number 
manipulations (157)) or translation rate (e.g. by improving codon bias (158) or by 
reducing expression noise (159)).  In all these applications, multiple cloning sites are 
thought to be benign, non-interacting elements that exist for mere convenience.  
However, a promoter element is usually placed upstream of the MCS.  As a result, 
several base pairs (or even multiple restriction sites) will appear in the 5’ untranslated 
region (5’UTR) of the mRNA of the cloned gene depending on the restriction site chosen.  
Thus, it is conceivable that the composition of these sites can significantly influence 
translation efficiencies of the downstream gene.  Here, we demonstrate the first 
performance-based assessment of multiple cloning sites and develop a novel theoretical 
framework enabling the prediction of a MCS’s effect on translation.  Furthermore, we 
apply this understanding to rationally redesign these sites for improved function and 
reduced variability associated with restriction enzyme choice.  We posit that this 
phenomenon of 5’UTR structure inhibition is most pronounced when using shorter, 
codon-optimized genes. 
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Secondary structure in the 5’UTR of messenger RNA has been found to affect 
expression in both prokaryotes (160,161) and eukaryotes (162-167) at the translational 
level.  In prokaryotes, translation is initiated by the assembly of the 70S initiation 
complex on the ribosome binding site (RBS), normally within a few base pairs of the start 
codon, and it is thought that RNA secondary structure can inhibit translation by occluding 
the RBS (160,168).  In fact, predictive models of RBS performance explicitly treat the 
inhibitory effect of 5’UTR secondary structure (160).  Due to the differences in 
translation initiation in prokaryotes, the design criteria of prior methods would be of little 
use in highly relevant eukaryotic systems such as S. cerevisiae.  Hence, a novel modeling 
approach resulting from a distinct theoretical framework is needed to address the issue of 
5'UTR secondary structure for yeast systems.  In eukaryotes, the 43S initiation complex 
must scan along the 5’UTR before commencing translation at the start codon, often 50 bp 
or more from the 5’ cap structure (168).  It has been hypothesized that the presence of 
secondary structure in these organisms decreases the rate of translation initiation by 
impeding ribosome scanning (165).  Multicloning sites impose distance (and therefore a 
high likelihood of structure) between a promoter and the gene of interest in a restriction 
site-dependent manner, leading to the hypothesis that cloning location affects protein 
expression, especially in eukaryotes.  In several cases, irreproducible or conflicting 
results have been explained by differences in restriction site usage (169,170).  However, 
most attempts at mitigating translation-inhibiting secondary structure in eukaryotes result 
in “quick fixes” such as point mutations which are only applicable for the precise gene 
construct under consideration (171-175).  Moreover, no prior work has successfully 
minimized secondary structure to optimize a genetic component of such widespread 
importance as the multicloning site or to develop a system which achieves nearly context-
independent levels of protein expression, both of which are of critical significance to 
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obtaining high titers of heterologous proteins in eukaryotes and to enabling precise 
control of genetic circuits.  Therefore, due to their enormous utility and widespread use 
for heterologous gene expression, the characterization and optimization of MCSs to 
minimize the effects of mRNA structure in a more general context represents a promising 
and novel avenue toward improving protein titers and controlling protein production.   
A variety of algorithms exist for the prediction of RNA secondary structure 
(34,176,177).  A common approach is to compute the free energy of the strand of interest 
through a partition function, using empirically-determined base-stacking energies to 
weight each possible conformation (178,179).  One limitation of this approach is that 
enumeration of all possible conformations becomes impractical for large strands, so 
certain classes of folds (e.g. pseudoknots) are commonly ignored, though are possibly 
significant.  It is important to note that a strand’s free energy of folding computed in this 
manner is not a simple function of its composition.  Since MCSs must additionally 
contain certain sequence motifs, any attempt to rationally design MCSs based on 
minimized free energy is prohibitively difficult, necessitating the use of a metaheuristic 
such as a genetic or hill-climbing algorithm.  This difficulty is exacerbated by the 
requirement that designed MCSs refrain from folding regardless of where the gene of 
interest is inserted, highlighting the potential rarity of desirable MCSs. 
In this study, we establish the variations in downstream protein translation 
imparted by multicloning sites and isolate the effect of secondary structure-based 
inhibition especially in cases of short, codon-optimized genes.  This effect is 
demonstrated using the MCS of a common yeast vector system (180,181).  Due to the 
unacceptably large variance found along the cloning site, a predictive model was 
developed to redesign multiple cloning sites with minimized secondary structure and thus 
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improved mRNA translation.  These models led to promoter-specific, re-designed 
multiple cloning sites that outperform standard constructs. 
4.2 RESULTS 
4.2.1 Performance-based Assessment of the pBLUESCRIPT SK multiple cloning 
site in yeast 
 To gain a quantitative performance assessment of a commonly used multiple-
cloning site in yeast, we inserted an optimized YFP fluorescent protein, yECitrine (182), 
after each restriction site in the p416 vector (181).  This base vector is derived from the 
commonly used pRS yeast shuttle vector (180) and contains the popular pBLUESCRIPT 
SK MCS.  Three common, distinct yeast promoters were chosen to drive expression of 
these cassettes.  Protein output (as measured by fluorescence of YFP) changes 
significantly and exhibits drastic decreases as a function of position along the MCS 
(Figure 4-1).  These results demonstrate that the choice of restriction site is not benign 
and can significantly influence performance.  Moreover, this phenomenon is not strictly 
controlled by spacing/length as the relative fluorescence at each site depends strongly on 
the promoter being used to drive transcription.  Additionally, it is clear that there exist 
promoter-specific effects beyond what would be expected from strength differences.  
Indeed, if the fluorescence trend was simply scaled by promoter strength, the graphs 
shown in Figure 4-1 would be identical.  It is also worthy of note that the fluorescence 
trends are not monotonically decreasing, implying that any predictor function of MCS 
performance must not vary monotonically with the length of mRNA between the end of 
the promoter and the start codon.  To determine whether decreased efficiency across the 
multicloning site was due to translation or transcription limitations, yECitrine transcript 
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using an expanded data set consisting of the TEFpmut5 promoter (79,184) and various 
intervening sequences (Appendix Table A3-1).  This dataset represented the first 
instance in which we observed this translational inhibition, inspiring a more complete 
characterization of this effect in the wild-type, canonical TEF1, GPD1, and CYC1 
promoters in subsequent experiments.  TEFpmut5 is almost identical to pTEF1, 
containing 8 point mutations and retaining 95% of TEF’s promoter activity, indicating 
that the two promoters are comparable.  Relative fluorescence was plotted against length 
and GC content for these TEFpmut5 constructs (Figure 4-3A,B), and no clear 
relationship was observed in either variable.   However, upon plotting the computed 
thermodynamic folding energy of the 5’UTR (a more direct predictor of secondary 
structure) against yECitrine expression (Figure 4-3C), a clear monotonic downward 
trend was observed, consistent with earlier reports that significant 5’UTR secondary 
structure can inhibit gene expression (164-166).  Since RNA transcription begins in the 3’ 
end of the promoter, different promoters will yield different base pair compositions (and 
hence differing secondary structure) in the 5’UTR.  This result partially explains the 
promoter-specific impact of MCS found in Figure 4-1.  Therefore, it was hypothesized 
that restriction site-dependent inhibition in the pBLUESCRIPT SK multicloning site was 
best explained by the thermodynamic free energy of folding of the 5’UTR. 
 Figure 4-3: Prospective Correlates of Ex
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yECitrine was inserted at each restriction site as for the pBLUESCRIPT SK MCS, and 
the results are shown in Figure 4-5.  Despite the crudeness of this original model for 
MCS performance, both TEF1 and CYC11 showed improved desirable performance.   
 The redesigned MCS TEF1, using the TEF1 promoter, is remarkable in that it 
maintains a narrow range of reporter expression between the 2nd and 9th restriction sites.  
In this region, the expression from pTEF1xYFP ranges between 0.69 and 0.42, whereas 
the expression from pBLUESCRIPT SK ranges between 1.03 and 0.26 in the same 
region.  This property makes TEF1 more appropriate for applications in which 
consistency in expression across varying sites within the MCS is desired.   
 The redesigned MCS CYC11, using the CYC1 promoter, yields yECitrine 
expression equal to or greater than the pBLUESCRIPT SK for all but one of the available 
restriction sites, making this multicloning site desirable.  Furthermore, the 2nd, 5th, and 6th 
sites attain the same level of expression as 1st, allowing more cloning possibilities without 
decreasing effective promoter strength.  It is interesting to note that increases in 
expression can be attained by adding nucleotides to the 5’UTR (exemplified by 
pCYC115YFP and pCYC116YFP), illustrating that MCS inhibition is not simply due to 
length.  This observation also required a different model for inhibition, as free energy of 
folding of the 5’UTR always decreases as more base pairs are added to the MCS.  The 
assumption that the entire 5’UTR produces translation-inhibiting secondary structure was 
therefore incorrect, and so the model was reevaluated to create better multiple cloning 
sites for each of the three promoters. 
 Figure 4-5: Performance of designed mu
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Two MCSs were designed to minimize the ensemble free energy of the 5’UTR when placed after TEF or 
CYC1, respectively.  Data in (A) has been scaled to the fluorescence of pTEF01YFP and in (B) to 
pCYC111YFP.  Position on the MCS has been measured according to the unique restriction sites in the 
p416 vector.  Error bars represent the standard deviation in fluorescence observed across biological 
triplicates. 
4.2.5 Re-engineering Multicloning Sites for Function and Convenience 
 Given the substantial effect MCSs can have on protein production, we sought to 
redesign these elements by mitigating secondary structure inhibition.  An initial, crude 
model based on complete minimization of secondary structure across the entire 5’UTR 
enabled the design of improved MCSs: TEF1 and CYC11.  However, this model is 
fundamentally limited as it suggested that protein output always decreased as a function 
of length across the 5’UTR.  Counterexamples to this feature were found in our dataset.  
Due to this shortcoming, GPD1 was not constructed and a more accurate model 
framework was developed to redesign multicloning sites for all promoters. 
 To address the observation that adding specific sets of nucleotides between the 
promoter and the start codon can yield increases in translational efficiency, a new model 
framework was developed incorporating two (or more) regions whose free energy of 
folding correlates with protein production (Figure 4-6).  Such a model is grounded in the 
fundamental biology of the process.  Successful initiation requires the presence of eIF4a, 
an ATP-dependent helicase which unwinds mRNA in preparation for ribosome loading.  
In addition, scanning through a structured 5’UTR requires ATP, though the enzyme 
responsible is unknown (168).  Thus, the initiation complex can be modeled as a particle 
passing through several states (Figure 4-6), each separated by a free energy of folding, 
before reaching the start codon (See Materials and Methods). The models which best 
explained the available data (CYCModel1, TEFModel1, and GPDModel1) are shown in 
Table 4-2.  It is important to note that in no model was the presence of mRNA structure 
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mRNA structure is also major limiting factor in this promoter (Figure 4-8B), albeit not as 
limiting as in the GPD promoter case. 
 Applying this approach for a yet weaker promoter (pCYC1), a new MCS, CYC12, 
was designed that provides better, more consistent performance across the first four 
restriction sites than CYC11 or pBLUESCRIPT SK (Figure 4-7C).  However, CYC11 
(Figure 4-5) provides better performance than CYC12 or pBLUESCRIPT SK when 
cloning after the fourth restriction site.  The measured performance of CYC12 was well 
predicted by CYC1Model1, validating its predictive ability (Figure 4-8C). 






esigned Multicloning Sites (A) GPD2, (B) TEF2, 
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Prospective MCSs were designed according to the procedures described in Materials and Methods.  
Observed values for the expression levels allowed by each designed multicloning site are plotted as in 
Figure 4-7.  Position on the MCS has been measured according to the unique restriction sites in the p416 
vector.  Error bars represent the standard deviation in fluorescence observed across three biological 
replicates.  Designed multicloning sites show good agreement with model predictions.   
 Taken together, these results indicate that the expression-inhibiting effects of 
multicloning sites can be substantially mitigated in a variety of transcriptional contexts 
through minimization of 5’UTR secondary structure.  In addition, no designed MCS 
elicited a significant change in gene expression noise, indicating that these constructs are 
ideal for development of precisely controlled gene networks (Figure 4-9).  However, it 
should be noted that neither TEF2 nor CYC12 matched the outstanding performance of 
GPD2, either due to random errors in the modeling process or due to the manifestation of 
other rate-limiting steps in expression not accounted for in our simplistic structure-based 
model of expression.  As pTEF and pCYC1 are both substantially weaker promoters than 
pGPD, the presence of additional rate-limiting factors (possibly stemming at the 
transcriptional level) is not surprising.  Finally, all data collected above was used to 
upgrade the weighting factors and relevant 5’UTR regions in our models (Table 4-2).  
These upgraded models are expected to give researchers more accurate predictions of 
5’UTR structure-based inhibition of protein expression in yeast. 
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Expression noise is seen to be largely invariant with respect to restriction site and MCS.  pCYC119YFP and 
pTEF29YFP had fluorescence near the detection limits of our flow cytometer, leading to the decreased 
coefficients of variants seen in these constructs. 
4.3 DISCUSSION  
We have demonstrated that simplistic models of 5’UTR RNA secondary structure 
can be used to predict and rationally design multicloning site performance.  The approach 
defined here is novel and significant for several reasons: (1) most modeling and 
prediction efforts in this area have examined prokaryotic systems (esp. for ribosome 
binding sites) whereas this work utilizes yeast, a eukaryotic system.  The mechanics of 
eukaryotic translation are sufficiently different and require a novel mechanistic approach.  
(2) Most prior studies evaluate the impact of 5' hairpin loops and their inhibitory effect on 
translation, especially when sequestering the start AUG.  In contrast, our work 
demonstrates that the observed translation inhibition by structure was highly dependent 
on the position of the secondary structure, and not always a set distance from the 
transcription initiation site.  (3) Most prior studies evaluate the impact of specific point 
mutations that can change secondary structure.  No prior work has successfully predicted 
and achieved a global redesign of a genetic circuit of such widespread importance as a 
multicloning site.      
 In contrast to prior studies, this method of prediction and optimization of 5’UTR 
structure is valid in a general context, enabling significant increases in expression despite 
the implementation of a diverse set of promoters and restriction sites.  This aspect of 
translation-level control seems to be most strongly pronounced when expressing short, 
codon-optimized gene products.  Moreover, this effect exhibits a promoter-specific nature 
implying that individual components of gene expression cassettes cannot be designed in 
isolation.  It is also important to note that this phenomenon is not a generic effect of 
5’UTR length, as indicated by (1) the significant increases in expression observed upon 
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adding length to the 5’UTR, and (2) the inability of one-part folding models to predict the 
behavior of TEF1 and CYC11.  Although this effect was first experimentally 
characterized here for pBLUESCRIPT SK, it is expected that other MCSs will behave 
similarly in yeast and perhaps other eukaryotes.  In particular, 5’UTR based folding 
models predict that significant secondary structure issues can arise in other common 
MCSs such as the one present in pUC.  As a result, it is important to understand and 
appreciate this impact especially when attempting to compare experiments or genes 
cloned into distinct sites. 
 Optimization of 5'UTR secondary structure therefore represents a facile and cost-
effective way to increase protein expression and product titers in eukaryotic bioprocesses, 
especially when it is undesirable to change promoters.  Designed MCSs were found to be 
superior to the multicloning site found in the commonly used pBLUESCRIPT SK 
plasmids, and in the case of GPD2 showed negligible activity reduction along the MCS.  
This experiment shows not only that MCSs have a significant effect on translation, but 
also that MCSs can be rationally engineered to mitigate this effect.  Such a model-based 
optimization approach is unprecedented for this ubiquitous genetic component and 
highlights the importance of rational design in synthetic biology.  It is expected that a 
similar approach can be undertaken for other eukaryotic expression vectors.  Control of 
5'UTR secondary structure also represents an alternative to promoter engineering, 
allowing protein expression to be controllably weakened by up to an order of magnitude 
without altering the dynamics of its regulation. 
 As we have demonstrated, optimization of 5'UTR secondary structure is context-
specific, making the performance of each multicloning site highly dependent on the 
upstream promoter.  It is not unreasonable to expect that the nucleotides of the open 
reading frame could also participate in translation-inhibiting secondary structure.  
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Therefore, in cases where inhibition due to secondary structure is significant (i.e. in 
highly codon optimized genes), the assumption of interchangeability of promoter, MCS, 
and gene becomes highly questionable.  These results go against several of the tenets of 
synthetic biology, especially with respect to the assumption of completely 
interchangeable, non-interacting parts, and are part of a growing body of work indicating 
the non-modularity of genetic components (188).  Yet, as the cost of gene synthesis 
decreases, these results demonstrate that it is more desirable to create entire self-sustained 
transcriptional/translational units—from promoter to terminator.  This paradigm is in 
contrast to the widespread assumption that two arbitrary sequences, when attached, will 
not generate translation-inhibiting secondary structure. 
 These results have significant implications beyond redesign of gene expression 
cassettes.  Expression vectors with multiple cloning sites have seen widespread use 
across the field of functional genetics and basic cloning.  Given the strong difference in 
performance across sites in the MCS, experiments and conclusions will be highly 
dependent on these sites.  Therefore, conclusions about gene impact, function, or activity 
as well as promoter strength analysis will depend highly on the cloning sites used.  As a 
result, many conflicting results and conclusions may be attributed to this phenomenon.  
More broadly, this research shows that the secondary structure inherent to the 5’UTR has 
significant impacts upon the efficiency of translation initiation.  Any mRNA, whether it 
has been derived from a natural system or designed synthetically, will contain a 5’UTR 
with this regulatory potential.  Therefore, it is imperative for metabolic engineers to 
design synthetic constructs with this initiation efficiency in mind, especially because this 
will be the rate-limiting step for the production of codon-optimized genes which are 
otherwise translationally optimal.   
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 In conclusion, we have demonstrated the first performance-based analysis of 
multiple cloning sites in yeast systems.  Following this, we have shown that a simplistic 
model of 5’UTR secondary structure with two regions can predict this phenomenon when 
it is the most dominant determinant of protein translation.  Under these conditions, we 
have for the first time successfully redesigned multiple cloning sites for function rather 
than simple convenience.  It is anticipated that this work can be extended to other vectors 
and potentially to other organisms, both eukaryotic and prokaryotic alike.  The capacity 
to design MCSs with consistent performance across multiple cloning sites will greatly 
impact the ease and utility of recombinant cloning and genetic analysis. 
  
 67
Chapter 5: Development of Operons in Yeast through 2A Peptides 
5.1 INTRODUCTION 
For metabolic engineering or synthetic biology applications, it is often desired to 
co-regulate the expression of several gene products such that the pathway or circuit of 
interest functions in a coordinated and efficient manner.  Although the number of well-
characterized promoters is growing rapidly for many organisms, there remains a lack of 
non-homologous promoters which enable co-regulation (i.e. perform the same regulatory 
function).  Therefore, co-regulation necessarily introduces instability to yeast vectors, as 
regions of high sequence homology are a prime target for recombination-induced 
excision.  However, even if a collection of non-homologous co-regulatory DNA parts 
existed, the structure of yeast expression cassettes poses a challenge.  In particular, the 
extra DNA space needed to encode separate promoters and terminators for each gene 
poses a significant synthesis cost (sometimes as much as 50% of the total cost of the 
construct) to metabolic engineers.  Although translational fusions can overcome these 
issues for applications in which co-localization of pathway enzymes is appropriate (189), 
there remains a need for a general strategy for co-regulation of gene products in yeast 
which is not susceptible to homologous recombination-induced construct instability.   
In prokaryotes, co-regulation can be achieved in a facile manner through the use 
of operons, in which a single promoter controls the transcription of multiple genes.  
Translation rates of each gene are controlled by the strength of the ribosome binding site 
which precedes each open reading frame.  Although the rules regarding ribosome binding 
and translation are distinct in eukaryotic systems, this organizational paradigm provides 
an attractive alternative to yeast expression cassettes in their current implementation.   
In order to enable to facile co-regulation of multiple genes in yeast, we 
endeavored to characterize the activity of known 2A sites in yeast and implement them 
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for the facile expression of multigene pathways.  This capability would enable significant 
cost savings in terms of DNA synthesis and assembly (2A sites are only ~60bp whereas 
promoters and terminators in yeast often measure 400bp and 200bp, respectively) as well 
as reduce the likelihood of homologous-recombination associated instability.  Finally, the 
implementation of 2A sites in yeast would enable facile co-regulation of multiple genes.  
Although a publication demonstrating the utility of 2A sites as engineering tools was 
released as this research was being undertaken (190), we endeavored to complete this 
research in order to lay the foundation for future work developing a more highly optimal 
2A site system. 
5.2 RESULTS 
5.2.1 Characterization of a Panel of 2A Sites 
Although many viruses have been shown to contain 2A sites, sites from three 
viruses are most commonly used in studies characterizing function and demonstrating 
efficacy: equine rhinitis A virus, porcine teschovirus-1, and Thoseaasigna virus (42).  
Codon-optimized versions (191) of these 2A sites (E2A, P2A, and T2A) were cloned into 
a bicistronic reporter construct to test 2A site function, in which mStrawberry comprised 
the first cistron and YFP comprised the second.  In this method, a functional 2A site 
would enable a high level of mStrawberry and YFP production in the presence of 
galactose, but not in the presence of glucose.  We also included a his-tag to the c-
terminus of YFP to facilitate characterization by western blotting.  To identify putatively 
functional 2A sites, cells expressing bicistronic cassettes containing either 2A site were 
analyzed with flow cytometry (Figure 5-1).  It can be seen that, unlike the other sites, 
T2A is nonfunctional in this context, exhibiting background levels of expression of the 
second cistron upon galactose induction, and reduced expression of the first cistron.  
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Protein extracts from cells expressing the remaining 2A sites (E2A and P2A) were then 
analyzed through western blotting (Figure 5-2).  It can be seen that while the cleaved 
product is visible in the case of P2A, no cleavage can be seen in the case of E2A.  This 
indicates that while E2A enables translation of the entire bicistronic construct, it does not 
enable separation of the two gene products.  However, cleavage enabled by P2A appears 
to be quite efficient, with minimal production of the uncleaved product.  Interestingly, 
these results stand in direct contradiction to work indicating that T2A was functional and 
that P2A was nonfunctional in a related strain of yeast (190).  Nevertheless, this data 
confirms that the P2A site is functional in BY4741, thus opening the door to the use of 
operon architecture for the construction of pathways in this system.   Furthermore, it is 
exciting to note that through the use of a 2A site, inducible co-expression of two genes 
was enabled in a facile manner, which until this point required the expression of 
riboswitches (38).   
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in a related strain of S. cerevisiae (CEN.PK2) and T2A, rather, to be functional.  The 
ability to use 2A sites in yeast is very exciting, not only enabling significant cost savings 
in terms of DNA synthesis, but also reducing the likelihood of homologous 
recombination-associated construct instability.  Furthermore, this site also enables facile 
co-regulation of gene products, which has not heretofore been easily achieved for yeast.  
It is also interesting to note that generation of alternative 2A sites through re-coding was 
not completely successful – use of a P2A with alternative codons completely abolished 
polypeptide cleavage.  This indicates that peptide sequence, although important, may not 
be the only factor influencing 2A site functionality.  In addition, translation rate or tRNA 
structure may also have an effect.  This finding may shed light on our observation that 
P2A was functional in yeast while T2A was not, contradicting the results of an earlier 
study.  In fact, the 2A sites in other studies used an alternative coding for P2A and T2A.  
This apparent contradiction emphasizes the importance of elucidating the precise 
requirements for 2A site functionality and efficiency.  Once these rules have been 
identified, it will be feasible to use 2A sites as a generic tool for the facile construction 
and regulation of multi-gene pathways in yeast. 
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Chapter 6: Tuning Translation through Internal Ribosome Entry in 
Yeast 
6.1 INTRODUCTION 
As an alternate method to enable polycistronic gene expression in eukaryotes, 
viruses have developed unique RNA structures which enable internal ribosome entry.  In 
this work, we have attempted to use a combination of random and site-directed mutagenic 
approaches to develop efficient IRESs in yeast.  In the process, we have characterized 
most IRESs previously reported to function in this organism as well as attempted to 
identify translational machinery which may be inhibitory towards the functionality of 
IRESs in this organism.  Despite our best efforts, this approach was unsuccessful at 
identifying a definitively improved IRES, as detailed below. 
6.2 RESULTS 
6.2.1 Initial IRES Library 
Our first attempt at developing an IRES in yeast focused on random mutagenesis 
of the EMCV IRES (193).  In addition, randomized 50-nucleotide DNA segments were 
screened for IRES activity, following an earlier report claiming that such templates 
contained functional yeast IRESs (194).  In order to detect IRES activity, we used a 
bicistronic reporter cassette consisting of the GPD promoter driving the expression of 
HIS3 in the first cistron and YFP in the second cistron.  These two open reading frames 
were separated by a library of IRES candidates and screened for high YFP expression 
using flow cytometry.  Four libraries were constructed with varying levels of 
mutagenesis: High, Medium and Low, and Very Low.  The library sizes obtained for this 
experiment were as follows: High: 124k, Medium: 124k, Low: 160k, Very Low: 166k, 
50N: 11k.  After screening through fluorescence activated cell sorting, several variants 
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were isolated which enabled higher YFP expression than EMCV (Figure 6-1).  These 
variants were sequenced and the unique variants were re-transformed into yeast and 
characterized (Figure 6-2).  Unfortunately, no re-characterized variants displayed 
increased activity compared with EMCV.  It was hypothesized that the inability to isolate 
functional variants was due to insufficient library size, so yeast homologous 
recombination was used to expedite the library construction process in the next library. 
Figure 6-1: EMCV and 50N Isolates obtained from IRES Library 3. 
Units of YFP fluorescence for this and all following figures have been arbitrarily defined by the flow 
cytometer upon which the measurements were taken.  In most cases, yeast autofluorescence has a value 



























Figure 6-2: Re-characterization of EMCV isolates obtained from IRES Library 3. 
6.2.2 IRES Screening on a High Copy Vector 
EMCV was subjected to random mutagenesis and screening as before, with the 
exception that variant libraries were generated in a high copy number vector.  Four 
libraries were constructed with varying levels of mutagenesis: High, Medium and Low, 
and Very Low.  In addition, a library containing a randomized 50bp sequence was 
constructed in the same vector.  The library sizes obtained for this experiment were as 
follows: High: 406k, Medium: 389k, Low: 372k, Very Low: 321k, 50N: 53k.  After 
screening, several variants were isolated which enabled higher YFP expression than 
EMCV (Figure 6-3).  These variants were then sequenced and the unique variants were 
re-transformed into yeast and characterized (Figure 6-4).  We were pleased to observe 
that many IRESs maintained significantly higher YFP expression than wild-type.  
Therefore, we replaced the GPD promoter in these constructs with a terminator in order 
to test promoter activity of these putative IRESs.  Of these, four (50NB4, 50NB8, 




























promoter activity to wild-type EMCV (Figure 6-5).  This was very exciting, as these 
variants were the best-performing candidates identified to date.  
Figure 6-3: EMCV and 50N Isolates obtained from IRES Library 5 
























































































































































































































































Figure 6-5: Characterization of promoter activity enabled by IRES Library 5 isolates 
It was at this time that we noticed a shortcoming with our screening vector.  We 
observed that the HIS3 gene which was placed upstream of YFP had substantial promoter 
activity.  This phenomenon could be due to the fact that HIS3 is located only 300bp 
upstream of DED1 in the yeast genome and thus may contain sequences necessary for the 
transcriptional regulation of that gene.  Nevertheless, we assayed the promoter activity of 
a panel of fluorescent proteins in order to identify a substitute (Figure 6-6).  mStrawberry 
was chosen to replace HIS3 in our screening cassette, as it exhibits minimal promoter 
activity and negligible homology to YFP.  We then constructed two variants of this 
vector: one with GPD replaced by a terminator and one with a stemloop placed after GPD 
(Figure 6-7).  These three screening vectors would enable us to test each candidate’s 
promoter activity as well as their propensity to form translational fusions in a consistent 




















































































































































With this updated set screening vector, we wished to confirm the IRES 
functionality of the candidates mentioned above.  In addition, we assayed a panel of 
IRESs from the dicistroviridae family (PSIV, HIPV, and CrPV) recently shown to have 
some activity in yeast (53) (Figure 6-8).  Unfortunately, it was observed that of the four 
IRES candidates isolated above, the activity shown by 50NB4, 50NB8, 50ND3 and 
50ND7 was due to substantial promoter activity.  The promoter activity of these 
contstricts was not identified using the previous screening construct because of 
interference from the high promoter activity of HIS3.  This data also showed that EMCV 
contained substantial promoter activity, whereas the dicistroviridae IRESs contained 
almost undetectable amounts of promoter activity, with slight levels of IRES 
functionality.  It is important to note that becase the dicistroviridae IRESs enable 
translation in an AUG-independent manner, the start codon of YFP was removed for 
these constructs in order to reduce promoter-derived YFP expression (50).  We also 
undertook a characterization of many other reported IRESs using this screening system.  
It has been reported that the 5’ untranslated regions of YAP1 and p150 contain IRESs 
which function in yeast (195).  Therefore, we tested these putative cellular IRESs along 
with several viral IRESs (whitespot syndrome baculovirus IRES (SWSS) (196), turnip 
vein clearing virus IRES (crTMV) (197), and the IRES from the gypsy transposon 
(gypsy)  (198)) (Figure 6-9).  Through this analysis, it was concluded that the YAP1 
IRES functioned as a strong promoter, the p150 IRES contained negligible IRES activity, 
SWSS enabled a small amount of IRES activity, and both crTMV and gypsy functioned 
as strong promoters as well. Taken together, these results indicated that the more 
promising starting points for future development of IRES functionality may be the three 
dicistroviridae IRESs characterized here as well as SWSS. 
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Figure 6-8: Characterization of Dicistroviridae, EMCV, and isolated IRESs using 
































Figure 6-9: Characterization of alternative IRESs using updated screening system 
6.2.3 Engineering Dicistroviridae IRESs 
HIPV, PSIV, CrPV, and SWSS were subjected to random mutagenesis and 
screening in the new screening vectors.  Three libraries were constructed for each 
template with varying levels of mutagenesis: High, Medium and Low.  In addition, a 
library containing a randomized 50bp sequence was constructed and tested in parallel.  

























































Medium: 113k, CrPV High: 187k, HIPV Low: 102k, HIPV Medium: 69k, HIPV High: 
72k, PSIV Low: 238k, PSIV Medium: 83k, PSIV High: 77k, SWSS Low: 15k, SWSS 
Medium: 25k, SWSS High: 38k, 50N: 2.7k.  After screening, several variants were 
isolated which enabled higher YFP expression than their respective wild-type (Figure 6-
10).  These variants were then sequenced and cloned into the terminator-containing or the 
stemloop containing screening vectors for re-analysis (Figure 6-11).  We observed two 
promising mutants (HM3 and SM7, derived from HiPV and SWSS, respectively) which 
enabled a higher level of YFP expression while exhibiting minimal promoter activity.  
However, this increase in YFP expression came at the expense of a slight decrease in 
mStrawberry expression.  The cause of this decrease is unknown and it is unclear whether 
it is indicative of a false positive result.    Although these results were promising, the high 
level of effort required to clone each IRES candidate into several screening vectors for re-
characterization highlighted the need for a scheme for negative selection during screening 
to eliminate false positives due to promoter activity. 
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Figure 6-11: Re-characterization of isolates obtained from IRES library 6 
6.2.4 IRES Screening with Inducible Promoter 
In order to reduce the incidence of false positives, we replaced the GPD promoter 
of our screening vectors with the inducible GAL1 promoter.  In this way, IRESs could be 































































low YFP expression upon growth in glucose.  Several rounds of positive and negative 
selection may then be easily undertaken to enrich for sequences which enable high YFP 
expression in the absence of promoter activity.  HIPV, PSIV, CrPV, SWSS, HM3, and 
SM7 were subjected to random mutagenesis and screening in the new screening vector.  
Three libraries were constructed for each template with varying levels of mutagenesis: 
High, Medium and Low.  After screening, several variants were isolated which enabled 
higher YFP expression than their respective wild-type with low promoter activity (Figure 
6-12).  These variants were then retransformed into yeast to confirm activity (Figure 6-
13).  Unfortunately, it was observed all of the hits either exhibited negligible IRES 
activity or slightly increased promoter activity.  After this disappointing result and in 
light of previous failed attempts to generate an IRES, we hypothesized that random 
mutagenesis may be a suboptimal strategy for identifying improved IRESs as IRES 
functionality is thought to result from the effect of RNA secondary structure, and random 
mutagenesis may have a high propensity to disrupt this structure.  Therefore, we 
investigated alternative mutagenesis strategies in later work. 




















































































Figure 6-13: Re-characterization of isolates obtained from IRES Library 7 
In addition, we characterized the activity of several additional putative IRESs 
using this screening system.  It has been proposed that the URE2 5’UTR contains an 
internal ribosome entry site, and therefore we wished to confirm this finding (199) 
(Figure 6-14).  We were also approached by the Jewett laboratory to confirm the in vivo 
efficacy of some yeast IRESs identified through an in vitro approach.  Therefore, we 
cloned these sequences into our galactose screening vector and IRES activity was 
measured for these sequences (Figure 6-15).  It can be seen that URE2 appears to have 
slight IRES activity, while most of the IRESs from the Jewett lab function mainly as 
promoters, thus precluding attempts to characterize IRES activity.  However, one variant, 
G38 appears to activate upon exposure to galactose, indicating either that this variant is a 
promising starting point for further development of IRES activity or that it is a galactose-
responsive promoter.  However, the fact that this construct enables a high amount of YFP 
expression in the presence of glucose indicates a high level of background promoter 
















































































Figure 6-14: Characterization of the URE2 5’UTR using galactose screening vector 
Figure 6-15: Characterization of IRES candidates from the Jewett lab using the galactose 
screening vector 
6.2.5 Site-Directed Mutagenesis of IRESs 
HIPV, PSIV and CrPV were subjected to site-directed mutagenesis as each of 























































was predicted to be unhybridized at equilibrium was annotated and targeted for 
randomization.  However, because of the large sequence space possible by randomizing 
each region in the context of each other, these regions were clustered into 5 groups of 
approximately equal number of randomized base pairs, thus forming 5 separate site-
directed libraries for each template (Figure 6-16).  The library sizes obtained for this 
experiment were as follows: CrPV #1: 480k, CrPV #2: 1056k, CrPV #3: 804k, CrPV #4: 
888k, CrPV #5: 441k, HIPV #1: 639k, HIPV #2: 393k, HIVP #3: 462k, HIPV #4: 765k, 
HIPV #5: 396k, PSIV #1: 357k, PSIV #2: 384k, PSIV #3: 312k, PSIV #4: 261k, PSIV 
#5: 444k).  After screening, several variants were isolated which enabled higher YFP 
expression than their respective wild-type (Figure 6-17).  These variants were then 
sequenced, and it was found that all hits contained sequences which enabled translational 
fusions.   This disappointing result spurred us to look at the problem of IRES 






























































































































EIF2Ap to bind met-tRNA and the 40S ribosome during the process of intiation complex 
formation.  In the absence of this protein, eukaryotic initiation factor 2 (EIF2p) takes over 
and binds met-tRNA and the 40S ribosome in a GTP-dependent manner (201).  
Therefore, it is thought that by knocking out EIF2A, competitive inhibition of this protein 
during the translation of non-AUG transcripts (such as those containing an IRES) may be 
removed.  In light of this hypothesis, we decided to investigate the effect of this knockout 
on the activity of the dicistroviridae IRESs.  We did indeed observe a significant increase 
in YFP expression enabled by IRESs expressed in the ∆EIF2A background.  Encouraged 
by this result, we endeavored to identify other components of the yeast translational 
machinery which may interfere with IRES activity.  Therefore, we tested IRES 
functionality in knockouts of yeast translation machinery-related proteins which were 
available in the yeast knockout database.  In addition, we investigated the effect of 
overexpression of each subunit of EIF2 (SUI2, SUI3, and GCD1) in order to enhance the 
rate of AUG-independent protein synthesis (Figure 6-18).  We observed several strain 
backgrounds which enabled significantly higher YFP expression than our wild-type 
strain, with one knockout (RMD9) enabling up to 9-fold increases in YFP expression.  
However, for each strain, we also observed that increases to YFP came concurrently with 
increases to mStrawberry expression, indicating that these knockouts did not increase 
IRES activity specifically, but rather the amount of total expressed protein present in each 
cell (Figure 6-19).  Indeed, several of the high-performing knockouts (rmd9 and arc1) 
have been annotated to result in slow cell growth, indicating that improvements observed 
to YFP expression may simply be the result of increased protein accumulation due to a 
reduced cell dilution rate. In addition, the EIF2 overexpression constructs and blank 
plasmid controls exhibited uniformly increased YFP and mStrawberry expression, 
consistent with the reduced growth observed during maintenance of extra plasmids.  
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Taken together, these results indicate that EIF2A knockout (and other knockouts to 
yeast’s translational machinery) may serve to simply arrest cell growth and prevent 
protein dilution rather than increasing IRES expression specifically.  It is interesting to 
note that none of the studies claiming that EIF2A knockout increases IRES activity 
performed an appropriate control to measure the changes to the expression of a non-
IRES-mediated transcript (199,200).  However, the increase to protein expression on a 
per-cell basis conferred by these knockouts may serve to increase the sensitivity of a 
screen for variants of slightly improved IRES activity.   





















































































































Figure 6-19: Correlation between mStrawberry and YFP expression during growth on 

























































































During this study, extensive optimization of a sensitive screen to detect IRES 
activity was undertaken with the aim of minimizing the occurrence of false positives.  
Unfortunately, it became readily apparent that bicistronic reporter constructs are prone to 
the detection of false positives resulting from promoter activity or translational fusions.  
Even the use of an inducible promoter to enable facile positive and negative screening is 
prone to the development of inducible promoter activity in the IRES.  Therefore, a novel 
methodology for the high-throughput detection of IRES activity is needed which is not 
prone to these failure modes.  This work also emphasized the difficulty in the use of 
IRESs in multiple contexts, as many of the IRESs which have been previously reported to 
be functional did not show detectable activity in the screening system implemented here.  
For IRESs to be generally applicable as a methodology for polycistronic gene expression, 
they must be able to function in a variety of contexts.  Interestingly, it has been shown 
that the efficiency with which an IRES can enable the translation of a downstream open 
reading frame is dependent upon the particular gene being expressed (202,203).  It is 
reasonable that IRES functionality would be highly dependent upon context, since 
activity is thought to be a secondary structure-based effect.  Therefore, any IRESs 
developed for use in a biotechnological context must be designed to be extremely robust 
to the disruptive effects of a wide variety of sequence contexts.  Finally, this work 
characterized the effects of several gene deletions or overexpressions on IRES activity, 
and no modification to yeast’s translational machinery was shown to improve IRES 
efficiency in a specific manner.  Collectively, this work emphasizes that more work is 
needed to confirm the presence of IRESs in yeast and may inform future efforts directed 
at improving the functionality of IRES elements in yeast and other organisms.   
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Chapter 7: Rapid Evolution of Parts and Pathways through an in vivo 
Continuous Evolution Approach 
7.1 INTRODUCTION 
For classical in vitro directed evolution studies, the main bottleneck to realizing 
high library sizes (and thus high success rates of an evolutionary approach) is the 
transformation efficiency of the host of interest, which for yeast typically falls around 106 
per microgram of DNA.  This limits sequence coverage, especially for long sequences 
containing multiple genes.  In addition, iterating multiple rounds of directed evolution is 
a laborious process, requiring several hands-on DNA manipulation steps.  Although there 
have been systems developed which enable the continuous generation of sequence 
diversity in prokaryotes, these systems are limited to the development of transcriptional 
activators and require continuous flow bioreactors to generate and maintain selective 
pressure.  Hence, there is a strong need for a technique to generate diversity which would 
allow the facile construction and screening of large libraries of arbitrary sequences in in 
vivo without the requirement for specialized and expensive equipment. 
Retrotransposons are mobile genetic elements found in nearly all eukaryotic 
genomes (204).  These sequences have high homology to viral genomes and replicate 
through a similar mechanism.  There are five classes of retrotransposons in yeast, of 
which Ty1 is the most well-studied (205).  Ty1 encodes proteins responsible for assembly 
of virus-like particles (VLPs), noninfectious virus-sized elements in which 
retrotransposon mRNA is converted to cDNA through an encoded reverse transcriptase.  
This cDNA can be integrated into the genome through either an element-encoded 
integrase or via homologous recombination (Figure 7-1).  To overcome the limitations of 
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This promoter replaces the native low strength promoter found in Ty1, yet is truncated at 
its 3’ end to prevent any GAL1 promoter sequences from appearing in the Ty1 transcript.  
Inducibility ensures that successful isolates will not mutate the gene of interest after 
screening has taken place and before the new sequence of the gene of interest can be 
determined.   
Reverse transcription is the critical step for mutagenesis with ICE.  It has been 
shown that the 5’ and 3’ ends of Ty1 contain sequences which must be present in cis to 
ensure efficient reverse transcription (207).  These sequences enable primer (tRNAiMet) 
binding, strand transfer, and critical secondary structure formation.   Thus, any 
mutagenesis cassette must contain these sequences in order to be retrotranscribed.  The 
mutation rate induced by the reverse transcriptase is also essential to achieving high 
library sizes.  Native Ty1 reverse transcriptase has been shown to introduce mutations at 
rates of approximately 0.18 per kbp (208), which is the level of error required for 
mutagenesis of 5.5kb gene fragments or pathways.  This indicates that Ty1 may be a 
promising starting point for the development of a system which generates large library 
sizes of pathway and gene-sized lengths of DNA. 
Once a mutated cDNA has been generated, site-specific reintegration into the 
original locus on a plasmid or the host genome completes the in vivo continuous 
evolution cycle.  Integration into nonhomologous locations is performed by the Ty1 
integrase and integration into homologous locations occurs via homologous 
recombination.  It has been shown that both processes occur in native Ty1 elements 
(209), but that in Ty1 elements utilizing HIV reverse transcriptase, integration occurs 
solely via homologous recombination (210).  In this way, Ty1 retroelements can enable 
the generation of directed sequence diversity without the necessity for researcher 
intervention.  Furthermore, as this diversity is generated, screening for improved 
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phenotypes can take place, thus enabling continuous generation and selection for 
beneficial variants.  This approach thus bypasses limitations due to transformation 
efficiency, enables mutant generation in a facile manner, and does not require specialized 
equipment.  Finally, because this mutagenesis process occurs independently in every cell 
under induction, and due to the high cell densities achievable with yeast cultures, the 
number of variants which can be generated with this method scales with the size of the 
culture, which is the fundamental upper limit to any evolutionary process.  In this work, 
we developed and optimized this approach with the aim of enabling the creation of 
library sizes several orders of magnitude larger than can be achieved with the current 
state-of-the-art. 
7.2 RESULTS 
7.2.1 Construction and performance of Inducible, Marked Retrotransposon 
(pGALmTy1-HIV) 
The yeast retrotransposon Ty1 was chosen as a scaffold for in vivo continuous 
evolution (ICE) because this element has been well-studied and has been shown to be 
highly amenable to engineering efforts.  In particular, Boeke, et al have shown that 
transcription of this element may be placed under the control of a GAL promoter (206).  
Furthermore, it has been shown that transposition of this element may be monitored 
through the use of an intron-containing auxotrophic marker (211).  In addition, the 
reverse transcriptase of this element may be replaced by the reverse transcriptase native 
to HIV, indicating Ty1 may be highly modular (210).  As the mutation rate in the ICE 
technique is dictated by the reverse transcriptase, and as HIV reverse transcriptase 
(HIVRT) has a much higher error rate than that of Ty1 (Ty1RT) (212), we were most 
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7.2.2 Strain optimization 
Numerous studies have indicated gene knockouts which increase Ty1 
transposition (213-218).  80 of these knockouts from the yeast systematic gene deletion 
project were transformed with pGALmTy1-HIV and transposition efficiency was 
measured according to the Low OD induction method.  BY4741 Δmre11, BY4741 Δapl2, 
and BY4741 Δhir3 showed significantly higher transposition efficiency than BY4741 
(Figure 7-5).  The most proficient of these strains enabled library sizes of up to 1.1*10^6 
to be generated in one week in a 1L culture containing 10^10 yeast cells.  Interestingly, a 
highly beneficial gene knockout for the HIV-containing retroelement did not yield similar 
increases in the context of the Ty1 reverse transcriptase, indicating that performance 
enhancements enabled by changes to the strain background are highly context-dependent 
(Figure 7-6).  Previous research has also shown that BY4741 Δhir3 Δcac3 and BY4741 
Δhir3 Δcac2 could also activate Ty1 transposition to a large extent (16).  This suggested 
that combinations of knockouts may further improve the transposition rate of 
pGALmTy1-HIV or pGALmTy1-Ty1.  Thus, a set of single and double knockout strains 
were constructed in BY4741, including BY4741 Δcac2, BY4741 Δcac3, BY4741 
Δhir3/Δapl2, BY4741 Δhir3/Δmre11, BY4741 Δapl2/Δmre11, BY4741 Δhir3/Δcac2, 
and BY4741 Δhir3/Δcac3.  The full series of double and single knockouts was tested in 
BY4741 with either Ty1 or HIV reverse transcriptase (Figure 7-7 and 7-8).  The best 
knockout with Ty1 and HIV reverse transcriptase were Δrrm3 and Δhir3/Δcac3, 
generating a library size of 1.07107 and 1.18106, which were ~1.76- and ~31.5-fold 
higher than the wild type, respectively.  Surprisingly, very few knockouts were beneficial 
to Ty1-containing retroelements.  Oppositely, most knockout strains for HIV-containing 
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structural knowledge of HIV reverse transcriptase.  HIV Reverse transcriptase is 
commonly understood to exist as a heterodimer, one monomer of which contains the 
polymerase, connection, and RNase domains, while the other monomer consists of only 
the polymerase and connection domain but in a divergent configuration (219).  This 
dimer is formed through the action of an HIV protease which cleaves the connection and 
RNase domains (220).  However, the Ty1 protease is not known to act at this junction in 
the Ty1 reverse transcriptase, suggesting that improper dimer formation may be the cause 
of HIVRT’s inefficiency (221).  Furthermore, it has been suggested that the HIVRT 
connection domain is responsible for primer tRNA binding, suggesting that swapping this 
domain may enable this enzyme to recognize the divergent primer tRNA of Ty1 (222).  
Thus, in order to combine the properties of the Ty1 and HIV reverse transcriptases, 
chimeras of each enzyme were generated by swapping the connection and RNAseH 
domains of each enzyme, as informed by a sequence alignment of the two enzymes (222).  
For each chimera, the HIV polymerase domain was used as it is thought that this domain 
is responsible for fidelity in this enzyme.  These chimeras (denoted HHH, HHT, HTH, 
and HTT) were cloned into the pGALmTy1 vector. As HIV replication is primed by a 
different tRNA than Ty1 (205,219), we also generated a variant of pGALmTy1 
containing the primer binding sites found in HIV (pGALmTy1H).  Each chimera was 
cloned into this vector as well.  In addition, high-copy vectors expressing truncated 
chimeras lacking an RNaseH domain (p425-GPD-tHH and p425-GPD-tHT) were 
generated.   
Each chimera, primer binding site, and truncated reverse transcriptase were 
systematically combined in BY4741 Δmre11 and transposition rate was measured as 
above.  Unfortunately, no variant was able to outperform strains containing pGALmTy1-
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into high copy vectors and co-expressed with either pGALmTy1-Ty1 or pGALmTy1-
HIV in BY4741 or BY4741 Δmre11.  It was found that overexpression of HSX1, a gene 
encoding arginine tRNA, can improve transposition rate by as much as 5-fold in 
retroelements expressed in BY4741 Δmre11, and by approximately 40% when expressed 
in BY4741 (Figure 7-10).  This is particularly interesting because the rarity of tRNAArg 
causes the ribosome to “pause” at a particular location when translating Ty1, and in a 
process known as frameshifting, the ribosome is able to “slip” to a codon one nucleotide 
downstream and continue translation (226).  Given this mechanism, it is unclear how 
increasing the concentration of tRNAArg improves transposition rate, as the protease, 
integrase, and reverse transcriptase of Ty1 are products of ribosomal frameshifting.  
However, because nucleocapsid protein is formed from the un-frameshifted polypeptide, 
it may be that the concentration of this species is limiting to our engineered system.  In 
addition, increasing the concentration of a rare tRNA may simply make translation of the 
downstream genes more efficient, offsetting the effect of a decrease in frameshifting.  It 
is interesting to note that the GPD promoter used for overexpression of HSX1 is not 
driven by polIII, and so the 5’UTR provided by this promoter may make the resulting 
tRNA significantly different than the native yeast tRNA.  In this way, it is possible that 
this nonfunctional tRNA actually interferes with the native tRNA through competitive 
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It can be seen that CEN.PK enables a much higher rate of transposition than BY4741, and that this increase 
is magnified during HSX1 co-expression. 
Then, a set of single knockout strains were constructed in CEN.PK2, including 
CEN.PK2-ΔICE2, Δcac2, Δcac3, Δrrm3, Δapl2, Δhir3, Δmre11, Δmrc1, and Δckb2.  
Although BY4741 Δrrm3, Δcac2, and Δcac3 showed the highest transposition rate of the 
BY4741 strains when using the Ty1 reverse transcriptase (Figure 7-13A), these same 
knockouts in CEN.PK showed no substantial benefit.  A similar result was also observed 
with HIV reverse transcriptase, in which case BY4741 Δrrm3 had ~5-fold higher 
transposition rate than CEN.PK Δrrm3 (Figure 7-13B). Only in the case of Δice2 did 
CEN.PK2 have a higher transposition rate than BY4741.  Although further engineering of 
the CEN.PK strain background could have resulted in higher transposition rates, the 
immediate availability of knockouts which made the BY4741 strain background superior 
















trains.   
 BY4741 were not beneficial 
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7.2.6 Increasing Expression Level of URA3 Increases the Transposition Rate of 
Ty1-Containing Retroelements 
We wished to investigate the extent to which the expression level of the gene of 
interest affected transposition rate.  To test this, we cloned 3 promoters of varying 
strengths (pCYC1, pTEF1, or pGPD) in place of the HIS3 promoter (which normally 
drives URA3 expression in pGALmTy1) and tested transposition rate.  It was found 
(Figure 7-14) that while substitution of alternative promoters generally decreased the 
transposition rate of HIVRT-containing retroelements, substitution of the strong promoter 
TEF was found to increase the transposition rate of Ty1-containing retroelements by 
approximately 33%.  We hypothesize that at low expression levels (such as that conferred 
by pCYC, for example), the expression level of URA3 is insufficient to allow some 
transposants to grow in uracil dropout media.  At very high expression levels (such as 
that conferred by pGPD), we hypothesize that substantial presence of transcriptional 
machinery interferes with the progress of RNA polymerases initiated at the upstream 
GAL1 promoter and thus decrease the rate of transposition.  Nevertheless, these 
experiments demonstrate that our engineered retroelement is suitable to evolve high-
expression level pathways which are particularly relevant to metabolic engineering 
applications.  Using this optimized retroelement, the top knockout strains achieved 
improved transposition rates (Figure 7-15).  The Ty1 transposition rate in BY4741 
Δhir3Δcac2 and BY4741 Δrrm3 improved by 1.84- and 2.03-fold respectively, 
generating a maximum library size of 1.97107.  Meanwhile, the HIV transposition rate 
in BY4741 Δrrm3 improved by 2.72-fold, generating a library size of 1.41106.  This 
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7.2.7 Measurements of Transposition Rates at High Culture Volumes and for 
Extended Periods of Time 
 Previous estimates of transposition rates have been based on experiments in 
which yeast expressing our synthetic retroelements have been grown in 1mL of liquid 
medium and allowed to transpose for 3 days.  However, as ICE is most effective for large 
(~1L ) culture volumes and must be able to apply a sustained rate of mutation over the 
timescale of several weeks, we performed a transposition rate test in 50mL cultures over 
the period of one week to determine what effects, if any, culture volume and time had on 
transposition rate (Figure 7-16).  It can be seen that the number of transposants steadily 
increases with time for strains expressing pGALmTy1-HIV or pGALmTy1-Ty1 even 
though cells had reached stationary phase.  Furthermore, the transposition rate observed 
in 50mL of culture is in agreement with that observed at the 1mL scale.  This justified the 
economical use of 1mL volumes during large-scale experiments to identify strains with 
high transposition rates and also indicates that synthetic retroelements remain active in 
the absence of cell growth, confirming that ICE may be implemented for large culture 
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that we could achieve upwards of 5.6*10^6 distinct variants of a 1kb gene after 1 week of 
galactose induction of 1L of culture (227), which is substantially higher than what can be 
achieved with traditional in vitro techniques and is also substantially easier to achieve.  
However, it was also observed that HIVRT enabled mutation rates at a significantly 
lower value than Ty1RT, which was puzzling given that HIVRT is known to be highly 
error-prone, especially for the variant we were testing, which had been reported to be 2-3 
times more error-prone than wild-type HIVRT (228).  We hypothesized that this HIVRT 
variant was only minimally active in yeast, such that endogenous Ty1RT provides much 
of the reverse transcriptase activity in this system.  Nevertheless, detection of mutations 
in our system was highly encouraging and laid the foundation for future optimization of 
the engineered retroelement system as well as the undertaking of preliminary evolution 
experiments.   
 Additional analysis of the next-generation sequencing data was conducted to 
better characterize the mutations introduced during the ICE process.  In particular, each 
type of mutation was quantified and normalized to a control, resulting in bias indicators 
that can be used to compare the mutational spectrum introduced through ICE to that 










Ty1 Mutazyme II Taq
Bias Indicators   
Ts/Tv 0.75 0.9 0.8 
AT->GC/GC->AT 2.1 0.6 1.9 
A,T->N (%) 76.8 50.7 75.9
G,C->N (%) 19.6 43.8 19.6
Insertions and Deletions 
Insertions (%) 0.17 0.7 0.3 
Deletions (%) 3.8 4.8 4.2 
Mutation Frequency 
Mutations per kb 0.13 3 - 16 4.9 
Table 7-1: Mutational spectrum of Ty1 reverse transcriptase 
Although the overall mutation rate in the Ty1 ICE system is lower than that of these error-prone 
polymerases, the distribution of mutations it introduces is fairly comparable to Taq polymerase, which is 
commonly used for directed evolution experiments.   
7.2.10 Next-Generation Sequencing of Saturation Mutagenesis Libraries 
In order to increase the error rate of the native Ty1 reverse transcriptase while 
maintaining its relatively high transposition rate, a library of enzyme variants was created 
by performing site-specific saturation mutagenesis on several residues. The amino acids 
in positions 145, 225, and 226 are highly conserved and have been identified as playing a 
key role in fidelity (228-232).  A library of 19 variants containing each amino acid 
substitution was created for each of these three sites, using pGALmTy1-Ty1 containing 
the URA3 expression cassette as a template. These 57 plasmids were then transformed 
into the BY4741 Δrrm3 strain, and the transposition rate of each was measured at High 
OD, as described in the Methods section.  Furthermore, mutational analysis was 
conducted by extracting total DNA after the High OD galactose induction, with URA3 
sequences resulting from transposition events amplified via PCR.  PCR products were 
then pooled and next-generation sequencing was performed on the mixture.  It was found 
that in many Ty1 RT mutants, transposition activity was significantly reduced, and no 
increase in mutation rate could be observed (Figure 7-21).  However, an increase in both 
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transposition rate and mutation rate was observed in strains with three different point 
mutations in the Ty1 RT: L145S, F225Y and F225H.  It is estimated that a system 
incorporating the Ty1 RT with any of these three mutations would increase the library 
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7.2.12 Engineering HIV Reverse Transcriptase to Improve Expression and Activity 
In an effort to create a retroelement system incorporating HIV RT with a higher 
retrotransposition activity, several variants of the pGALmTy1-HIV construct were made.  
First, two HIV RT mutations introduced previously were reverted to create a wild-type 
HIV RT variant.  Next, the retroelement RT primer binding sites were changed from 
those native to Ty1 into those native to HIV.  Finally, the sequence between the integrase 
gene and the reverse transcriptase gene, coding for the protease cleavage site wherein the 
polypeptide is cleaved to form the two mature enzymes, was altered to code for the native 
Ty1 cleavage site with either 0, 3, or 6 additional amino acids from the Ty1 RT gene 
downstream.  It was hypothesized that if the HIV RT was inactive due to improper 
protease cleavage, including more native Ty1 RT amino acids at this site would facilitate 
more effective cleavage and thus more active enzyme.  Sixteen constructs were made 
through combinations of each of these factors.   Each was then transformed into a 
BY4741 strain and the transposition rate under galactose induction was measured.  No 
clear pattern was found in the retrotransposition activity of these 16 pGALmTy1-HIV 
constructs (Figure 7-24).  There was some variation between strains, but none displayed 
a higher retrotransposition rate than strains containing pGALmTy1-ART, the construct 
with no reverse transcriptase.  This data seemed to indicate that the low activity 
previously observed with pGALmTy1-HIV was probably not due to improper protease 
cleavage, but more likely due to HIV RT interfering with reverse transcription catalyzed 
by natively present Ty1 RT.  The variable activity observed in the different variants may 
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was able to generate high levels of mRNA upon induction, only elements containing 
Ty1RT were able to generate significant levels of cDNA.  These results suggested that 
HIVRT is nonfunctional in our retroelement, a conclusion that is supported by its low 
transposition rate and the questionably low levels of mutations we observed for HIVRT-
containing retroelements as measured by next-generation sequencing.  Based upon 
previous experiments which failed to generate functional chimeric retroelements and 
chimeric reverse transcriptases, we were doubtful that HIVRT can be easily modified to 
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7.2.15 Decreasing Proposed Genomic Integration of Tranposants through Integrase 
Engineering 
We hypothesized that the pGALmTy1-Ty1 plasmid generates cDNAs which are 
preferentially integrated into the genome as opposed to plasmids.  Because such genomic 
integration may generate effects which are not related to the function of the enzyme being 
mutated, it is desirable to minimize the extent of this phenomenon.  However, it is known 
that in Ty1, the integrase and reverse transcriptase are processed as a polyprotein which 
is subsequently cleaved (236).  Therefore, it is possible that stop codon mutagenesis of 
the integrase will also remove reverse transcriptase functionality, which is undesirable.  
To generate a mutant version of Ty1 in which the functionality of Ty1 integrase is 
eliminated while still maintaining reverse transcriptase activity, two series of Ty1 
integrase mutants were constructed.  In the first series, 5 variants were constructed in 
which stop codons were inserted at one of 5 positions spaced 100bp apart.  In the second 
series, 6 variants were constructed in which 100bp sections of the integrase were deleted 
between the 5 positions used above for stop codon insertion.  The 5’ and 3’ boundaries of 
the integrase also served to define these variants.  The transposition rate of these variants 
was tested, and the extent of genomic integration was tested by counting the size of the 
resulting colonies on media lacking uracil.  Small colonies were considered to be the 
result of genomic integration, as expression levels of URA3 (and hence growth rate in 
uracil-deficient media) are likely to be much lower as a single genomic integration than 
as a part of a high-copy plasmid, and large colonies were considered to be the result of 
plasmid integration.  It can be seen (Figure 7-27) that one integrase mutant in particular: 
Ty1intdel4, maintained a similar level of plasmid-based insertion while reducing the level 
of genomic insertion by approximately half.  This mutant was considered to be possibly 
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7.2.16 Integration of Ty1 cDNA 
In order to characterize the extent of genomic integration of the synthetic 
retroelement more thoroughly, a retroelement was introduced into a URA3-marked vector 
which contains a HIS3 cargo.  In this way, the same retrotransposition rate test could be 
carried out in this system with the opposite selection (histidine dropout plates instead of 
uracil).  Initial tests with this vector demonstrated that the overall rate of 
retrotransposition was approximately equivalent to the URA3-marked construct.  This 
construct was then used to characterize the extent of genomic integration of reverse 
transcribed cDNA according to the scheme described below. 
Cultures of BY4741 containing this new construct were first grown and plated on 
both YPD plates and YPD plates containing 5-FOA, which is toxic to cells expressing 
URA3.  Colonies were observed on both plates, indicating that cells can spontaneously 
lose a URA3-containing plasmid upon plating if 5-FOA is present.  In addition, a separate 
aliquot of cells were plated on uracil dropout plates.  The resulting colonies were then 
picked and spread directly on YPD+5-FOA plates and growth was observed, further 
indicating that cells expressing a URA3-marked plasmid can be cured in the presence of 
5-FOA.  Next, retrotransposition was induced at high OD using galactose media, 
followed by plating on histidine- and uracil-dropout media as well as histidine-dropout 
media with 5-FOA present.  Since 5-FOA precludes growth of cells containing URA3, 
but histidine-dropout media requires a functional HIS3 (and thus retrotransposition and 
re-integration of cDNA), the only cells that could grow on these plates were those which 
re-integrated cDNA directly into the genome, then lost the original plasmid.  However, 
while colony counts of the histidine and uracil dropout plates confirmed the expected 
retrotransposition rate, no colonies grew on 5-FOA-containing histidine-dropout plates.  
This test then implied that all cDNA reverse transcribed from the retroelement-containing 
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plasmid is reintegrated into the plasmid, and no copies are integrated into the yeast 
genome. 
7.2.17 Effects of Transcript Length on Ty1 Retrotransposition 
During the ICE retrotransposition process, the entire synthetic retroelement is 
transcribed and reverse transcribed.  However, all experiments exploring the rate of 
retrotransposition had been done using one cassette, containing the URA3 gene with an 
artificial intron.  It is possible that inserting a longer DNA sequence, and thus requiring a 
longer RNA transcript to be reverse transcribed, could affect this rate.  To determine the 
effect of transcript length on retrotransposition rate, several constructs were created by 
inserting truncated genes without promoters (denoted “cargo” DNA) into the 
retroelement between the URA3 gene and the reverse transcriptase gene.  These 
constructs were then tested using high-OD galactose induction in BY4741 Δrrm3 after 
varying lengths of time to explore the effect of lengthening induction time on the rate of 
retrotransposition.  These experiments revealed a clear relationship between length of 
“cargo” sequence and a reduced rate of retrotransposition; exogenous sequences up to 
~5000 bp reduces transposition by an order of magnitude, and up to ~6000 bp reduces 
this rate by a further order of magnitude.  However, lengthening the induction time at 
high OD from 3 to 7 days can slightly increase the number of retrotransposition events, 
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A fluorescent reporter was placed under the control of the Gal1 promoter, and fluorescence was measured 
in the presence of various carbon sources. It can be seen that galactose greatly increases the expression 
level enabled by the Gal1 promoter, as expected, and also that xylose seems to be permissive for pGal1 
expression as well. 
7.2.20 Construction of XylA-containing Retroelement System 
An efficient xylose isomerase enzyme in yeast has the potential for significant 
improvements to xylose utilization, since this bacterial pathway bypasses cofactor 
requirements found in yeast’s native oxidoreductase pathways.  Previously, classical 
directed evolution of the Piromyces sp.  xylose isomerase (encoded by xylA) has led to a 
beneficial mutant (designated as xylA3) with a 77% increase in enzymatic activity (238).  
The same genes xylA and xylA3 were evolved using the ICE system by inserting xylA and 
xylA3 into the optimized retroelement pGALmTy1-Ty1-TEF1, yielding pGALmTy1-
Ty1-MCS-XylA-TEF1 and pGALmTy1-Ty1-XylA3-TEF1.  Based on strain BY4741 
Δrrm3, two additional Δgre3 strains with or without an extra copy of xylulokinase 
(XKS1) integrated into the genome were constructed and transformed with the XylA(3)-
containing retroelement system.  GRE3, which encodes an aldose reductase, was knocked 
out in order to reduce endogenous xylose utilization and allow any potential 
improvements in XylA to confer a greater phenotypic advantage, thus increasing the 
sensitivity of a growth-based screen. 
Three strains: BY4741 Δrrm3, BY4741 Δrrm3/Δgre3, and BY4741 
Δrrm3/Δgre3/XKS1 were transformed with plasmid pGALmTy1-Ty1-MCS-XylA-TEF1 
or pGALmTy1-Ty1-XylA3-TEF1, yielding six strains BY4741Δrrm3-XylA, 
BY4741Δrrm3-XylA3, BY4741Δrrm3/Δgre3-XylA, BY4741Δrrm3/Δgre3-XylA3, 
BY4741 Δrrm3/Δgre3/XKS1-XylA, and BY4741 Δrrm3/Δgre3/XKS1-XylA3.  All six 
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7.2.22 Inefficient Plasmid Segregation Limited the Success of ICE 
Inefficient plasmid segregation could severely limit the success of ICE.  If a small 
fraction of a mother’s plasmid population is transferred to her daughter cell, then a 
mother will have to bud multiple times before she will be likely to pass on a mutated 
plasmid, even if the mutated plasmid is beneficial.  The progenitor to the P4xx series of 
plasmids used in this study, the pRS series, has been reported to be lost through mitotic 
segregation at rates of approximately 4.4% of progeny per doubling.  This loss rate would 
imply (see materials and methods) that, on average, a mother cell containing 30 copies 
(239) will only transfer 3 of them to her daughter cells.  Given that only one out of 30 
plasmids is likely to contain a mutation in the first place, this implies that the transfer rate 
of mutated plasmids can be extremely low, even if the mutated plasmid confers a growth 
advantage.  On the other hand, if a mother cell contains 3 plasmid copies (as is the case 
for low-copy centromeric vectors), a rate of loss of 4.4% would correspond to 2 plasmid 
copies being transferred to a daughter cell and thus a much higher probability that a 
daughter cell would contain a mutated plasmid.  Therefore, we synthesized low-copy 
versions of our retroelement in order to reduce the effect of segregation efficiency and 
improve the ability of ICE to select for improved mutants.   
7.2.23 Construction of Low-copy Vectors for Evolution Experiments 
Since experiments have shown that including the optimized retroelement on a 
low-copy vector does not significantly affect the rate of transposition, low-copy versions 
of the retroelement constructs containing XylA, Spt15, XylA-3, and Spt15-300 were made.  
In a cell expressing a small number of plasmids, any putatively beneficial mutation 
obtained through the ICE retrotransposition cycle will be more likely to be selected for 
than in a cell with a high number of plasmids all expressing the wild-type gene.   
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7.2.24 Reduction of Wild-type Background through the Inclusion of Introns in 
Synthetic Retrotransposon 
Because we were unable to observe any mutant generation during initial evolution 
experiments of XylA, XylA3, SPT15, and SPT15-300, we also wished to include a feature 
to our retroelement which would enable facile recovery of constructs which have 
undergone retrotransposition (and so would be more likely to contain mutations).  
Therefore, we generated constructs which contain an intron interrupting the coding 
sequence of XylA, XylA3, SPT15, and SPT15-300.  The purpose of this intron was 
twofold.  Firstly, the presence of an intron would prohibit the expression of enzymes 
contained within retroelements which have not undergone transposition, ensuring that 
mutants would not be produced within a cell containing a high background of wild-type 
enzyme, thus potentially amplifying the effect of the mutant.  Secondly, isolation of 
mutants would be facilitated through the inclusion of a restriction site within the intron, 
allowing the researcher to enrich for transposed retroelements during plasmid isolation 
through a simple restriction digest before transformation into E. coli.  This strategy, 
coupled with the use of low-copy vectors to propagate our retroelement, was expected to 
result in higher isolation efficiencies of mutated retroelements. 
7.2.25 Development of Nonevolving Controls for Evolution Experiments 
A major challenge of ICE is the propensity for strain adaptation to take place as 
directed evolution is occurring.  As this process can potentially confound the 
identification of beneficial mutants, it is important to understand the extent to which 
strain adaptation is occurring in future evolution experiments.  To address this need, we 
developed 2 control plasmids for each target which each lack the Ty1 reverse 
transcriptase, thus reducing retrotransposition (and thus mutation) by several orders of 
magnitude.  In one of these control plasmids (pGALmTy1-(x)intron), the gene to be 
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optimized is interrupted by an intron, whereas the other control (pGALmTy1-(x)) 
maintains an intact copy of the gene.  In this way, cells containing the pGALmTy1-
(x)intron plasmid are left to adapt in the context of the retroelement overexpression alone, 
and cells containing the pGALmTy1-(x) plasmids will adapt in the context of both 
retroelement and gene overexpression.  By comparing the growth rates of the 
experimental strain and the two controls, the experimenter will be able to determine if the 
mutagenic activity of the reverse transcriptase towards the gene of interest is conferring 
an additional phenotypic benefit than strain adaptation alone, thus indicating that the 
experimental strain contains beneficial mutants.  We thus constructed control strains for 
each gene of interest in this study: SPT15, SPT15-300, XylA, and XylA3.   
7.2.26 Evolution Study of Spt15 and Spt15-300 
Two versions of Spt15, which encodes the TATA-binding protein in 
Saccharomyces cerevisiae, were chosen for in vivo continuous evolution: wild-type Spt15 
and a previously identified beneficial mutant Spt15-300 (1).  In prior work, evolution of 
Spt15 was undertaken with a high-copy vector without an artificial intron, resulting in a 
high level of wild-type background.  Therefore, the retroelement was cloned in a low-
copy plasmid to eliminate inefficient plasmid segregation.  Also, the coding sequences of 
Spt15 and Spt15-300 were interrupted with an artificial intron.  The six plasmids, 
pGALmTy1-Ty1-Spt15intron-TEF1 (low copy), pGALmTy1-Spt15intron-TEF1 (low 
copy), pGALmTy1-Spt15-TEF1 (low copy), pGALmTy1-Ty1-Spt15-300intron-TEF1 
(low copy), pGALmTy1-Spt15-300intron-TEF1 (low copy), and pGALmTy1-Spt15-300-
TEF1 (low copy)  were then transformed into BY4741 Δrrm3, and the resulting strains 
were designated as STI, SAI, SA, S3TI, S3AI, and S3A.  These strains were then used for 
evolution in either the continuous or oscillatory mode. 
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In continuous mode, all six strains were pre-cultured in glucose medium and then 
induced in galactose medium under high OD for three days.  The cultures were then 
transferred to a medium containing 120g/L galactose and 6% ethanol, which was 
designed to provide a high selective pressure while simultaneously maintaining induction 
of the pGAL1 promoter.  As these strains grew to saturation, they were subcultured to 
fresh media containing the same amount of galactose but 0.5% more ethanol.  
Additionally, the inoculum volume was decreased (Figure 7-31 (top)).  It can be seen 
(Figure 7-32A,B) that STI attained higher growth rates than SAI or SA after subcultures 
2, 4, and 5, while S3TI attained higher growth rates than S3AI or S3A after subcultures 2 
and 3.  We expect that STI continued to accumulate beneficial mutations throughout its 
evolutionary trajectory, allowing it to surpass both of the control strains.  Although S3TI 
initially outperformed the control strains (indicating the presence of beneficial 
mutations), it appears that an adaptive mutation appeared in the genome of S3A after 
subculture 4, enabling it to grow faster than S3TI.   
In the oscillatory strategy, all six strains were pre-cultured in glucose medium and 
then induced in galactose medium under high OD for three days.  Several repeated 
rounds of retrotransposition induction and selection were then undertaken by serial 
culture in an alternating sequence of galactose and glucose plus ethanol medium.  Here, 
galactose medium was used for induction while glucose plus ethanol medium was used 
for selection.  A higher concentration of ethanol was added in the selective medium over 
each subculture in order to further enrich for beneficial mutants (Figure 7-31 (bottom)).  
The growth curves of the oscillatory evolution process for Spt15 and Spt15-300 are 
shown in Figure 7-32C and D, respectively.  Each galactose induction period is 
indicated as orange dotted lines.  In total, there were seven subcultures and the ethanol 
concentration was increased up to 8.25% (v/v).  Unfortunately, the strain (STI/S3TI) with 
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retroelement cassette showed similar growth profile compared with the control strains, 
and no significant improvement was observed.  It was observed that the control strains 
SA and S3A could also grow up in the selective medium, possibly due to the acquisition 
of an adaptive mutation within the genome.  Surprisingly, the control strains (SAI/S3AI) 
which include an artificial intron in the target gene and lack the reverse transcriptase also 
showed comparable growth profiles in the selective medium.  One possible explanation 
for these results is that alternating between selective and nonselective conditions might 
permit global modifications to the genome through adaptive evolution.  These 
preliminary results indicated that ICE has the potential to generate strains with 
significantly improved phenotypes than could be attained through strain adaptation alone, 
indicating the generation of improved mutants.  In addition, these results indicated that 
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Strains were transformed with plasmids containing evolution cassettes for SPT15 and SPT15-300 and the 
associated control strains.  These strains were then subcultured in increasing concentrations of ethanol in 
either continuous or oscillatory mode.  A) SPT15 in continuous mode.  B) SPT15-300 in continuous mode.  
C) SPT15 in oscillatory mode.  D) SPT15-300 in oscillatory mode.  It can be seen that continuous mode 
enables the greatest separation between the experimental and control strains.   
7.2.27 Mutant Recovery 
Cultures from each round of evolution were processed to confirm mutant 
sequences using several strategies.  In the first strategy, 1.5 mL culture was collected to 
purify yeast plasmid.  This was further digested with AscI (a restriction enzyme specific 
to the intron sequence) to eliminate any untransposed background plasmid.  This digested 
plasmid was then transformed into E. coli for sequencing.   Sequencing results indicated 
that either the wild type plasmid with intron was still present or plasmids in which the full 
retroelement was excised were present.  In later subcultures, the fraction of plasmids in 
which the full retroelement was excised was increased.  This phenomenon was also 
observed in previous experiments attempting evolution using high-copy plasmids and in 
experiments using URA3AI.   
In the second strategy, genomic DNA was extracted from single colonies.  Any 
integrated TEF-Spt15 or TEF-Spt15-300 expression cassettes were then PCR amplified 
and digested with AscI.  After a gel check of digestion product, the cassette with intron 
should be cleaved into two small fragments of 762 and 449 bp, or should appear as a 
1.21kb band if it is uncleaved.  In contrast, cassettes without intron should appear as a 
1.14kb product.  It was observed that all tested colonies showed two bright bands of 762 
bp and 449 bp, while only one colony from subculture 4 of Spt15 oscillation evolution 
(referred as SO4-1) had two additional faint bands of 1.14 kb and 1.21 kb.  Both bands 
were gel extracted and sequenced, confirming that the intron was indeed excised from the 
smaller product.  However, as the sequencing read showed a mixture of intron-containing 
and intronless sequences, no mutants could be clearly distinguished.   
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In the third strategy, genomic DNA was digested with AscI first before amplifying 
the TEF-Spt15 or TEF-Spt15-300 expression cassettes.  Still, only SO4-1 showed the 
promising 1.14 kb band.  However, this strategy increased the concentration of the 1.14 
kb product, as visualized by gel electrophoresis.  The sequence results showed that the 
intron of plasmid in SO4-1 was excised, but no mutations were present. 
In the fourth strategy, instead of amplifying the whole gene cassette, two pairs of 
intron-spanning primers were specifically designed to amplify either the intronless TEF 
promoter or the intronless Spt15(300).  These primers were then used to PCR gDNA 
extracted from a single colony or gDNA from 3 mL from the evolution culture.  Among 
all the TEF amplicons, 15 out of 64 showed evidence of a transposed product, while 
others have faint off-target products.  Among all the Spt15 or Spt15-300 amplicons, 30 
out of 64 PCRs showed evidence of a transposed product.  Unfortunately, all 15 TEF 
promoter products and 30 SPT15(300) products were wild-type.  
7.2.28 Genomic Integration of Optimized Ty1 Retroelement 
Until this point, all ICE experiments have used plasmids containing the optimized 
retroelement.  However, during cDNA reintegration, it is not clear whether the cDNA 
integrates back into a plasmid or elsewhere in the genome.  This could result in multiple 
copies of the retroelement, which would impair both the evolution of genes and pathways 
contained within and the recovery/characterization of these parts.  To improve this 
process, a strain containing a genomic integration of the optimized retroelement was 
created and transposition rate was measured.  Although transposition rate was 
significantly reduced to 4*105 per liter, each colony obtained from the transposition rate 
analysis showed one unique transposition event which replaced its parent sequence in the 
genome.  Furthermore, one sequence excitingly contained an amino acid substitution of 
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the URA3 gene, indicating not only that the Ty1 reverse transcriptase can generate 
detectable levels of mutation through standard sequencing analysis, but also that URA3 is 
tolerant to some level of amino acid substitution, indicating that measurement of 
transposition rate using this gene may not be highly sensitive to mutation rate.   
7.2.29 Improvement of Transposition Rate of Genome-Encoded Retroelements 
In order to further improve the transposition rate enabled by genomically encoded 
retroelements, we investigated the effect of inducing transposition at low temperatures, as 
it has been shown that 22º C greatly enhances the rate of transposition (240).  Although 
we previously investigated this temperature for increasing the transposition rate of 
plasmid-encoded retroelements, no increases to transposition rate were observed.  To our 
pleasant surprise, we observed that induction at this temperature greatly increased 
transposition rate to almost 108 per liter (Figure 7-33).  This places the efficiency of the 
genome-encoded retroelement in the same regime as that of plasmid-encoded 
retroelements (but with a greater capacity for sequence retrieval) and so inspired us to 
reconstitute the evolution cassettes for SPT15(300), XylA(3) and the XylA-XKS pathway 
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genome contributed to the reported activity of this enzyme (210).  Finally, we have 
optimized the Ty1 retrotransposon for use as a tool for directed evolution, both by 
modifications which increase the activity of the retroelement itself, but also by 
developing strategies to recover mutants after the directed evolution process is complete.  
The library size for a 1kb gene attainable through the approach as it is currently 
implemented is 1.1*106, which is equal to that which can be obtained through the current 
state-of-the-art, yet has the potential to be generated continuously in yeast.  We have 
shown the utility of this approach for improving the tolerance of yeast to high 
concentrations of ethanol and galactose.  The failure to isolate causal mutations for our 
initial demonstration of ICE illustrates a major limitation of undertaking within-cell 
mutagenesis in a multi-copy plasmid system.  It is expected that integration of evolution 
cassettes into the yeast genome, coupled with optimization of transposition rate as 
undertaken for plasmid-based systems, will enable successful implementation of ICE for 
future evolution experiments.   
To overcome limitations to library size due to mutation rate, it will be necessary 
to develop highly mutagenic reverse transcriptases.  To this end, we devised a two-color 
fluorescence assay to enable simultaneous measurement of both transposition rate and 
mutation rate through flow cytometry.  In this assay, the cargo of the retroelement is a 
translational fusion of mStrawberry and YFP.  Before transposition, neither protein may 
be expressed due to the presence of an intron interrupting the coding sequence of 
mStrawberry.  After transposition has occurred, both genes will be expressed.  However, 
if any one of the genes has been mutated by the reverse transcriptase, it may not be 
functional.  This scheme will enable the deduction of both transposition rate and mutation 
rate from the fraction of cells expressing YFP only, RFP only, or both fluorescent 
proteins.  In practice, a culture expressing a single reverse transcriptase variant will be 
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induced and allowed to transpose over the course of several days, after which a large 
number of cells will be queried using flow cytometry.  Using this technique, several 
hundred reverse transcriptase variants may be analyzed per day, and the variant enabling 
high library sizes will be selected for use in downstream applications and for further 
optimization of mutation rate.  
In the future, we also plan to implement ICE for the evolution of entire pathways.  
First, the effect of terminators on Ty1 retrotransposition must be ascertained.  
Incorporating at least one terminator in the retroelement is important for the evolution of 
multiple gene pathways in a single construct, but it is possible that any bi-directionality in 
terminator activity could also interfere with the transcription or reverse transcription 
process.  Once this effect has been characterized, and suitable mono-directional 
terminators have been found, evolution will commence on two model pathways: xylose 
and arabinose utilization. 
In order to initially demonstrate that ICE can simultaneously co-evolve a 
collection of synthetic parts to improve the performance of an entire pathway, we will 
construct a Ty1 retroelement system for the evolution of xylose utilization through a 
pathway composed of xylose isomerase (XylA or XylA3) and xylulokinase (XKS1).  The 
expression of xylose isomerase and xylulokinase will be controlled under the TEF1 and 
GPD promoters, respectively.  Two short synthetic terminators, Tkc1 and Tkc6, will be 
investigated for termination of transcription (unpublished work).  Upon integration of this 
construct into BY4741 Δrrm3 and BY4741 Δrrm3/Δgre3, we plan to use in vivo 
continuous evolution to improve the activity of the xylose catabolism pathway. 
As a second proof-of-concept for the evolution of pathways in yeast, ICE will be 
implemented for the evolution of arabinose catabolism.  Arabinose is the second most-
abundant pentose sugar in lignocellulosic biomass, yet yeast does not possess the ability 
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to effectively utilize this carbon source.  Our lab has recently isolated a strain of yeast (U.  
bevomyces) which displays the remarkable ability to grow on arabinose as the sole carbon 
source in minimal media.  Genome sequencing indicated a 5-gene pathway which may be 
responsible for this phenotype, and it has been shown that the introduction of this 
pathway is also sufficient to confer this phenotype to S. cerevisiae.  In spite of this, the 
ability of S. cerevisiae to utilize this carbon source (as measured by cell growth rate) 
remains very poor.  Therefore, we intend to improve the ability of yeast to utilize 
arabinose by subjecting the entire 5-gene pathway to in vivo continuous evolution.  In 
addition, we will also be constructing shortened versions of this pathway because 
preliminary experiments indicate that all five genes may not be necessary for arabinose 
utilization.  Because this pathway is so long (up to 8.6kb), several challenges must be 
addressed, including the effect of cargo size on retrotransposition as well as the effect of 
terminators on retrotransposition.  Once these effects have been characterized (and 
mitigated if necessary), this pathway will be evolved using ICE.  These demonstrations 
will unequivocally show the utility of ICE as a tool to accelerate the development of 




Chapter 8: Optimization of a Yeast RNA Interference System for 
Controlling Gene Expression and Enabling Rapid Metabolic 
Engineering 
8.1 INTRODUCTION 
In this chapter, we demonstrate the utility of a synthetic RNAi system in yeast for 
gene expression control.  First, we elucidate key design principles for the construction of 
hairpin RNA expression cassettes in yeast as well as optimize expression of key 
components of the RNAi pathway.  We then use these parameters to demonstrate the 
controlled regulation of a synthetic fluorescent protein.  Finally, we demonstrate that this 
heterologous RNAi pathway can enable rapid strain prototyping by examining three 
industrially relevant strains of yeast (BY4741, CEN.PK2-a, and Sigma 10560-4A) to 
quickly identify routes for the improvement in titer of itaconic acid (a top value-added 
chemical from biomass (241)), thus demonstrating that this synthetic approach can speed 
the design-build-test cycle in yeast. 
As a further extension of this method, we develop an optimized RNAi system 
enabling the use of cDNA fragments as guide RNAs.  This work enables us to apply 
RNA interference to detect beneficial knockdowns on a transcriptome-wide scale for the 
improvement of 1-butanol, isobutanol, and lactic acid tolerance in yeast.  This work 
represents the first high-throughput search for knockdown targets on a genome-wide 
scale in yeast.  This work thus accelerates high-throughput strain modification towards 
improvement of relevant phenotypes.  This approach may be further extended through the 
use of RNAseq to elucidate the transcriptome-wide responses to gene knockdown, thus 
enabling directed learning about the phenotype of interest and informing future strain 
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hairpin would increase the amount of dsRNA substrate available for Argonaute and 
Dicer, thus increasing the magnitude of downregulation.  Heterologous expression of 
YFP was driven by either a weak (pCYC1) or strong (pTDH3) promoter.  When the 
hairpin was expressed from a weak (pCYC1) promoter, we obtained insignificant 
downregulation of YFP fluorescence regardless of reporter level (Figure 8-2).  However, 
we observed that increased expression of the hairpin (from a strong pTDH3 promoter, 
Design Cycle 1) resulted in increased knockdown capacity.  Specifically, we found a 2.3-
fold increase in downregulation when YFP is weakly expressed and upwards of 3-fold 
increase in the extent of downregulation when YFP is strongly expressed (Figure 8-2).  
In total, this construct enabled up to 80% downregulation to be obtained.  We 
additionally confirmed that the RNAi system had an insignificant effect upon growth rate 
(Figure 8-3).  These results confirm both that RNA interference is functional in yeast and 
also highlight that the absolute extent of downregulation may be altered by synthetically 
controlling the expression of the hairpin RNA.  This approach represents a significant 
reduction in labor compared to current genomic manipulation techniques(242) and 
enables metabolic engineers to quickly test the effects of multiple expression levels on a 
phenotype of interest.  This technique also enables the capacity to simultaneously alter 
the extent and timing of gene downregulation by coupling the expression of the hairpin 
RNA to an inducible promoter(243) or a logic circuit (244).  For the remainder of this 
work, we optimized the synthetic RNAi system in the context of high hairpin expression, 
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RNAs and thus a greater probability that Argonaute will recognize and cleave an 
unstructured part of the corresponding mRNA substrate (248).  To test this hypothesis, 
we increased hairpin length from 100 bp to 200 bp (Design Cycle 2) and observed an 
improvement in downregulation efficiency by 30% when YFP is strongly expressed, and 
by nearly 6-fold when YFP is weakly expressed (Figure 8-2).  Through this second 
design round, we were able to obtain inhibition levels of up to 94%, a significant 
improvement upon the 80% described above.  It should be noted that the construction and 
propagation of inverted repeats of this increased length in E. coli were difficult, 
potentially due to interference with DNA replication machinery (249), thus necessitating 
the use of an intron-containing spacer region to ensure plasmid stability (250). 
8.2.3 Decreasing Hairpin-Containing Plasmid Copy Number Improves RNAi 
Efficiency 
The ability of RNAi to confer a useful phenotype is dependent upon the cell-to-
cell variability in the extent of downregulation.  Interestingly, flow cytometry analysis 
revealed a bimodal distribution of downregulation, with some cells almost completely 
downregulating YFP expression, and others exhibiting little downregulation (Figure 8-
4A).  To investigate the cause of this phenomenon, we explored the effectiveness of 
expressing the hairpin RNA on a centromeric (low-copy) plasmid containing either an 
auxotrophic (TRP1) or an antibiotic resistance marker (KanMX). For this design cycle 
(which was performed in the context of genomic YFP expression), we observed that a 
low-copy auxotrophic vector (Design Cycle 4) enabled up to 93% downregulation in the 
fluorescence of strongly-expressed YFP and 80% downregulation of weakly-expressed 
YFP, an improvement of  2.6-fold and 1.6-fold, respectively, over Design Cycle 3.  
Furthermore, the population of weakly downregulated cells was significantly reduced 
from previous design cycles (Figure 8-4A).  While no improvements to efficiency were 
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seen when using a vector expressing antibiotic resistance, even when exposed to a 
saturating, 10-fold excess of antibiotic (Design Cycle 5), these results highlight the 
potential to use such a construct in heterotrophic strains (Figure 8-2).  Interestingly, the 
extent of knockdown did not correlate the coefficient of variation in expression levels 
enabled by these plasmid constructs (Figure 8-4B), indicating that a mechanism other 
than copy number control is responsible for the improved knockdown observed when 
using low copy auxotrophic vectors.  Nevertheless, these promising results inspired us to 
use this low-copy vector for hairpin expression in future experiments.  Collectively, these 
design cycles were able to develop a synthetic RNAi system in yeast capable of efficient 
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8.2.4 Implementation of RNAi in Alternate Yeast Strains 
To demonstrate the generality and portability of this approach, we wished to 
implement RNAi in two additional commonly-used strains: CEN.PK and Sigma.  We 
expected that the portability of this system would enable rapid prototyping in multiple 
strains simultaneously.  In order to conserve auxotrophic markers in our system and 
further decrease expression noise, we condensed vector design by co-expressing 
Argonaute and Dicer from the same low-copy plasmid.  In addition, we re-designed our 
YFP-specific hairpin to target regions of YFP mRNA with increased variability in 
secondary structure, as it has been indicated that these regions are ideal targets for RNAi 
(246).  As a result, the length of the hairpin was increased to 240 bp.  Finally, since 
genome modification techniques are rather inefficient for Sigma, we were unable to 
generate YFP-integrated versions of this strain and so tested downregulation of plasmid-
borne YFP in all three strains.  Across these strains, we achieved between 85% and 77% 
downregulation of YFP fluorescence, and between 90% and 97% downregulation of YFP 
mRNA (Figure 8-5).  CEN.PK showed the highest overall downregulation competency, 
whereas Sigma showed the lowest.  These strain-specific differences could be due to 
variations in the translation efficiencies of Argonaute and Dicer.  In addition, although 
decreases in YFP fluorescence were well-correlated with decreases in YFP mRNA, 
knockdowns in fluorescence intensity were consistently lower than for mRNA levels.  
Regardless of these slight differences, these results demonstrate that our synthetic RNA 
interference is portable and efficient in a wide variety of strains, thus enabling reduction-
of-function experiments and rapid prototyping to be easily performed in many strain 
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this gene knockdown in other genomic contexts, we expressed a long hairpin specific to 
ADE3 under the control of three yeast promoters (pCYC1, pTEF1, and pTDH3) which 
collectively span a wide range of expression.  We also streamlined the RNAi system by 
integrating Argonaute and Dicer on the same LEU2-marked low-copy plasmid.  This 
change was made because the HIS3-marked plasmid previously used for expression of 
Dicer was unavailable due to the possibility that the ADE3 knockdown would confer 
histidine auxotrophy.  The hairpin was maintained on a separate plasmid for modularity 
and ease of cloning.  Next, itaconic acid production was measured upon co-expression of 
Dicer, Argonaute, and CAD1 in three separate strains of yeast: BY4741, CEN.PK2-a and 
Sigma 10560-4A.  We observed significant increases in IA production for at least one 
expression level of hairpin RNA in each of the three strains we tested, as indicated by a 
Student’s t-test (Figure 8-6).  As a result, these experiments indicate that a gene 
knockdown is an adequate, quick surrogate test for genotype-phenotype linkages.  
Expression of a sham hairpin specific for YFP did not elicit significant improvements to 
IA production, indicating that the observed improvements to IA titer were not simply due 
to the presence of dsRNA in the cell.  These results also indicate that of the tested strains, 
S. cerevisiae Sigma 10560-4A is the most advantageous for IA production, and that ade3 
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we tested.  In this regard, this work demonstrates the potential of RNAi to significantly 
expedite the design-build-test cycle. 
8.2.6 Characterization of RNAi in yeast using unstructured RNA 
We have also developed a scheme for efficient gene knockdown which avoids the 
use of hairpin constructs, because generation of hairpin constructs on a library scale is 
quite difficult.  On the other hand, a scheme which would enable significant levels of 
gene knockdown from non-inverted-repeat constructs would enable existing techniques 
for cDNA or gDNA library generation to be used for RNAi in yeast.  Our initial design 
cycle (Table 8-2, Design Cycle 0) consisted of a dual promoter construct, in which one 
promoter (pTDH3) drives the expression of the sense strand of a 400bp YFP fragment 
and another promoter (pTEF1) drives the expression of the antisense strand.  This dual 
promoter construct was expressed on a high-copy vector.  In addition, RNAi machinery 
(argonaute and dicer) was expressed on separate low-copy vectors driven by strong 
promoters.  In order to determine the effects of target gene expression, YFP was driven 
by either a strong or a weak promoter on a low-copy plasmid.  In this scheme, we 
achieved 50% downregulation of strongly-expressed YFP and insignificant 


























































































YFP expression was downregulated through expression of Argonaute, Dicer, and a YFP-specific hairpin 
using the schemes listed in Table 8-2 in order to elucidate design rules for RNAi in yeast.  Red bars 
indicate the downregulation of plasmid-borne YFP and blue bars indicate the downregulation of YFP 
expressed from the genome.  For each condition, the knockdown was normalized to its corresponding “no 
hairpin” control.  Bars with a white background indicate downregulation of strongly expressed (pTDH3) 
YFP and a purple background refers to the downregulation of weakly expressed (pCYC1) YFP.  Dashed 
lines denote the representative range of YFP expression levels observed in cells which do not express a 
hairpin.  Error bars represent the standard deviation observed among three biological replicates.  Through 
iteratively improving upon our synthetic RNAi pathway, expression of genomically-encoded proteins was 
downregulated by up to 93%. 
We next wished to investigate the ability of our dual-promoter construct to 
downregulate chromosomal gene expression.  Therefore, we integrated YFP under the 
control of a strong or a weak promoter into the yeast genome.  Under this scheme 
(Design Cycle 1), downregulation of strong YFP expression was decreased to 30%, 
whereas we still observed insignificant downregulation of weakly-expressed YFP. 
In order to further increase the extent of downregulation, we integrated introns 
into our dual-promoter construct, as it has been shown that transcripts which are subject 
to RNA splicing are more effective at downregulation.  These introns were placed 
immediately downstream of each promoter in the downregulation cassette.  Using this 
system (Design Cycle 2), downregulation of strongly-expressed YFP remained similar to 
the extent of downregulation without introns, whereas downregulation of weakly-
expressed YFP increased to 40%.  
We also wished to express our downregulation cassette on a low-copy plasmid, as 
we have found that this approach significantly increases the downregulation efficacy of 
hairpin constructs in previous work.  By expressing our downregulation cassette in this 
way (Design Cycle 3), we observed significantly increased downregulation: up to 85% 
for strongly expressed genes and 94% for weakly expressed genes.  We also found that 
exchanging pTDH3 for pCYC1 in our downregulation cassette enabled tunable 
downregulation, such that strongly expressed genes were downregulated by 60% and 
weakly expressed genes by 65%.  Taken as a whole, these results show that non-hairpin-
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based downregulation cassettes can achieve significant levels of downregulation, and that 
the extent of this downregulation may be tuned through a simple cloning step.  In 
addition, these results indicate that cDNA is a promising substrate to guide RNAi to 
downregulate transcription, enabling genome-wide searches for knockdown candidates in 
order to rapidly generate improved strains for a particular application. 
8.2.7 Improving Isobutanol, 1-Butanol, and Lactic Acid Tolerance through a 
Genome-Wide Knockdown Search 
Because we showed that RNAi can efficiently downregulate genomically-encoded 
genes using a linear guide RNAs, we wished to expand the power of RNAi from an 
approach for targeted strain engineering towards a method for knockout identification on 
a genome-wide scale.  Using this method, it would be possible to transform a genomic 
library of knockdown cassettes and screen for beneficial phenotypes, thus identifying 
candidates for strain modification in a high-throughput manner.  Importantly, this 
approach could elucidate knockdown targets for strains which are not sequenced or do 
not have a curated metabolic model.  In addition, knockdown targets could be identified 
for the improvement of complex phenotypes which cannot be modeled using current 
approaches.  In order to investigate the ability of RNAi to identify strain engineering 
targets on a genome-wide scale, we used this approach to improve the tolerance of yeast 
to 1-butanol, isobutanol, and lactic acid.   
Although bioethanol is the most commonly produced liquid fuel from biomass, 
ethanol suffers from several issues limiting its widespread use, including high 
hygroscopicity and low octane rating.  Butanol, on the other hand, has a higher octane 
rating, does not readily absorb water, and can serve as a drop-in substitute for gasoline.  
However, the high toxicity of butanol limits its production in a microbial setting.  It has 
been observed in our lab that butanol concentrations of greater than 10 g/L severely limit 
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the growth of S. cerevisiae, indicating that substantial strain engineering is necessary to 
make biological production of butanol feasible in this organism.  Furthermore, lactic acid 
is commonly used in fermentation processes to inhibit bacterial contamination, and so 
development of a method to quickly confer lactic acid tolerance to yeast would be highly 
desirable.  It has been observed in our lab that lactic acid concentrations of greater than 9 
g/L prohibit the growth of S. cerevisiae. Because alcohol and acid tolerance are complex 
phenotypes and thus are difficult to improve using rational approaches, genome-wide 
knockdown searches (such as that afforded by RNAi) are ideal to ensure a high likelihood 
of success.   
We thus demonstrated the utility of RNAi knockdown libraries in improving 
chemical tolerance through the use of the optimized antisense RNAi substrates developed 
above.  A cDNA library of the parent strain (S. cerevisiae BY4741) was generated 
through established procedures (252), sheared and cloned into vectors containing 
converging promoters to generate a library of antisense RNAi constructs.  This procedure 
thus generated 4 libraries: either strong (RNAi cassette driven by pGPD) or weak (RNAi 
cassette driven by pCYC1) downregulation using 200bp or 400bp transcript fragments.  
Each of these libraries contained over 105 distinct members, thus enabling good coverage 
of the yeast transcriptome.  These antisense constructs were then transformed into the 
parent strain along with the RNAi machinery and selection for high butanol or lactic acid 
tolerance was undertaken through serial subculture in inhibitory concentrations of these 
compounds, as shown in Figure 8-9.  These screening libraries were then allowed to 
grow until they reached an optical density of greater than 1, at which point they were 
subcultured at a 1:100 ratio to a fresh culture with an increased concentration of the 
inhibitory compound.  For lactic acid and isobutanol, a second screening was undertaken 
which started at a lower concentration of the compound of interest.  A sample of cells 
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was also taken at this time in order to extract an enriched collection of downregulation 
cassettes.  This process was repeated a total of 3 times in order to generate 4 enriched 
collections of downregulation cassettes for each library/compound combination.  Finally, 
isolated members of these enriched collections were sequenced at random in order to 
identify the knockdown cassettes responsible for improved tolerance.  These knockdown 
cassettes were then retransformed into their parent strain to confirm the causal nature of 
phenotype improvement.  Those knockdown cassettes which are promising to improve 
the growth rate of BY4741 in inhibitory concentrations of 1-butanol and isobutanol are 
shown in Table 8-3 and Appendix Table A7-10.  Of these targets, the ADH1 cassettes 
showed the greatest ability to improve the growth of yeast on 1-butanol.  Interestingly, 
this gene catalyzes the conversion of acetaldehyde to ethanol, and is often knocked out of 
butanol-producing strains to improve product yield (253).  Cassettes encoding fragments 
of RPL28, SOD1, and SSB1 showed the greatest ability to improve the growth of yeast on 
isobutanol. It is interesting to note that both RPL28 and SSB1 are associated with 
translation (254,255), indicating that their deletion may impact the expression of a large 
number of genes.  SOD1 is an interesting target that was identified during both the 1-
butanol and isobutanol selections, and is involved with the detoxification of reactive 
oxygen species (256). The downregulation of this gene is therefore counterintuitive, but it 
may indicate an inappropriate cellular response to butanol toxicity.  Current work is 
focused on investigating the effect of total gene knockout on tolerance for these 
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Compound/Concentration (g/L) Cassette 
Expression 
Level 
Genomic Target Name 
1-butanol (8 g/L) Low (pCYC1) SOD1 1B-5-1 
1-butanol (8 g/L) Low (pCYC1) RPL28 1B-6-1 
1-butanol (8 g/L) Low (pCYC1) ADH1 1B-8-1 
1-butanol (8 g/L) Low (pCYC1) SSB1 1B-12-1 
1-butanol (8 g/L) Low (pCYC1) ADH1 1B-13-1 
1-butanol (8 g/L) Low (pCYC1) RPL15A 1B-14-1 
1-butanol (8 g/L) Low (pCYC1)  unknown 1B-17-1 
1-butanol (8 g/L) Low (pCYC1) Ty1 gag-pol 1B-19-1 
1-butanol (8 g/L) Low (pCYC1)  unknown 1B-21-1 
1-butanol (8 g/L) Low (pCYC1) YDR524C-B 1B-22-1 
1-butanol (8 g/L) Low (pCYC1) MHF1 or ADH1 1B-23-1 
1-butanol (8 g/L) High (pGPD) Ty1 gag-pol 1B-24-1 
1-butanol (8 g/L) High (pGPD) ADE5,7 1B-28-1 
1-butanol (8 g/L) High (pGPD)  unknown 1B-29-1 
1-butanol (8 g/L) High (pGPD) TPI1 1B-30-1 
1-butanol (8 g/L) High (pGPD) ADH1 1B-32-1 
1-butanol (8 g/L) High (pGPD) RP6B 1B-33-1 
Isobutanol (16g/L) Low (pCYC1) RPL28 IB-1-1 
Isobutanol (16g/L) Low (pCYC1)  unknown IB-6-1 
Isobutanol (16g/L) Low (pCYC1) GRX3 IB-7-1 
Isobutanol (16g/L) Low (pCYC1) GCV3 IB-9-1 
Isobutanol (16g/L) High (pGPD) SCY1 IB-12-1 
Isobutanol (16g/L) Low (pCYC1) SED1+TPO1 IB-16-1 
Isobutanol (16g/L) Low (pCYC1) RPL36B IB-19-1 
Isobutanol (16g/L) Low (pCYC1)  unknown IB-20-1 
Isobutanol (16g/L) Low (pCYC1) CCW12 IB-21-1 
Isobutanol (16g/L) Low (pCYC1) RPS18A IB-24-1 
Isobutanol (16g/L) Low (pCYC1) Ribosome or TAR1 IB-25-1 
Isobutanol (16g/L) Low (pCYC1) SOD1 IB-26-1 
Isobutanol (16g/L) High (pGPD) RPL26B IB-28-1 
Isobutanol (16g/L) High (pGPD) SSB1/2 IB-32-1 
Isobutanol (16g/L) High (pGPD) SSB1/2 IB-33-1 
Isobutanol (16g/L) High (pGPD) RPL41B IB-35-1 




In this work, we have demonstrated that RNA interference is an effective tool for 
expediting the design-build-test cycle and enabling rapid prototyping of engineered yeast 
strains.  We have uncovered several important design principles influencing knockdown 
level, and have used an optimized scheme to demonstrate the effectiveness of RNAi 
through testing a putative genetic target for improved itaconic acid production.  We have 
additionally used this approach to enable the creation of genome-wide knockdown 
libraries and have applied this approach to successfully identify knockdown targets for 
the improvement of 1-butanol and isobutanol tolerance.  The portable nature of this 
approach (only requiring heterologous expression of Argonaute and Dicer) can enable 
rapid prototyping of both previously engineered and unsequenced industrial strains (esp. 
where polyploidy may be a substantial hurdle to genome engineering).  Due to the 
linkage between downregulation capacity and hairpin RNA expression, it is possible to 
develop more advanced control of this system through the use of inducible promoters 
(243), sophisticated logic circuits (244), or oscillators (257).  Finally, this work has the 
potential to be multiplexed (i.e. co-expressing many hairpin cassettes simultaneously) to 
investigate the impact of multiple gene knockdowns or streamlined by integrating all 
components necessary for RNAi (Dicer, Argonaute, and the hairpin) on the same vector.  
It is important to note that this system may be employed for rapid strain engineering in 
organisms which have not been sequenced or annotated and therefore may be highly 
beneficial for the rapid improvement of unsequenced industrial strains or environmental 
isolates.  Thus, this work opens the door for metabolic engineering in yeast using RNA 
interference, which enables wider exploration of knockout targets, more finely tuned 
control of knockdown level, and greater flexibility in strain evaluation, resulting in an 
expedited design-build-test cycle. 
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Chapter 9: Conclusions and Future work 
Taken together, the engineering strategies developed in this work enable a 
powerful approach to strain development, in which every control point for strain 
productivity has associated methods for either predictive design or comprehensive high-
throughput perturbation methods.  At the transcriptional level, we have shown that 
nucleosome occupancy is an important limiting factor to the activity of both native and 
synthetic promoters in yeast.  We have developed a method that, for the first time, allows 
researchers to increase native promoter strength in a single design-build-test cycle 
through computationally informed changes to promoter sequence.  Furthermore, this 
method enables the creation of fully synthetic yeast promoters (bearing no homology to 
any native sequence) which enable expression levels on par with the top 6% of highly 
expressed genes in yeast.  Not only does this method enable the creation of stronger (or 
weaker) promoters, but it also provides an intriguing platform for dissecting and 
optimizing synthetic promoter architecture in yeast.  By assembling transcription factor 
binding sites in a context unconfounded by nucleosome occupancy, researchers will gain 
clearer insight into the effects of transcriptional machinery position and orientation on 
promoter strength, thus uncovering the design rules behind native and synthetic yeast 
promoters.   
At the translational level, we have shown the significant impact of mRNA 
secondary structure on gene expression.  We showed that this effect is especially 
pronounced for codon-optimized genes, and that common sequences used for DNA 
assembly may be particularly inhibitory.  It is important to note that this phenomenon is 
not restricted to the context of multicloning sites upon which this study was based.  
Rather, any sequence appearing in the 5’UTR of a transcript, synthetic or otherwise, has 
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the potential to inhibit gene expression.  With this in mind, applications sensitive to gene 
expression levels (e.g. chemical production, biological part characterization, synthetic 
control of gene regulation, etc) must consider the effect of RNA context in the design of 
genetic constructs.  Further application of the techniques generated in this work may be 
useful for the design of optimized 5’UTRs for the creation of synthetic promoters. 
To accelerate the pace of protein engineering in yeast, we have developed a tool 
which enables mutagenesis and selection of large protein libraries in a continuous manner 
in vivo.  This powerful approach takes advantage of the mutagenic capabilities of reverse 
transcriptases which, coupled with the replicative machinery encoded in the Ty1 reverse 
transcriptase, enables the generation of mutant libraries of similar magnitude to those 
obtained using current state-of-the-art methods using significantly less effort.  We have 
shown that this approach is suitable to improve the tolerance of yeast to high 
concentrations of ethanol during osmotic stress through the mutagenesis of the global 
transcriptional regulator SPT15.   We expect to improve the success rate and reliability of 
ICE by optimizing our synthetic retroelement to function in a genomic context by 
improving transposition rates through optimizing culture conditions and expression of 
specific endonucleases.  In addition, we aim to improve the mutation rate of the reverse 
transcriptase through a combination of saturation mutagenesis, random mutagenesis, or 
expression of heterologous reverse transcriptases followed by screening for high mutation 
rates using several robust methods.  ICE, in its present form, enables the creation of 
libraries of the same size as which can be obtained through current methods, yet requires 
much less effort.  It is expected that these strategies mentioned above will in the near 
term enable ICE to far surpass state-of-the-art directed evolution techniques both in terms 
of success rate and labor intensity.  In addition to enabling the continuous directed 
evolution of expression cassettes and pathways, ICE may in the future be used in 
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conjunction with high-throughput sequencing to study evolutionary processes for a broad 
range of enzyme classes.  Excitingly, this synergy between techniques opens the door for 
the study of sequence-function relationships with much higher throughput than can be 
obtained with existing computational or experimental techniques.  Taken together, this 
work lays the foundation for a new platform technique in the engineering and study of 
yeast proteins. 
We have also developed a technique for rapid strain prototyping which makes use 
of RNA interference to tune gene expression in a facile manner.  We have elucidated the 
design rules for the construction of tunable downregulation cassettes, and we have shown 
that this approach may be implemented in a variety of yeast strains to controllably reduce 
gene expression without the need for time-consuming genomic modifications.  This 
approach was used for the rapid prototyping of the ade3 gene knockout for the 
improvement of itaconic acid production in three strains of yeast.  It was found that 
knockdown of ADE3 is beneficial to itaconic acid production in multiple strain contexts, 
thus demonstrating the utility of RNAi to screen potential strain modifications in a rapid 
manner before expending a significant amount of effort during genome editing.  This 
approach was then expanded to enable the construction of genome-wide libraries of 
downregulation cassettes, and the design rules for the construction of these vectors were 
elucidated in a similar fashion.  Then, this approach was used for the identification of 
knockdown targets which confer increased tolerance to 1-butanol, isobutanol, and lactic 
acid.  Upon verification of these knockdown targets through genome editing, we plan to 
iterate this approach in the context of an improved strain background to identify further 
targets.  In addition, by combining this approach with RNA-seq, genome-wide changes to 
gene expression enabled by our knockdown cassettes may be elucidated, thus uncovering 
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the genetic network related to our phenotype of interest and providing highly relevant 
knowledge for further strain engineering efforts.   
In addition to the strategies which have been successfully developed in this work, 
we can also gain insight by considering the approaches which did not go as planned.  
During the development of weak promoters, we discovered that the level of background 
transcription in standard expression vectors was quite large, especially for the low levels 
of expression we were interested in.  As a result, we became interested in developing a 
method that would enable accurate characterizations of promoter activity in a noise-free 
context.   Surprisingly, further work showed that we were unable to eliminate the context 
dependence of promoter activity by putting a terminator in front of each promoter.  It is 
possible that long-range context interactions, such as nucleosome occupancy, may have 
played a role in this result.  Therefore, in order to realize our original goal of developing 
robust, well-characterized weak promoters which enable a consistent level of gene 
expression regardless of context, what is needed is a synthetic insulator.  Such a part 
would enable gene circuits to behave reproducibly regardless of genetic context, and 
therefore would be highly useful in a broad range of applications to address growing 
concerns about the generality of complex synthetic constructs.   
Although we were unable to generate an IRES in yeast, our work illustrated the 
challenge inherent to proving IRES functionality.  In many cases, sequences which had 
been shown to exhibit IRES functionality in one context failed to show the same function 
in our screening vector, and instead showed promoter activity.  This certainly indicates 
that IRES functionality is highly context dependent, and may indicate that certain 
commonly used screening vectors are prone to false positives.  This conjecture has also 
been made by others (258).  Nevertheless, this work showed that a yeast IRES, if any, 
will be located at a substantial sequence and structural distance away from the 
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Dicistroviridae IRESs and that any screen for IRES functionality must not generate a 
positive signal if the IRES functions as a promoter.  Indeed, the ideal screen for future 
development IRES functionality would probably avoid the use of bicistronic reporter 
assays altogether and rather involve translation of an uncapped mRNA transfected 
directly into yeast, as this would better capture the innate features of an IRES and may be 
less prone to false positives.  It may be promising to use this assay as an orthogonal 
measure of IRES activity for the wild-type viral and cellular IRESs characterized in this 
work as well as for hits HM3 and SM7. 
In a broader sense, this work also illuminates some key characteristics of 
engineering biological systems.  Firstly, context is very important.  The DNA 
surrounding a synthetic construct can determine whether a design functions as expected, 
or whether it does not work at all.  However, by understanding the mechanism by which 
DNA context can modulate the activity of surrounding DNA parts, context effects can 
themselves be exploited to generate a more highly functional strain.  The multicloning 
site and nucleosome occupancy optimization studies both demonstrated that by designing 
biological parts with context in mind, great increases to construct functionality can be 
obtained.  As a second point, viruses are systems which have been evolutionarily 
optimized for doing genetic engineering; therefore, these systems may be a fertile source 
to fill many deficiencies in the metabolic engineer’s toolbox.  This work has shown that 
IRES elements, 2A peptides, retrotransposons, and RNA interference are all extremely 
useful to the metabolic engineer.  What is also remarkable is that each of these systems 
was originally developed by, or in response to, the action of viruses.  Although the idea 
of using viral parts for genetic engineering is by no means new, it is encouraging to note 
that as we endeavor to engineer a wider variety of organisms, we will always be able to 
take lessons from those systems which figured out how to deliver genetic material to our 
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favorite organism millions of years before we did.  Lastly, this work has emphasized that 
large populations of living systems are extremely clever.  If it is possible for a mutant 
strain to pass a selective pressure through a loophole, it will show up during a screen, 
often to the exclusion of mutants which passed the selective pressure in the way it was 
intended.  Although this phenomenon was an annoyance during the strain engineering 
conducted in this work, it copels us as the people who design living systems to respect 
the fact that the products we sell are prone to adaptation and selection throughout their 
life cycle.  Dr. Frances Arnold famously quipped: “You get what you screen for” 
because, as Dr. Ian Malcolm warned us: “Life finds a way.” 
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Chapter 10: Materials and Methods 
10.1 GENERAL METHODS 
10.1.1 Strains and Media 
 Yeast expression vectors were propagated in Escherichia coli DH10β.  E. coli 
strains were routinely cultivated in LB medium (259) (Teknova) at 37°C with 225 RPM 
orbital shaking.  LB was supplemented with 100 µg/mL ampicillin (Sigma) when needed 
for plasmid maintenance and propagation.  Yeast strains were cultivated on a yeast 
synthetic complete (YSC) medium containing 6.7 g of Yeast Nitrogen Base (Difco)/liter, 
20 g glucose/liter and a mixture of appropriate nucleotides and amino acids (CSM, MP 
Biomedicals, Solon, OH).  All medium was supplemented with 1.5% agar for solid 
media. 
 For E. coli transformations, 25 µL of electrocompetent E. coli DH10β(259) were 
mixed with 30 ng of ligated DNA and electroporated (2 mm Electrporation Cuvettes 
(Bioexpress) with Biorad Genepulser Xcell) at 2.5 kV.  Transformants were rescued for 
one hour at 37 °C in 1 mL SOC Buffer (Cellgro) plated on LB agar and incubated 
overnight.  Single clones were amplified in 5 mL LB medium and incubated overnight at 
37 °C.  Plasmids were isolated (QIAprep Spin Miniprep Kit, Qiagen) and confirmed by 
sequencing. 
For yeast transformations, 50 µL of chemically competent S. cerevisiae BY4741 
were transformed with 1 µg of each appropriate purified plasmid according to established 
protocols (242), plated on the appropriate medium, and incubated for three days at 30 °C.  
Single colonies were picked into 1mL of the appropriate medium and incubated at 30 °C. 
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10.1.2 Ligation Cloning Procedures 
 PCR reactions were performed with Q5 Hot-Start DNA Polymerase 
(NEB) according to manufacturer specifications.  Digestions were performed according 
to manufacturer’s (NEB) instructions, with digestions close to the end of a linearized 
strand running overnight and digestions of circular strands running for 1 hour at 37 °C.  
PCR products and digestions were cleaned with a QIAquick PCR Purification Kit 
(Qiagen).  Phosphatase reactions were performed with Antarctic Phosphatase (NEB) 
according to manufacturer’s instructions and heat-inactivated for 15 min at 65 °C.  
Ligations (T4 DNA Ligase, Fermentas) were performed for 6 h at 22 °C followed by heat 
inactivation at 65 °C for 15 min. 
10.1.3 Flow Cytometry Analysis 
Yeast colonies were picked in triplicate from glycerol stock, grown in the 
appropriate medium to mid-log phase, and analyzed (LSRFortessa Flow Cytometer, BD 
Biosciences.  Excitation wavelength: 488 nm, Detection wavelength: 530 nm).  Day-to-
day variability was mitigated by analyzing all comparable transformants on the same day.  
An average fluorescence and standard deviation was calculated from the mean values for 
the biological replicates.  Flow cytometry data was analyzed using FlowJo software.   
10.2 METHODS FOR CHAPTER 2 
10.2.1 Strains and media 
Saccharomyces cerevisiae strains BY4741 (MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0) and BY4741 ΔPCYC1 (MAT a; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; PCYC1::ura3) 
were used in this study.  BY4741 ΔPCYC1 was generated using the “delete and repeat” 
knockout method (242) with the K. lactis URA3 gene from plasmid PUG72 as the 
selectable marker.  Primers for the generation of the knockout cassette are in Appendix 
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Table A1-2.  Integration of the CYC1 promoter variants and yECitrine cassettes was 
completed by cloning the K. lactis URA3 gene upstream of each CYC1 promoter variant 
cassette (see below for plasmid construction) and then using the “delete and repeat” 
method to integrate both genes into the TRP1 locus.  See Appendix Table A1-2 for 
primers. 
10.2.2 Plasmid construction 
All plasmids used in this study were based on the p413 vectors described 
previously (181).  These plasmids contain the HIS3 gene as the auxotrophic marker.  The 
TEF1 and CYC1 promoters were available in the parent plasmid set.  The TEF1 mutant 
series of promoters and the yECitrine and LacZ genes were cloned via PCR from 
plasmids described previously (26,27,37,242).  The HXT7 and HIS5 promoters were 
cloned via PCR from extracted BY4741 gDNA obtained using the Wizard Genomic 
DNA Extraction Kit from Promega (Madison, WI).  Re-designed and synthetic promoters 
were ordered as gBlock fragments from Integrated DNA Technologies, Inc. (Coralville, 
IA) and then cloned via PCR (see Appendix Table A1-1 for promoter sequences and 
Appendix Table A1-2 for all primer sequences).   
10.2.3 Beta-galactosidase assay 
Strains expressing the LacZ gene were evaluated for beta-galactosidase activity 
through the chemiluminescent Gal-Screen system (Applied Biosystems).  Yeast cultures 
were grown for 16 hours to mid-log phase from a starting OD600=0.005.  Prior to the 
assay, cultures were diluted with fresh media to approximately OD600=0.01 to 0.07.  
OD600 was measured, and then cultures were treated with Gal-Screen Reaction Buffer 
according to the manufacturer’s instructions.  Luminescence was quantified using a 
Mithras LB 940 luminometer (Berthold Technologies). Day to day variation was avoided 
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by measuring all samples on the same day. The average luminescence across biological 
replicates was calculated. 
10.2.4 Quantitative PCR 
To measure mRNA levels resulting from re-designed promoters, quantitative PCR 
was performed.  Yeast cultures were grown for 16 hours to mid-log phase from a starting 
OD600=0.005, and RNA was extracted using Zymolyase digestion of the yeast cell wall 
followed by the Quick-RNA MiniPrep kit according to manufacturer’s instructions 
(Zymo Research Corp.).  cDNA was generated from the purified RNA via the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems).  Primers for qPCR 
were designed using the PrimerQuest® tool and obtained from Integrated DNA 
Technologies (see Appendix Table A1-2 for primers).  Quantitative PCR was performed 
on a ViiA7 qPCR system (Life Technologies) using SYBR Green Master Mix from 
Roche (Penzberg, Germany), following the manufacturer's instructions with an annealing 
temperature of 58°C and 0.25 μL of cDNA product per 20 μL reaction.  The ALG9 gene 
was used as a housekeeping gene, and the relative yECitrine transcript level was obtained 
by calculating the average values between three technical replicates for each sample. 
10.2.5 Nucleosome mapping 
Nucleosome position and density was mapped in the CYC1 and CYC1v3 
promoters.  The BY4741 ΔPCYC1 strain was used for this part of the study in order to 
prevent contaminating genomic sequence from confounding the results.  Plasmids p413-
CYC1-yECitrine and p413-CYC1v3-yECitrine were independently transformed into the 
strain as described above.  Mono-nucleosome sized genomic DNA fragments were then 
isolated from each strain using a method described previously (260).  Briefly, 200 mL of 
culture was grown to approximately OD600=0.8.  Cells were treated with 1% 
 188
formaldehyde for 30 minutes at 30°C.  The reaction was stopped by adding glycine to a 
final concentration of 125mM and cells were centrifuged at 3000g and washed twice in 
20 mL of PBS.  Cells were then resuspended in in 20 mL Zymolyase buffer (1 M 
sorbitol, 50 mM Tris pH 7.4, 10 mM 2-mercaptoethanol), then spheroplasted with 50 U 
Zymolyase (Zymo Research Corp.) for 40 min at 30°C.  Cells were then washed once 
with 10 mL Zymolyase buffer and resuspended in 2 mL NP Buffer (1 M sorbitol, 50 mM 
NaCl, 10 mM Tris pH 7.4, 5 mM MgCl2, 0.075% NP 40, 1 mM 2-mercaptoethanol, 500 
µM spermidine).  Aliquots of 500 µL were split between four tubes for each sample, and 
CaCl2 was added to a final concentration of 3 mM.  Micrococcal nuclease (New England 
Biolabs) digestions were performed at concentrations ranging from 100 to 600 U/mL for 
10 min at 37°C.  Reactions were stopped by adding 100 µL stop buffer (5% SDS, 500 
mM EDTA).  Proteinase K (New England Biolabs) was added to each tube at a final 
concentration of 100 mg/mL and incubated at 65°C for approximately 8 hours.  DNA was 
purified using phenol-chloroform-isoamyl alcohol (25:24:1) extraction and ethanol 
precipitation.  Resuspended DNA was treated with DNase-free RNase (Promega) for 30 
min at 37°C, then re-extracted using phenol-chloroform-isoamyl alcohol and ethanol 
precipitation.  DNA was resuspended in 50 µL water and run in a 2% agarose gel.  The 
dilution with the most apparent mono-nucleosome sized band (approximately 150 bp) 
was extracted using the Invitrogen Pure-Link gel extraction kit (Life Technologies, 
Carlsbad, CA).   
A tiling array of primer sets was designed for each promoter as described 
previously (23) to perform quantitative PCR.  Primers were designed using the 
PrimerQuest® tool and obtained from Integrated DNA Technologies (see Appendix 
Table A1-3 for primers).  Quantitative PCR was performed  as described above using 0.5 
μL of mono-nucleosome DNA extract (at 10 ng/µL)  per 10 μL reaction.  A section of the 
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ampicillin gene on each plasmid was used as a control to account for any variation in 
total plasmid copy number between the two samples.  Standard curves were created for 
each primer set using a serial dilution of the corresponding whole plasmid with 
concentration varying from 5x107 to 5x103 copies per μL.  The relative copy number for 
each primer set in the promoter was calculated using these standard curves and 
comparing to the ampicillin primer set.   
10.2.6 Computational methods 
Nucleosome occupancy of native yeast promoters was optimized through the use 
of a computational algorithm.  First, transcription factor binding sites present in the wild-
type sequence were manually identified through the use of the Yeast Promoter Atlas16.  
Then, nucleotides outside these sites were systematically perturbed using a custom 
MATLAB script, which utilized a FORTRAN implementation of the Nucleosome 
Positioning Prediction (NuPoP) engine (146) to predict nucleosome affinity.  Minor 
modifications to NuPoP were made to enable the acceptance of command-line inputs.  
The cumulative sum of nucleosome affinities over each mutant promoter was then 
computed and the nucleotide substitution resulting in the largest decrease in total 
nucleosome affinity was saved.  This single nucleotide variant was then systematically 
perturbed as above so that successive increases in promoter strength were achieved in an 
iterative fashion.  This MATLAB script additionally avoided the creation of new 
transcription factor binding sites (148) and also restricted promoter designs to those 
which could be synthesized as gblocks by Integrated DNA Technologies, Inc. (Coralville, 
Iowa) which was the vendor chosen to provide the synthetic DNA in this project.   
The identity and placement of transcription factor binding sites in the synthetic 
promoter scaffolds were determined using a bioinformatics analysis of glycolytic 
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promoters as a guide.  The occurrence and relative positions of common transcription 
factor binding sites were catalogued and the average spacing values were calculated (See 
Table 1-1).  In addition to a consensus TATA box, four transcription factor binding sites 
were included in the upstream activating sequence area of the synthetic promoter:  a 
Reb1p binding site, a Rap1p binding site, and two Gcr1p binding sites.  Consensus 
binding site sequences were used (148).  Psynth1 was designed using the average lengths 
between binding sites and Psynth2 was identical, except that the minimum length of the 
two longest regions (between the GCR1p binding site and the TATA box and between 
the TATA box and the transcription start site) was used instead of the average length in 
an attempt to make a shorter promoter.  The TDH3 transcription start site and 5’ UTR 
was used for both synthetic promoters in order to prevent any confounding issues from 
having different 5’ UTR structures between promoters.  Once the binding sites and 
relative positions were chosen, this information was then used as input to a custom 
MATLAB script to generate the Psynth series of vectors.  First, the undetermined 
nucleotides between each transcription factor binding site were randomly seeded at a GC 
content of 35%. Once any inadvertent transcription factor binding sites generated in these 
regions were removed, nucleosome affinity was reduced in an iterative fashion as above.  
As before, the creation of new transcription factor binding sites or sequences which could 
not be synthesized was avoided.  All computations were performed on an Intel Core 2 
Duo processor running Windows 7.   
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10.3 METHODS FOR CHAPTER 3 
10.3.1 Plasmid Construction 
Plasmids constructed in this study were constructed through restriction digestion 
followed by ligation.  The schemes for construction of these plasmids are detailed in 
Appendix Tables A2-2,3,4. 
10.3.2 Growth Rate Analysis 
Strains of interest were precultured for 3 days in the appropriate selective 
medium, and 1 uL of this precultured was used as an inoculum for a 250 uL culture in 
selective medium containing 5-FOA and reduced concentrations of uracil.  Growth rate 
measurements were then obtained using a Bioscreen C (Growth Curves USA). 
10.4 METHODS FOR CHAPTER 4 
10.4.1 Plasmid Construction 
10.4.1.1 Plasmid Construction: yECitrine Insert Series 
Oligos 5-15 (Appendix Table A3-3) were annealed by combining 750 pmol of 
each complementary oligo in 1X T4 DNA Ligase Buffer (NEB) and incubating at 95 °C 
for 150 sec.  The mixture was then steadily cooled from 75 °C to 25 °C over 24 min. The 
annealed product was cleaned with a MERmaid Spin Kit (Qbiogene), digested with XbaI, 
and ligated to the phosphatased XbaI fragment of a p416 (181) vector expressing 
yECitrine with either a mutant TEF promoter (TEFpmut5 (184)), GPD, or CYC1.  Vector 
and insert digestions were performed for 3 hours at 37 °C and cleaned with a QIAquick 
PCR Purification Kit (Qiagen) and MERmaid Spin Kit, respectively.  Ligations were 
performed at room temperature for 30 min, followed by heat inactivation.  Plasmids from 
distinct E. coli colonies were isolated, sequenced, and transformed into yeast.  The 
yECitrine Insert Series is detailed in Appendix Table A3-1. 
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10.4.1.2 yECitrine pBLUESCRIPT SK Multicloning Site Series  
 yECitrine was cloned from pT5Y (Appendix Table A3-1) using PCR.  Primers 
matching 29 base pairs of yECitrine were used to add restriction sites to both ends of the 
gene, for a total of 8 different yECitrine PCR products (forward primers: 16-23, reverse 
primer: 25).  After digestion, these yECitrine fragments were each ligated separately into 
the multi-cloning sites of p416-TEF, p416-GPD, and p416-CYC.  The pCYC0xYFP 
series used oligo 26 as reverse primer because the XhoI site is not unique in p416-CYC.  
pGPD06YFP, pTEF06YFP, pCYC06YFP, and pCYC08YFP were made with assembly 
PCR (see Designed Multicloning Site Series.  TEFp, GPDp, or CYC1p, CYC1 
terminator, and assembly oligos (pGPD06YFP, pTEF06YFP, and pCYC06YFP: 28-29, 
pCYC08YFP: 28 & 30) comprised the first reaction.  Full-length product was amplified, 
digested, and ligated as for the designed MCS series). pCYC09YFP was constructed by 
swapping CYC1 for GPD in construct pGPD09YFP through SacI-XbaI fragmentation.  
This resulted in 27 distinct plasmids, detailed in Appendix Table A3-4. 
10.4.1.3 yECitrine Designed Multicloning Site Series  
 Novel MCSs were generated with assembly PCR.  PCR products of TEFp 
(primers 31-32), GPDp (primers 33-34), or CYC1p (primers 35-36) were combined with 
CYC1 terminator (primers 37-38) and assembly oligos (39-42, 43-45, 46-48, 49-52, or 
53-56) at 30 nM each and amplified (94 °C for 1 min, 68 °C for 2 min, 72 °C for 3 min, 
25 cycles).  Full-length product was then amplified from 2.5 µL of this mixture (forward 
primers 31, 33, or 35; reverse primer 38), digested with SacI and KpnI, and ligated to a 
phosphatased SacI-KpnI fragment of p416.  yECitrine was inserted at each restriction site 
as for the pBLUESCRIPT SK series (forward primers 16-24, reverse primers 25,26, or 57 
as necessary) resulting in the constructs shown in Table 4.  pCYC111YFP was 
constructed with CYC1p, CYC1 terminator, and primer 58 using assembly PCR because 
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XhoI is not unique in this construct.  The yECitrine Designed Multicloning Site Series is 
listed in Appendix Table A3-2. 
10.4.1.4 LacZ pBLUESCRIPT SK Multicloning Site Series  
 LacZ was isolated from whole-genome extract of E. coli K12-MG1665 (Wizard 
Genomic DNA Purification Kit, Promega) with PCR (primers 59-60), fragmented with 
XbaI and ClaI, and ligated to p416-GPD.  LacZ was inserted at XbaI as for the 
pBLUESCRIPT SK series (primers 61-62).  pTEF03LacZ, pTEF05LacZ, pTEF07LacZ, 
and pTEF09LacZ were constructed using assembly PCR (LacZ-CYC1term (primers 38 & 
63) and assembly oligos (pTEF03LacZ: 65, pTEF05LacZ: 66-67, pTEF07LacZ: 66 & 68, 
pTEF09LacZ: 66, 69-70) comprised the first reaction.  Full-length product was amplified 
in a second reaction (primers 38 & 64)).  Each product was digested with XbaI and KpnI, 
and ligated to p416-TEF.  The resulting LacZ pBLUESCRIPT KS Multicloning Site 
Series is detailed in Appendix Table A3-5. 
10.4.1.5 GFP pBLUESCRIPT SK Multicloning Site Series 
GFP was isolated from pZE-GFP (185) using PCR (forward primers 71-75, 
reverse primer 76), fragmented, and ligated to p416-TEF at XbaI, BamHI, EcoRI, ClaI, 
and XhoI as for the pBLUESCRIPT SK series.  The resulting GFP pBLUESCRIPT SK 
Multicloning Site Series  is detailed in Appendix Table A3-6. 
10.4.2 RT-PCR Assay 
 For each tested variant, the replicate yielding the most typical fluorescence 
measurement was grown to an optical density of 0.5 and its RNA was extracted 
(Ribopure Yeast Kit, Ambion).  100 ng RNA was reverse-transcribed and quantified in 
triplicate using an iScript One-Step RT-PCR Kit with SYBR Green (Biorad) immediately 
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after RNA extraction.  yECitrine transcript levels were measured relative to that of ALG9 
(Primers 1-4) on a 7900HT Real Time PCR Instrument (Applied Biosystems).   
10.4.3 β-Galactosidase Assay 
 Yeast colonies were picked in triplicate, grown in YSC Ura- to an optical density 
of 0.5, and prepared according to manufacturer’s instructions (Novabright β-
Galactosidase Enzyme Reporter Gene Chemiluminescent Detection Kit for Yeast Cells, 
Invitrogen).  Luminescence was quantified with a SpectraMax M3 Multi-Mode 
Microplate Reader (Molecular Devices).  Day-to-day variability was accounted for by 
analyzing all comparable transformants on the same day. 
10.4.4 Computational Studies and Modeling Efforts 
 Nupack2.1.2 (176) was used to perform all RNA folding calculations.  Folding 
conditions of 30 °C, 1 M Na+, and 0 M Mg2+ were utilized.  All reported energies are the 
free energies of the ensemble of potential structures, as opposed to the minimum free 
energy structure.  Pseudoknots were not considered due to computational limitations.  1st 
and 2nd round computations were run on an intel Xeon processor running MATLAB.  3rd 
round computations were run on all cores of an intel core i7 processor running 
MATLAB.  Most optimizations were run over 24 hours.   
10.4.4.1 1st round of optimization 
 The first set of MCSs (pTEF1xYFP and pCYC11xYFP) were designed with the 
goal of maximizing the ensemble free energy of the complete 5’UTR (261-264).  Design 
proceeded using a hill-climbing algorithm in a two-step process, using the free energy of 
the longest possible 5’UTR (i.e. cloning into the last possible restriction site in the MCS) 
as its score.  The restriction sites were first reordered to maximize free energy, followed 
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by the addition of up to 5 bp between each restriction site to further increase free energy 
(Figure 10-1B,C).   
10.4.4.2 2nd round of modeling and optimization 
 To address the limitations of the first model of structure-based translation 
inhibition, a model framework was developed incorporating two (or more) regions whose 
free energy of folding correlates with protein production.  These free energy barriers can 
occur as the complex is scanning along the 5’UTR or as the complex is binding to the 5’ 
cap structure.  If Ni is the number of complexes in state i and Ni+1 is the number of 
complexes in the next state, then we have:  
௜ܰାଵ ൌ ௜ܰ݁ݔ݌	ሺെߚ ∗ ∆ܩሻ 
where ΔG is the magnitude of the free energy barrier and β represents the 
Boltzmann constant of the system (i.e. how energetic each complex is and thus how 
likely it is to traverse energetic barriers).  Such results from statistical mechanics are 
valid due to the large number of yeast cells measured.  If there are N complexes in the 
first (unbound) state, we have: 
௜ܰ ൌ ܰ ∗ෑ݁ݔ݌	ሺെߚ௜ ∗ ∆ܩ௜ሻ
௜
 
where βi are the Boltzmann constants at each state, ΔGi are the free energies of 
each barrier between them.  We can rewrite the product to yield 
௜ܰ ൌ ܰ ∗ ݁ݔ݌	ሺ෍െߚ௜ ∗ ∆ܩ௜
௜
ሻ 
Assuming there are i states and the rate of translation initiation (hence protein 
production) is proportional to the number of initiation complexes in the last state (the 
state closest to the start codon), we have 




where f is the fluorescence value and C is a proportionality constant (since the 
data have been normalized to the fluorescence of a particular construct).  If we take the 
logarithm of both sides, we can correlate the logarithm of the fluorescence to barrier free 
energies by fitting the Boltzmann constants and the proportionality constant, C: 
log	ሺ መ݂ሻ ൌ 	෍െߚመ௜ ∗ ∆ܩ௜
௜
൅ ܥመ  
where the hat denotes the estimator of a variable.  This framework was used to 
develop models for the 2nd and 3rd rounds of modeling. 
 Models and novel MCSs were evaluated using the ensemble free energies of two 
disjoint segments of RNA as predictors.  The boundaries for each segment were 
measured relative to the start codon.  Although possibly between the boundaries of each 
segment, nucleotides which were not between the start of the 5’UTR and 30 bp after the 
start codon were not included in folding calculations.  
 In addition to the pBLUESCRIPT SK MCS data, the yECitrine expression 
resulting from a number of other post-promoter “inserts” (see “yECitrine insert series”) 
were also used to train the predictive model for each promoter.  A hill-climbing algorithm 
was implemented to search for the two segments whose free energies best correlated with 
the data for all the available constructs according to the framework above (Figure 10-
1A).  The correlation coefficient was used to score each potential model.   
 Hill-climbing algorithms were similarly used to search for the best possible MCS 
in a two-step process similar to the first round of optimization (Figure 10-1B,C).  For 
each potential MCS, a score was calculated using the model developed above.  A positive 
value was given to those positions which, when yECitrine was inserted at that site, 
resulted in a higher predicted fluorescence than had been predicted at the same position 
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step process: (B) a hill-climbing algorithm to find the optimal ordering of restriction sites followed by (C) a 
hill-climbing algorithm to further decrease the likelihood of secondary structure formation.  (D)  The 
second round of modeling undertook an exhaustive search of all possible pairs of regions to find the set 
which showed the greatest predictive ability. 
10.5 METHODS FOR CHAPTER 5 
10.5.1 Plasmid Construction 
Plasmids in this study were constructed by first PCRing the appropriate template 
with the indicated primers, as detailed in Appendix Tables A4-1,2,3, and 4.  These PCR 
products were then digested with DpnI (NEB), gel-purified (GeneJet Gel Extraction Kit, 
Thermo Scientific), phosphorylated with T4 polynucleotide kinase (NEB), and ligated 
with T4 DNA ligase (NEB).   
10.5.2 Western Blotting 
10.5.2.1 Characterization of a Panel of 2A Sites 
50mL of exponential-phase cells expressing the desired bicistronic reporter 
construct in the appropriate growth medium were pelleted and protein was extracted (Y-
PER Yeast Protein Extraction Reagent, Thermo Scientific).  This extract was then 
denatured (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, 
0.125 M Tris-HCl, pH 6.8), applied to an SDS-PAGE gel (12% stacking, 6% separating) 
and proteins were separated through electrophoresis (mini-PROTEAN system, BioRAD).  
This gel was then incubated in transfer buffer (25 mM Tris, 190 mM Glycine, 20% 
methanol, pH 8.3) and proteins were transferred to a PVDF membrane through 
electrophoresis at 150 mA for 1.4 h.  This membrane was then blocked for 1h with 
TBST+milk (20mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween 20, 5% milk), then 
exposed to an HRP-conjugated anti-his antibody for 1 h and washed 3 times with TBST.  
Conjugated HRP was then visualized with Supersignal West Pico Chemiluminescent 
Substrate (Thermo). 
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10.5.2.2 Characterization of 2A Variants 
50mL of exponential-phase cells expressing the desired bicistronic reporter 
construct in the appropriate growth medium were pelleted and protein was extracted (Y-
PER Yeast Protein Extraction Reagent, Thermo Scientific).  This extract was then 
denatured (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, 
0.125 M Tris-HCl, pH 6.8), applied to an SDS-PAGE gel (12% stacking, 6% separating) 
and proteins were separated through electrophoresis (mini-PROTEAN system, BioRAD).  
This gel was then incubated in transfer buffer (25 mM Tris, 190 mM Glycine, 20% 
methanol, pH 8.3) and proteins were transferred to a nitrocellulose membrane.  This 
membrane was then blocked overnight with TBST+milk (20mM Tris pH 7.5, 150 mM 
NaCl, 0.1% Tween 20, 5% milk), washed 5 times then TBST, then exposed to an HRP-
conjugated anti-his antibody for 30 mins and washed again 5 times with TBST.  
Conjugated HRP was then visualized with Immun-star HRP substrate (Bio-rad). 
10.6 METHODS FOR CHAPTER 6 
10.6.1 Plasmid Construction 
Plasmids for this study were constructed according to the schemes detailed in 
Appendix A5.  The procedure for recombination cloning was identical to that used in 
chapter 6, and the procedure for phosphorylation ligation was identical to that used in 
chapter 4. 
10.7 METHODS FOR CHAPTER 7 
10.7.1 Recombination Cloning in Yeast 
1 ug of each PCR fragment was digested with DpnI and cotransformed into S. 
cerevisiae BY4741 according to the procedure described in (242).  This transformation 
mixture was then plated on the appropriate dropout medium and allowed to grow for 3 
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days at 30 C.  Yeast colonies from this plate were scraped and plasmids were extracted 
(Zymoprep Yeast Miniprep Kit, Zymo Research).  This plasmid mixture was then 
transformed into E. coli DH10β and plated.  Individual colonies were then amplified in 
liquid culture and plasmids were extracted.  Correctly assembled plasmids were 
confirmed through restriction digestion and sequencing. 
10.7.2 Analysis of Transposition Efficiency 
10.7.2.1 Plate-based induction 
Three to five biological replicates of a yeast strain carrying the engineered 
retrotransposon of interest were used to inoculate 1 mL liquid cultures lacking histidine 
and containing galactose, thus inducing retroelement transcription.  After 3 days of 
growth at 30 C, cultures were plated on agar containing glucose and either lacking 
histidine or lacking both histidine and uracil and allowed to grow for 3 days at 30 C.  
Colonies were counted manually or through automated software (265) and counts were 
used as inputs to the Fluctuation Analysis Calculator (266)  implementing the Ma, Sandri, 
and Sarkar Maximum Likelihood Estimation method (267).  Calculated mutation rates 
per cell were divided by the time spent in galactose medium to determine the 
transposition rate per cell per generation (r as defined above) as well as 95% confidence 
intervals.  This value was then used to estimate a library size as described above. 
10.7.2.2 Low OD induction 
Three biological replicates of a yeast strain carrying the engineered 
retrotransposon of interest were used to inoculate 50 mL liquid cultures lacking histidine 
and containing galactose, thus inducing retroelement transcription.  After 3 days of 
growth at 30 C, cultures were plated on agar containing glucose and either lacking 
histidine or lacking both histidine and uracil and allowed to grow for 3 days at 30 C.  
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Colonies were counted manually or through automated software (265) and counts were 
used as inputs to the Fluctuation Analysis Calculator (266) implementing the Ma, Sandri, 
and Sarkar Maximum Likelihood Estimation method (267).  Calculated mutation rates 
per cell were divided by the time spent in galactose medium to determine the 
transposition rate per cell per generation as well as 95% confidence intervals.  This value 
was then used to estimate a library size. 
10.7.2.3 High OD induction 
For high OD tests, cells were first cultivated in 50 mL liquid cultures lacking 
histidine and containing glucose and then resuspended in 50 mL liquid cultures lacking 
histidine and containing galactose to an initial OD of 1.  After 3 days of growth at 30 C, 
cultures were plated on agar containing glucose and either lacking histidine or lacking 
both histidine and uracil and allowed to grow for 3 days at 30 C.  Colonies were counted 
manually or through automated software (20) and counts were averaged.  This average 
was then used as an estimate for the number of transpositions which occurred during the 
experiment. 
10.7.3 qPCR Analysis 
Yeast strains carrying pGALmTy1-HIV were grown to mid-log phase (OD=0.5) 
in 5 mL YSC containing either glucose or galactose.  Total RNA was extracted (Ribopure 
Yeast Kit, Life Technologies) from half of each culture and converted to cDNA (High 
Capacity cDNA Reverse Transcription Kit, Life Technologies).  Total DNA was 
extracted (Wizard Genomic DNA Purification Kit, Promega) from the other half of the 
culture.  qPCR was conducted using 10ng of either cDNA or total DNA (FastStart SYBR 
Green Master, Roche) using primers specific for an intronless URA3 (URA3RTPCRF and 
URA3RTPCRR) and with Alg9 as an internal standard (Alg9F and Alg9R). 
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10.7.4 Models 
10.7.4.1 Model for Mutation Accumulation in Continuous Culture 
If a collection of yeast cells is held at a constant cell density and transposition is 
induced, mutants will begin to accumulate.  If we assume that wild-type and mutant cells 
grow at the same rate, then the fraction of unmutated cells will decrease solely due to 
mutation and not competition with faster-growing cells.  If f0 represents this fraction and 
r represents the mutation rate per cell per unit of time, then we have 
݀ ଴݂
݀ݐ ൌ െݎ ଴݂ 
with f0(0)=1.  The fraction of singly mutated cells (f1) similarly decreases in proportion to 
its size but is replenished by the decrease in f0.  For this population and indeed for all 
cells with containing n transpositions we have 
݀ ௡݂
݀ݐ ൌ ݎ ௡݂ିଵ െ ݎ ௡݂ 
for n>0 and with fn(0)=0.  These equations may be solved to yield 
௡݂ሺݐሻ ൌ 1݊! ሺݎݐሻ
௡ ∗ exp	ሺെݎݐሻ 
Thus, computation of the mutation rate per cell per time enables a highly detailed picture 
of the culture to be ascertained.  In this work, mutation rates will be calculated per cell 
per 1.5 hours (one doubling time) and library sizes will be calculated assuming 10^10 
cells growing for one week in continuous culture by computing (1-f0(100))*10^10.   
10.7.4.2 Computational framework for deducing transposition rate and mutation 
rate from the two-color assay 
Assume the following: 
௧݂ = transpositions / cell (~0.1 for Ty1) 
ݎ௠ = mutation rate / bp (~0.0001 for Ty1) 
ܮଵ = Length of gene 1 (YFP = 717bp)  
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ܮଶ = Length of gene 2 (RFP = 711bp) 
ூ݂భ= fraction of mutations which inactivate gene 1 (assumed to be approximately 
0.3) 
ூ݂మ= fraction of mutations which inactivate gene 2 (assumed to be approximately 
0.3) 
݌௡௠ = probability of getting n mutations in gene 1 and m mutations in gene 2, 
given transposition 
ܫ଴଴ = prob of no inactivation given n mutations in gene 1 and m mutations in gene 
2 
ܫଵ = prob of inactivating only gene 1 given n mutations in gene 1 and m mutations 
in gene 2 
ܫଶ = prob of inactivating only gene 2 given n mutations in gene 1 and m mutations  
in gene 2 
ܫଵଶ	= prob of inactivating both genes given n mutations in gene 1 and m mutations 
in gene 2 
Probabilities of: 
No transposition: 
1 െ ௧݂ 
Transpose and inactivate 1: 






Transpose and inactivate 2: 






Transpose and inactivate both: 
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What is ݌௡௠? 
݌௡௠ ൌ ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡ ቀ
ܮଶ݉ቁݎ௠௡ሺ1 െ ݎ௠ሻ௅మି௠ 
What is ܫ଴଴? 










What is ܫଵ? 













What is ܫଶ? 








ܫଶ ൌ ൫1 െ ூ݂భ൯
௡൫1 െ ൫1 െ ூ݂మ൯
௠൯ 
What is ܫଵଶ? 











ܫଵଶ ൌ ൫1 െ ൫1 െ ூ݂భ൯
௡൯൫1 െ ൫1 െ ூ݂మ൯
௠൯ 
Therefore we have the fraction of cells not fluorescent: 
1 െ ௧݂ ൅ ௧݂ ∗෍ ෍ ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡ ቀ
ܮଶ݉ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅మି௠൫1 െ ൫1 െ ூ݂భ൯







1 െ ௧݂ ൅ ௧݂ ∗෍ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡൫1 െ ൫1 െ ூ݂భ൯







1 െ ௧݂ ൅ ௧݂ ∗ ቀ1 െ ൫1 ൅ ൫1 െ ூ݂భ൯ݎ௠ െ ݎ௠൯
௅భቁ ቀ1 െ ൫1 ൅ ൫1 െ ூ݂మ൯ݎ௠ െ ݎ௠൯
௅మቁ 
And similarly for the fraction of cells in region exhibiting dual fluorescence: 
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௧݂ ∗෍ ෍ ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡ ቀ








௧݂ ∗෍ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡൫1 െ ூ݂భ൯







௧݂ ∗ ൫1 ൅ ൫1 െ ூ݂భ൯ݎ௠ െ ݎ௠൯
௅భ൫1 ൅ ൫1 െ ூ݂మ൯ݎ௠ െ ݎ௠൯
௅మ 
RFP only: 
௧݂ ∗෍ ෍ ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡ ቀ








௧݂ ∗෍ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡൫1 െ ൫1 െ ூ݂భ൯







௧݂ ∗ ቀ1 െ ൫1 ൅ ൫1 െ ூ݂భ൯ݎ௠ െ ݎ௠൯
௅భቁ ൫1 ൅ ൫1 െ ூ݂మ൯ݎ௠ െ ݎ௠൯
௅మ 
YFP only: 
௧݂ ∗෍ ෍ ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡ ቀ
ܮଶ݉ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅మି௠൫1 െ ூ݂భ൯







௧݂ ∗෍ቀܮଵ݊ ቁ ݎ௠௡ሺ1 െ ݎ௠ሻ௅భି௡൫1 െ ூ݂భ൯







௧݂ ∗ ൫1 ൅ ൫1 െ ூ݂భ൯ݎ௠ െ ݎ௠൯
௅భ ቀ1 െ ൫1 ൅ ൫1 െ ூ݂మ൯ݎ௠ െ ݎ௠൯
௅మቁ 
A MATLAB script has been developed to infer mutation rate and transposition 
rate given the proportions of cells which are nonfluorescent, exhibit dual fluorescence, or 
which only express a single fluorescent protein.  We have shown this script to accurately 
infer these parameters for mutation rates up to 0.0009, a greater than 6-fold increase in 
mutation rate over wild-type Ty1RT, and a mutation rate which would enable 
significantly higher library sizes for smaller DNA sequences.   
10.7.4.3 Plasmid Segregation Inefficiency Calculations 
If we assume that each plasmid contained within the mother cell has an equal 
probability (p) of being transferred to the daughter cell (total plasmid number = n) and we 
observe some fraction of daughter cells which do not contain a plasmid (f), then we must 
have the following relationship: 
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݂ ൌ ሺ1 െ ݌ሻ௡ 
Thus, we can infer p from measurements of n and f.  Then, the average number of 
plasmids delivered to a daughter cell per budding is simply equal to p*n.   
10.7.5 Next-Generation Sequencing 
10.7.5.1 Next-Generation Sequencing Sample Preparation 
Ten replicates from BY4741 Δrrm3 plus pGALmTy1-Ty1 or BY4741 
Δhir3Δcac3 plus pGALmTy1-HIV were cultivated in 50 mL liquid cultures lacking 
histidine and containing glucose.  After 3 days of growth at 30 C, 1 mL culture was 
removed and the plasmids were extracted using Zymoprep Yeast Plasmid Miniprep Kit II 
(Zymo Research).  The rest of the culture was then resuspended in 50 mL liquid cultures 
lacking histidine and containing galactose to an initial OD of 1.  After 3 days of growth at 
30 C, 1 mL culture was extracted to obtain plasmids, and 1 mL culture was plated on agar 
containing glucose and either lacking histidine or lacking both histidine and uracil and 
allowed to grow for 3 days at 30 C.  Colonies were counted manually or through 
automated software (268) and counts were averaged.  This average was then used as an 
estimate for the number of transpositions which occurred during the experiment.  Two 
sequencing primer pairs with different barcodes were used to amplify the ampicillin 
sequence region from fresh pGALmTy1-Ty1 plasmid and pGALmTy1-Ty1 plasmid 
extracted from glucose medium, and 20 primer pairs amplified the URA3 sequence region 
from the 20 minipreps of galactose cultures.  The PCR products were purified and the 
concentrations were determined by nanodrop.  A final concentration of 50 ng/μL sample 
was prepared by combining 22 PCR purified products, with a 5:2 molar basis of 
ampicillin amplicon to URA3 amplicon.  This mixture was then sequenced using an 
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Illumina Miseq in 2x250bp paired-end mode.  All PCR fragments and their 
corresponding primers are listed below. 
10.7.5.2 Analysis of Next Gen Sequencing Data 
 Paired-end reads were matched up and error-corrected using pandaseq 
(269) using stringent quality filtering (threshold=0.9).  Matched pairs were then divided 
up based upon barcode sequence using sabre, allowing for single nucleotide mutations 
(since each barcode was at least 2bp away from one another) and barcodes were removed 
with the trimmingreads.pl script of the NGS QC toolkit (270).  After combining reads 
originating from the same culture into the same file, alignment to the unmutated amplicon 
was performed using ssaha2 (271).  Custom shell scripts were then used to extract the 
total number of mutations identified (Appendix B.2) and 95% confidence intervals for 
mutation counts were computed using the method of the Clopper-Pearson Interval (272) 
10.7.6 Vector Construction 
10.7.6.1 Construction of Vectors with Homologous Recombination in Yeast 
All vectors which were constructed using yeast homologous recombination were 
assembled according to the schemes listed in Tables A6-1,2, and 3 
10.7.6.2 Generation of Transpositional Activator Expression Plasmids 
TEC1, ELG1, RTT101, HSX1, and TYE1 were amplified from the genome of S. 
cerevisiae using the primers listed in Table1.  These PCR fragments were digested with 
XmaI and XhoI and ligated to p425-GPD treated with XmaI, XhoI, and Antarctic 
phosphatase (NEB) using T4 DNA ligase according to the manufacturer’s instructions, 
generating p425-GPD-TEC1, p425-GPD-ELG1, p425-GPD-RTT101, p425-GPD-HSX1, 
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and p425-GPD-TYE1.  These plasmids were co-transformed with the appropriate 
retroelement in both BY4741 and BY4741 Δmre11 and transposition rate was measured. 
10.7.6.3 Generation of Truncated Reverse Transcriptase Expression Plasmids 
Truncated reverse transcriptases containing the HIV polymerase domain and 
either the HIV or Ty1 connection domain (tHT and tHH) were amplified from 
pGALmTy1-HIV and pGALmTy1-HTT with the primers listed in Table 3.   These PCR 
fragments were digested with SpeI and XhoI and ligated to p425-GPD (181) treated with 
SpeI, XhoI, and Antarctic phosphatase (NEB) using T4 DNA ligase according to the 
manufacturer’s instructions, generating p425-GPD-tHH andp425-GPD-tHT.  These 
plasmids were co-transformed with the appropriate retroelement in BY4741 and 
transposition rate was measured. 
10.7.6.4 Saturation Mutagenesis of Ty1 Reverse Transcriptase 
The pGALmTy1-Ty1 containing the CAN1 cassette was mutated at each of the 
three Ty1 Reverse Transcriptase target sites using a QuikChange Multi Site-directed 
Mutagenesis Kit (Agilent Cat#200514), using Ty145QCF, Ty225QCF, and Ty226QCF 
according to the manufacturer’s direction.  The resulting library was transformed into 
electrocompetent E. coli as described above and plated.  Single clones were amplified in 
5 mL LB medium and incubated overnight at 37 °C.  Plasmids were isolated using Zyppy 
Plasmid Mini-Prep Kit (Zyppy Cat#D4037) and the mutations were confirmed by 
sequencing. 
To construct the double mutants L145S/F225Y and L145/F225H, the QuikChange 
Multi Site-directed Mutagenesis Kit (Agilent Cat#200514) was used to introduce the 
L145S mutation into the previously made plasmids containing the F225Y or F225H 
mutations; in both cases, the QMTy1RTL145Sf and QMTy1RTL145Sr primers were 
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used.  For the other three point mutations, the pGALmTy1-Ty1 was used as a template in 
three PCR reactions using either primers Ty1RTL151Af and Ty1RTL151Af, 
Ty1RTK93Rf and Ty1RTK93R94rev, or Ty1RTR94Kf and Ty1RTK93R94rev.  Each 
reaction amplified a linear DNA fragment ~14 kbp in length, containing the entire 
retroelement sequence with a new single point mutation.  This PCR fragment was 
phosphorylated using Polynucleotide Kinase (New England Biolabs), and then 
subsequently ligated using T4 DNA Ligase (New England Biolabs) to form complete 
plasmids.   
10.7.6.5 Insertion of URA3-intron system into Ty1 Saturation Mutagenesis 
Library 
For each of the 57 variants in the three Ty1 saturation mutagenesis libraries, the 
CAN1 expression cassette was replaced by the URA3-intron cassette to allow testing of 
transposition rate.  First, URA3AI-2 was amplified through PCR using pGALmTy1-Ty1 
as a template and BefpptR and His3AIgenomeflankF primers.  The plasmid backbone 
was then digested with EcoRI and BsrGI (New England Biolabs) according to 
manufacturer instructions, which excised an approximately 650 bp region of the CAN1 
gene.  Transformation of the digested plasmid with the PCR product swapped the entire 
CAN1 gene with the URA3-intron system through homologous recombination.   
10.7.6.6 Construction of Retroelement Without Reverse Transcriptase 
The pGALmTy1-Ty1 was used as a template in PCR with primers 
His3AIgenomeflankF and ARTrev, resulting in a linear DNA fragment ~11 kbp in 
length, containing all parts of the retroelement except for the reverse transcriptase and 
incorporating a new stop codon after the integrase-reverse transciptase protein cleavage 
site.  This PCR fragment was phosphorylated using Polynucleotide Kinase (New England 
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Biolabs), then subsequently ligated using T4 DNA Ligase (New England Biolabs) to 
form the plasmid pGALmTy1-ART.  The plasmid sequence was verified by enzyme 
digestion and sequencing. 
10.7.6.7 Construction of HIV Reverse Transcriptase Variants 
First, two variants of pGALmTy1-HIV with both HIV and Ty1 primer binding 
sites were used as templates to revert two previously-made mutations in the HIV RT.  
This was done stepwise using the QuikChange Multi Site-directed Mutagenesis Kit 
(Agilent Cat#200514), first with primers HIVT1361GG1362AF and 
HIVT1361GG1362AR, then with primers HIVA343TQCF and HIVA343TQCR. 
Next, the protein cleavage site was inserted using PCR with the reverse primer 
PCSinsR and either PCS0insF, PCS3insF, or PCS6insF as the forward primer.  This 
resulted in a linear DNA fragment ~14 kbp in length, containing the entire retroelement 
sequence in addition to a new protein cleavage site and coding for either 0, 3, or 6 
additional amino acids from the Ty1 RT.  This PCR fragment was phosphorylated using 
Polynucleotide Kinase (New England Biolabs), and then subsequently ligated using T4 
DNA Ligase (New England Biolabs) to form a complete plasmid.  This process resulted 
in 16 pGALmTy1-HIV variants with each combination of the above factors – primer 
binding site, wild-type RT, and 4 variations of protein cleavage site. 
10.7.6.8 Construction of Vectors with Inactivated Integrase  
The pGALmTy1-Ty1 was used as a template in PCR with primers Ty2600F and 
Ty2600R, resulting in a linear DNA fragment ~14 kbp in length, containing the entire 
retroelement sequence in addition to a new 15-bp sequence in the integrase gene.  This 
PCR fragment was phosphorylated using Polynucleotide Kinase (New England Biolabs), 
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and then subsequently ligated using T4 DNA Ligase (New England Biolabs) to form a 
complete plasmid.   
10.7.6.9 Construction of “Cargo”-containing Retroelements 
The pGALmTy1-Ty1 vector was used as a template in PCR to create a linear 
DNA fragment with a break between the URA3 and RT gene.  To create various cargo 
genes, PCR fragments with homology were created using LacZ, eGFP, CAN1, and the 
mStrawberry-YFP gene (used in the two-color assay) as templates.  Primers were 
constructed such that homologous recombination added each gene after the stop codon of 
the RT with a frame-shift mutation in the start codon of the template gene, and none 
included a promoter sequence.  In this way, the DNA added should have a minimal effect 
due to transcription or expression.  The largest, pGALmTy1‐Ty1‐Cargo5, was made  by 
digesting Cargo3 and the mStraw‐YFP PCR fragment with EcoRI (New England Biolabs), 
and then subsequently ligating the two using T4 DNA Ligase (New England Biolabs) to 
form a complete plasmid.  All plasmid sequences were verified by enzyme digestion and 
sequencing.   
10.7.6.10 Construction of SPT15, XylA, and XylA Pathway Vectors 
The plasmids pGALmTy1-Ty1-XylA, pGALmTy1-Ty1-XylA3, pGALmTy1-
Ty1-Spt15 were constructed through homologous recombination cloning using the 
scheme outlined in the tables below.  The TEF1 promoter was then inserted into these 
plasmids in the following way.  The homologous XylA-TEF1 Spt15-TEF1 cassettes were 
amplified, digested with DpnI, and co-transformed with the above plasmids digested with 
NotI, yielding pGALmTy1-Ty1-XylA-TEF1, pGALmTy1-Ty1-XylA3-TEF1, and 
pGALmTy1-Ty1-Spt15-TEF1.  A multiple cloning site was then inserted into 
pGALmTy1-Ty1-XylA3 after the Ty1 reverse transcriptase.  A MCS cassette was 
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amplified through overlap-extension PCR of MCS1 and MCS2, and this construct was 
co-transformed with PXKSmcs digested with DpnI, yielding pGALmTy1-Ty1-MCS-
XylA3-TEF1.  The plasmid pGALmTy1-Ty1-MCS-XylA3-TEF1 was digested with NotI 
and EcoRI and ligated with NotI-XylA-TEF1-EcoRI cassette amplified from p415-TEF-
XylA, yielding the plasmid pGALmTy1-Ty1-MCS-XylA-TEF1.   
10.7.6.11 Construction of Low-copy Vectors 
The low-copy version of pGALmTy1-Ty1 was constructed through homologous 
recombination cloning using the scheme outlined in the tables below, using a p413 vector 
as a template for the CEN6/ARSH replication sequence and pGALmTy1-Ty1 as a 
template to make a linearized fragment lacking a replication site.  To construct low-copy 
versions of the four constructs used in current evolution experiments (XylA, XylA-3, 
Spt15, and Spt15-300), the same scheme and primers were used, and the high-copy 
version of each was used as a template for the homologous recombination.   
10.7.6.12 Construction of synthetic retroelements with intron-containing cargos 
pGALmTy1-Ty1-MCS-XylA-TEF1, pGALmTy1-Ty1-MCS-XylA3-TEF1, 
pGALmTy1-Ty1-Spt15-TEF1, and pGALmTy1-Ty1-Spt15-300-TEF1 were used as 
templates for PCR to generate products XylAintronnosite, XylA3intronnosite, 
Spt15intronnosite, and Spt15-300intronnosite.  These PCR products were digested with 
DpnI (New England Biolabs), phosphorylated with T4 polynucleotide kinase (New 
England Biolabs), and ligated with T4 DNA ligase (Fermentas, Inc) to generate 
pGALmTy1-Ty1-MCS-XylAintronnosite-TEF1, pGALmTy1-Ty1-MCS-
XylA3intronnosite-TEF1, pGALmTy1-Ty1-Spt15intronnosite-TEF1, and pGALmTy1-
Ty1-Spt15-300intronnosite-TEF1.  These vectors were then used to generate PCR 
products XylAintron, XylA3intron, Spt15intron, and Spt15-300intron, which were treated 
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as above to generate pGALmTy1-Ty1-MCS-XylAintron-TEF1, pGALmTy1-Ty1-MCS-
XylA3intron-TEF1, pGALmTy1-Ty1-Spt15intron-TEF1, and pGALmTy1-Ty1-Spt15-
300intron-TEF1. 
10.7.6.13 Construction of Nonevolving Controls 
pGALmTy1-Ty1-MCS-XylA-TEF1 (low copy), pGALmTy1-Ty1-MCS-XylA3-
TEF1 (low copy), pGALmTy1-Ty1-Spt15-TEF1 (low copy), pGALmTy1-Ty1-Spt15-
300-TEF1 (low copy), pGALmTy1-Ty1-MCS-XylAintron-TEF1 (low copy), 
pGALmTy1-Ty1-MCS-XylA3intron-TEF1 (low copy), pGALmTy1-Ty1-Spt15intron-
TEF1 (low copy), and pGALmTy1-Ty1-Spt15-300intron-TEF1 (low copy) were used as 
templates for PCR to generate products XylAlcnoRT, XylA3lcnoRT, SPT15lcnoRT, 
SPT15-300lcnoRT, XylAlcintnoRT, XylA3lcintnoRT, SPT15lcintnoRT, and SPT15-
300lcintnoRT, respectively.  These PCR products were digested with DpnI (New 
England Biolabs), phosphorylated with T4 polynucleotide kinase (New England Biolabs), 
and ligated with T4 DNA ligase (Fermentas, Inc) to generate pGALmTy1-MCS-XylA-
TEF1 (low copy), pGALmTy1-MCS-XylA3-TEF1 (low copy), pGALmTy1-Spt15-TEF1 
(low copy), pGALmTy1-Spt15-300-TEF1 (low copy), pGALmTy1-MCS-XylAintron-
TEF1 (low copy), pGALmTy1-MCS-XylA3intron-TEF1 (low copy), pGALmTy1-
Spt15intron-TEF1 (low copy), and pGALmTy1-Spt15-300intron-TEF1 (low copy). 
10.7.6.14 Construction of Ty1 and HIV Reverse Transcriptase Fluorescent Fusion 
Proteins 
To construct both Ty1-RT and HIV-RT fusion proteins, the pGALmTy1-Ty1 and 
pGALmTy1-HIV vectors were first linearized by digestion with BamHI and NotI (New 
England Biolabs).  PCR was used to create a fragment including the YFP gene with 
overlap such that the YFP would recombine before the stop codon of the RT (Either 
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YFPHARTfusF or YFPTARTfusF and YFPfusR).  Homologous recombination cloning 
using the scheme outlined in the tables below was carried out, and the correct plasmids 
were confirmed by digestion and sequencing.  Next, the linker was inserted using PCR of 
the entire vector with primers incorporating the additional sequence (either 
Ty1RTlinkerR or HIVRTlinkerR and YFPlinkerF).  This linearized vector was then 
phosphorylated (using T4 PNK, New England Biolabs), and subsequently ligated using 
T4 DNA Ligase (New England Biolabs) to form a complete plasmid 
10.7.6.15 Construction of Ty1 Two-color Fluorescent Retroelement system 
To construct the two-color fluorescent retroelement system, pGALmTy1-Ty1-
TEF-mStrawberry-intron-P2A-YFP, PCR was used to create a fragment including the 
mStrawberry-P2A-YFP gene with restriction sites for XmaI and EcoRI (using primers 
mStraw-YFPf and mStraw-YFPr).  Both this PCR fragment and pGALmTy1-Ty1-TEF-
XylA3 were digested with XmaI and EcoRI, and then subsequently ligated using T4 
DNA Ligase (New England Biolabs) to form a complete plasmid, pGALmTy1-Ty1-TEF-
mStrawberry-P2A-YFP.  Next, the artificial intron was inserted using PCR of the entire 
vector with primers incorporating the additional sequence (mStrawIntPmef and 
mStrawIntPmer).  This linearized vector incorporated a PmeI site in the artificial intron to 
enable more efficient ligation; the PCR product was then digested with PmeI (New 
England Biolabs), and subsequently ligated using T4 DNA Ligase (New England 
Biolabs) to form a complete plasmid.  This construction scheme was carried out using a 
high-copy plasmid as a template, and it was then transferred to a low-copy version 
through homologous recombination cloning, using a p413 vector as a template for the 
CEN6/ARSH replication sequence and pGALmTy1-Ty1-TEF-mStrawberry-intron-P2A-
YFP as a template to make a linearized fragment lacking a replication site.   
 215
10.7.6.16 Construction of Xylose Catabolism Pathway Vectors 
To construct the xylose catabolism pathway vector, fragments TEF1, XylA, XylA3, 
Tkc1, GPD, XKS1, and Tkc6 were amplified.  The plasmid pGALmTy1-Ty1-Tkc1-XylA-
TEF1 was constructed by three sequential ligations with TEF1, XylA, and Tkc1 into 
plasmid pGALmTy1-Ty1-MCS.  The plasmid pGALmTy1-Ty1-Tkc1-XylA3-TEF1 was 
constructed by three sequential ligations with TEF1, XylA3, and Tkc1 into plasmid 
pGALmTy1-Ty1-MCS.  The plasmid pGALmTy1-Ty1-Tkc6-XKS1-GPD was 
constructed by three sequential ligations with GPD, XKS1, and Tkc6 into plasmid 
pGALmTy1-Ty1-MCS.  Then the GPD-XKS1-Tkc6 cassette was amplified and ligated 
into plasmids pGALmTy1-Ty1-Tkc1-XylA-TEF1 and pGALmTy1-Ty1-Tkc1-XylA3-
TEF1 respectively, yielding xylose isomerase pathway plasmids pGALmTy1-Ty1-Tkc6-
XKS1-GPD-Tkc6-XylA-TEF1 and pGALmTy1-Ty1-Tkc6-XKS1-GPD-Tkc6-XylA3-
TEF1.  
10.7.6.17 Construction of Arabinose Pathway Vectors 
The DNA parts which comprised the arabinose pathway will be amplified through 
PCR, and individual expression cassettes will then be constructed by combining a 
promoter, gene, and terminator through assembly PCR.  Finally, these assembly PCR 
products will be transformed together with the pGALmTy1-Ty1 backbone to generate 
pGALmTy1‐Ty1‐ara3gene,  pGALmTy1‐Ty1‐aranoLXR,  pGALmTy1‐Ty1‐aranoXKS,  and 
pGALmTy1‐Ty1‐ara5gene, as detailed below.   
10.7.7 Strain Construction 
10.7.7.1 Construction of gene knockouts in S. cerevisiae BY4741 and CEN.PK2 
For all knockouts, a loxP-kanMX-loxP deletion cassette was constructed from 
plasmid PUG6 (24).  One kilobase of homologous sequence was amplified from the 
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upstream region of gene of interest in the genome, and then ligated at the 5’ end of the 
loxP-kanMX-loxP module.  A second kilobase of homologous sequence amplified from 
the downstream region of the gene was then ligated at the 3’ end of the loxP-kanMX-loxP 
module.  The whole gene disruption cassette was amplified and transformed into S. 
cerevisiae BY4741 and CEN.PK2, using a standard lithium acetate transformation 
method (242) and a version optimized for CEN.PK2 (273),  respectively.  Cells were then 
plated onto YPD plus G418 plates (200 μg/mL G418).  After one day of growth, the 
microcolonies were replicated onto new YPD plus G418 plates.  The resulting colonies 
were amplified in 3 mL YPD+G418 and the genomic DNA was extracted using Wizard 
Genomic DNA Purification kit (Promega).  Correct knockouts were confirmed by PCR.   
Confirmed single knockout strains were transformed with the cre expression 
plasmid pSH47 (242).  Cre recombinase was induced by incubating cell in YPG 
(galactose) medium for 24 h.  The cells were subsequently streaked onto YPD and 
replica-plated onto YPD plus G418.  The cre expression plasmid in G418-sensitive 
colonies was removed by incubating cells in YPD plus 5-FOA for 24 h, thus excising the 
plasmid and yielding a clean version of knockout strain with a single loxP site in the 
chromosome.  Sequential gene knockouts were introduced with the same protocol using 
the clean strain, yielding a double-knockout strain.  The constructed knockout strains are 
listed in Table A6-4. 
10.7.7.2 Construction of GRE Knockout strains 
The plasmid p415-TEF-XKS was first constructed through ligation of 
XbaIXKS1XhoI with p415-TEF digesed with XbaI and XhoI.  The GRE3KO+XKS and 
GRE3KO cassettes were amplified from p415-TEF-XKS, which share 40 nt of homology 
to upstream and downstream of gre3 gene.  The gene disruption cassettes were then 
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transformed into strain BY4741 Δrrm3, using a standard lithium acetate transformation 
method (242).  Cells were plated onto a yeast synthetic complete plate lacking leucine 
containing glucose.  10 colonies from each plate were amplified and the genomic DNA 
was extracted using a Wizard Genomic DNA Purification kit (Promega).  The correct 
knockouts were confirmed by PCR.  All PCR fragments and their corresponding primers 
are listed below.  The confirmed knockout strains were transformed with the appropriate 
plasmids for in vivo continuous evolution. 
10.7.8 Oscillation Evolution Strategy 
A strain containing the appropriate retroelement was first pre-cultured in a yeast 
synthetic complete medium lacking histidine and containing 2% glucose for 1 to 2 days.  
The pre-cultured cells were then resuspended into 20 mL of culture containing 2% 
galactose to an initial OD of 1, thus inducing retroelement transposition.  For the 
oscillation evolution strategy, after 3 days of growth at 30 C, cells were transferred to 
500-mL selective liquid culture (a yeast synthetic complete medium lacking histidine and 
containing 120 g/L glucose and 6% to 8.25% ethanol) to an appropriate initial OD of 
0.1―0.2.  The flasks were then tightly sealed with rubber stoppers and parafilm to 
prevent ethanol evaporation.  After exponential phase, the culture underwent additional 
retrotransposition induction and selection by serially culturing in a sequence of galactose 
and selective media for multiple alternating cycles.  For each round of selection, a 1 µL 
sample of culture was plated on glucose to isolate colonies.   
10.7.9 Continuous Evolution Strategy 
In the continuous evolution strategy, each culture was first grown up in glucose, 
then subcultured into 20 mL of 20 g/L galactose media at OD 1.0 for 3 days to induce 
retrotransposition.  The induced culture was then centrifuged, washed with water, and 
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inoculated into 500 mL of 120 g/L galactose with 6.0% ethanol.  The cultures were 
grown at 30oC until they reached stationary phase (OD > ~2.0), then subcultured again.  
The first subculture was 10% of the volume (50 mL), with each subsequent subculture 
using half the volume as the previous (5%, 2.5%, etc…).  In addition, each subculture had 
0.5% higher ethanol concentration (6.5%, 7.0%, etc…).  The OD of each culture was 
measured each day (see Figures 3 and 4). 
10.7.10 Mutant Isolation Method 
 All the PCR, digestion, gel electrophoresis, gel extraction, and sequencing 
followed general molecular cloning procedures.  Here the Q5-hot start high-fidelity DNA 
polymerase (New England Biolabs) was used as the polymerase.  Primers used for 
sequencing were listed in Table 1.  The primer LacZBegSeqrev was used to sequence 
plasmid-based evolution cassette.  The primers NotITEFF and SacIISpt15R were used to 
amplify and sequence genome-based evolution cassette.  The intron-spanning primers 
NotITEFF and Spt15NointronR were used to amplify and sequence TEF promoter, while 
primers Spt15NointronF and SacIISpt15R were used to amplify and sequence Spt15 or 
Spt15-300.   
10.8 METHODS FOR CHAPTER 8 
10.8.1 Strains and Media 
Yeast strains are listed in Appendix Table A7-2 and A7-7 
10.8.2 Cloning Procedures 
Restriction enzyme-based plasmid construction schemes are detailed in Appendix 
Table A7-5.  Oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, IA).  PCR reactions were performed with Q5 Hot-Start High-Fidelity DNA 
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Polymerase from New England Biolabs (Ipswich, MA) according to manufacturer 
specifications and the schemes listed in Appendix Table A7-4. Homologous 
recombination-based plasmid construction schemes are detailed in Appendix Table A7-
6.  All assembly reactions were performed according to standard procedures (274). 
10.8.3 RT-PCR Assay 
 For each tested variant, the replicate yielding the most typical fluorescence 
measurement or itaconic acid yield was grown to an optical density of 0.5 and its RNA 
was extracted (Quick-RNA Miniprep, Zymo Research Corporation).  2 µg RNA was 
reverse-transcribed (High Capacity cDNA Reverse Transcription Kit, Applied 
Biosystems) and quantified in triplicate (SYBR Green PCR Master Mix, Life 
Technologies) immediately after RNA extraction.  Transcript levels were measured 
relative to that of a housekeeping gene (ALG9) (Viia 7 Real Time PCR Instrument, Life 
Technologies).  Primers used for quantification are listed in Appendix Table A7-3. 
10.8.4 Itaconic Acid Production 
 Strains of interest were precultured for 3 days in the appropriate selective 
medium, and 30uL of this culture were used as inoculum for a 3mL culture in the same 
medium, which was grown for 3 days in a rotary drum incubator at 30 ºC.  This culture 
was then pelleted down (4 min at 1600 x g), and the supernatant was filtered using a 0.22 
µm syringe filter (Corning).  2.0 µL of filtrate was analyzed with a HPLC Ultimate 3000 
(Dionex) using a Zorbax SB-Aq column (Agilent) in a mobile phase composed of 99.5% 
potassium phosphate buffer (pH=2.0) and 0.5% acetonitrile at 30 ºC.   Flow rate was 
maintained at 1.25 mL/min and absorption was measured at 210 nm.    
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10.8.5 Growth Rate Analysis 
Strains of interest were precultured for 3 days in the appropriate selective 
medium, and 1 uL of this precultured was used as an inoculum for a 250 uL culture in the 
same selective medium.  Growth rate measurements were then obtained using a 
Bioscreen C (Growth Curves USA). 
10.8.6 cDNA Library Generation 
Total RNA was extracted from yeast using the RNA Extraction kit (Ambion) and 
converted to cDNA using a (High Capacity cDNA Reverse Transcription Kit, Applied 
Biosystems) according to manufacturer’s instructions with the exception that primer 
oligodTEcoRIR2 substituted for the random hexamer primer provided with the kit.  This 
cDNA was then purified using the Qiagen PCR cleanup kit and ligated to primer 
RNALigAd using T4 RNA Ligase (NEB) according to manufacturer’s instructions.  This 
ligation was purified using the Qiagen PCR cleanup kit and amplified using Q5 hot-start 
DNA polymerase and primers XmaIFlankF and EcoRIFlankR2 according to 
manufacturer’s instructions.  Amplicons ranging in size from 500bp to 5kb were gel-
extracted (Genejet gel purification kit) and re-purified using the Qiagen PCR cleanup kit.  
This purified, double stranded, full-length cDNA was then sheared using a covaris 
sonicator to an average length of 200bp or 400bp, blunt-ended and phosphorylated using 
the End-It DNA End Repair Kit (Epicentre), and ligated to either p414-CYC-rad9-MCS-








































































































































Appendix Table A1-1: Sequences of re-designed and synthetic promoters. 
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Underlined sequences in the synthetic promoters Psynth1 and Psynth2 are designated transcription factor 




































































Appendix Table A1-2: Primer sequences for cloning of promoters, yECitrine and 
LacZ genes, knockout and integration cassettes, and primers for qPCR of 
yECitrine. 
All re-designed and synthetic promoters were cloned using the “general promoter primers” with the 
exception of HIS5v1, which was cloned using the HIS5 promoter primer set 
 
Primer set Mid-amplicon location 
relative to start codon 

































































Appendix Table A1-3: Primers for nucleosome mapping tiling array. 
Primers sets marked with a * were used for both CYC1 and CYC1v3.  All other sets were used for a 
specific promoter as noted. 
Appendix A2 
Plasmid Name Source 
P413-CYC1 (181) 
P413-NUP57-URA3 Kate Curran 
P413-TFC1-URA3 Kate Curran 
P416-TEFpmut7-YFP (27) 
Appendix Table A2-1: Plasmids used in this study 






















Appendix Table A2-2: Primers used in this study (IDT) 
Name Primer 1 Primer 2 Template 
URA3 p416ura3BamH1fwd p416ura3EcoR1rev BY4741 genome 
CYC1 CYC1p F CYC1pmXbaSpeR P413-CYC1 
CYC1libs CYC1p F CYC1pmXbaSpeR P413-CYC1 
YFP MCS-Fwd-SpeI MCS-Rev-2 P416-TEFpmut7-YFP 
CYC1mut3 CYC1pF CYC1pmXbaSpeR P413-CYC1mut3-URA3 
CYC1mut7 CYC1pF CYC1pmXbaSpeR P413-CYC1mut7-URA3 
CYC1mut8 CYC1pF CYC1pmXbaSpeR P413-CYC1mut8-URA3 
CYC1mut13 CYC1pF CYC1pmXbaSpeR P413-CYC1mut13-URA3 
CYC1mut16 CYC1pmut16F CYC1pmut16R None 
CYC1mut17 CYC1pF CYC1pmut17R P413-CYC1mut17-URA3 
CYC1mut18 CYC1pF CYC1pmut18R P413-CYC1mut18-URA3 
CYC1mut19 CYC1pF CYC1pmut19R P413-CYC1mut19-URA3 
CYC1mut20 CYC1pmut20F CYC1pmut20R None 
CYC1mut22 CYC1pmut22F(2) CYC1pmut22R(2) P413-CYC1mut22-URA3 
CYC1mut23 CYC1pF CYC1pmut17R P413-CYC1-URA3 
Appendix Table A2-3: PCR products generated in this study 







P413-CYC1 URA3 BamHI EcoRI 
P413-CYC1libs-
URA3 
P413-CYC-URA3 CYC1libs SpeI SacI 
P423-CYC1-
YFP 












































P423-CYC1-YFP CYC1mut23 SacI SpeI 
































Appendix Table A2-5: Promoter mutants generated in this study 
Appendix A3 
pT5Y TEFpmut5-TCTAGA-AAA-YFP 
pT21(1) F TEFpmut5-TCTAGA-GAATTC-TCTAGA-AAA-YFP 



















pT21(3) F TEFpmut5-TCTAGA-GGGCCC-TCTAGA-AAA-YFP 
pT21(3) FF TEFpmut5-TCTAGA-GGGCCC-TCTAGA-GGGCCC-TCTAGA-AAA-YFP 
pT21(4) F TEFpmut5-TCTAGA-AAATTT-TCTAGA-AAA-YFP 
pT21(4) FF TEFpmut5-TCTAGA-AAATTT-TCTAGA-AAATTT-TCTAGA-AAA-YFP 
pT26 F TEFpmut5-TCTAGA-GA-GAATTC-AGG-TCTAGA-AAA-YFP 
pT26 RR TEFpmut5-TCTAGA-CCT-GAATTC-TC-TCTAGA-CCT-GAATTC-TC-
TCTAGA-AAA-YFP 








pG21(2) R GPD-TCTAGA-CCAACC-TCTAGA-AAA-YFP 




































pC21(1) F CYC1-TCTAGA-GAATTC-TCTAGA-AAA-YFP 












pC21(3) F CYC1-TCTAGA-GGGCCC-TCTAGA-AAA-YFP 
pC21(3) FF CYC1-TCTAGA-GGGCCC-TCTAGA-GGGCCC-TCTAGA-GGGCCC-
TCTAGA-AAA-YFP 
pC21(4) F CYC1-TCTAGA-AAATTT-TCTAGA-AAA-YFP 









































































































Appendix Table A3-2: pTEF1xYFP, pTEF2xYFP, pGPD2xYFP, pCYC11xYFP, 
and pCYC12xYFP. 
1 RT YFP Fwd TTCTGTCTCCGGTGAAGGTGAA 
2 RT YFP Rev TAAGGTTGGCCATGGAACTGGCAA 
3 RT ALG9 Fwd ATCGTGAAATTGCAGGCAGCTTGG 
4 RT ALG9 Rev CATGGCAACGGCAGAAGGCAATAA 
5 21(1) GC-TCTAGA-GAATTC-TCTAGA-GC 
6 21(2)F GC-TCTAGA-GGTTGG-TCTAGA-GC 
7 21(2)R GC-TCTAGA-CCAACC-TCTAGA-GC 
8 21(3) GC-TCTAGA-GGGCCC-TCTAGA-GC 
9 21(4) GC-TCTAGA-AAATTT-TCTAGA-GC 
10 26F GC-TCTAGA-GA-GAATTC-AGG-TCTAGA-GC 
11 26R GC-TCTAGA-CCT-GAATTC-TC-TCTAGA-GC 
12 36F GC-TCTAGA-AGTAGCC-GAATTC-TGTCAGTT-TCTAGA-GC 






16 YFPXbaIF GC-TCTAGA-ATGTCTAAAGGTGAAGAATTATTCACTGG 
17 YFPSpeIF G-ACTAGT-ATGTCTAAAGGTGAAGAATTATTCACTGG 
18 YFPBamHIF CG-GGATCC-ATGTCTAAAGGTGAAGAATTATTCACTGG 
19 YFPXmaIF TCC-CCCGGG-ATGTCTAAAGGTGAAGAATTATTCACTGG 
20 YFPEcoRIF G-GAATTC-ATGTCTAAAGGTGAAGAATTATTCACTGG 
21 YFPClaIF CC-ATCGAT-ATGTCTAAAGGTGAAGAATTATTCACTGG 
22 YFPSalIF TAACGC-GTCGAC-ATGTCTAAAGGTGAAGAATTATTCACTGG 
23 YFPXhoIF CCCCG-CTCGAG-ATGTCTAAAGGTGAAGAATTATTCACTGG 
24 YFPHindIIIF CCCCCC-AAGCTT-ATGTCTAAAGGTGAAGAATTATTCACTGG 
25 YFPXhoIR CCCCG-CTCGAG-TTATTTGTACAATTCATCCATACCATGGG 
26 YFPSalIR TAACGC-GTCGAC-TTATTTGTACAATTCATCCATACCATGGG 







31 TEFpF CCCCCC-GAGCTC-ATAGCTTCAAAATGTTTCTAC 
32 TEFpR AAACTTAGATTAGATTCGTATGCTTTCTTTC 
33 GPDpF CCCCCC-GAGCTC-AGTTTATCATTATCAATACTCGCCA 
34 GPDpR ATCCGTCGAAACTAAGTTCTGG 
35 CYC1pF CCCCCC-GAGCTC-ATTTGGCGAGCG 
36 CYC1pR TTAGTGTGTGTATTTGTGTTTGCG 
37 CYCtermF ATTAGTTATGTCACGCTTACATTCACG 





































57 YFPXmaIR TCC-CCCGGG-TTATTTGTACAATTCATCCATACCATGGG 
58 CD1-1R AGTGAATAATTCTTCACCTTTAGACAT-CTCGAG-
TTAGTGTGTGTATTTGTGTTTGC 
59 LacZExtF GC-TCTAGAAAA-ATGACCATGATTACGGATTCACTGG 
60 LacZExtR ACGCGTCGACGGTATCGAT-
TTATTTTTGACACCAGACCAACTGG 
61 LacZXbaIF GC-TCTAGA-ATGACCATGATTACGGATTCACTGG 
62 LacZXhoIR CCCCG-CTCGAG-TTATTTTTGACACCAGACCAACTGGT 
63 LacZF ATGACCATGATTACGGATTCACTG 
64 Mummcsfwd GC-TCTAGA-ACTAGT-GGATCC-CCC 
65 TL3F TCTAGA-ACTAGT-GGATCC-ATGACCATGATTACGGATTCAC 
66 TL57F TCTAGA-ACTAGT-GGATCC-CCCGGG-CTGCAG-GAATTC 





70 TL9F GATACC-GTCGAC-CTCGAG-ATGACCATGATTACGGATTCAC 
71 GFPXbaIF GC-TCTAGA-ATGCGTAAAGGAGAAGAACTTTT 
72 GFPBamHIF CG-GGATCC-ATGCGTAAAGGAGAAGAACTTTT 
73 GFPEcoRIF G-GAATTC-ATGCGTAAAGGAGAAGAACTTTT 
74 GFPClaIF CC-ATCGAT-ATGCGTAAAGGAGAAGAACTTTT 
75 GFPXhoIF CCCCG-CTCGAG-ATGCGTAAAGGAGAAGAACTTTT 
76 GFPXhoIR CCCCG-CTCGAG-TTAAACTGCTGCAGCGTAG 
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Appendix Table A3-4: pTEF0xYFP, pGPD0xYFP and pCYC10xYFP. 
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pTEF01LacZ TEF-TCTAGA-LacZ 
pTEF03LacZ TEF-TCTAGA-ACTAGT-GGATCC- LacZ 





Appendix Table A3-5: pTEF0xLacZ 
pTEF01GFP TEF-TCTAGA-GFP 








Appendix Table A3-6: pTEF0xGFP 
Appendix A4 
Plasmid Name Source 
P426-GAL-mStrawberry- PSIV -YFP Chapter 5 
Appendix Table A4-1: Plasmids used in this study 






















Appendix Table A4-2: Primers used in this study (IDT) 
Name Primer 1 Primer 2 Template 
P2A P2AYFPGlcF P2AstrawGlcR P426-GAL-mStrawberry-PSIV-YFP 
T2A T2AYFPGlcF T2AstrawGlcR P426-GAL-mStrawberry- PSIV -YFP 
E2A E2AYFPGlcF E2AstrawGlcR P426-GAL-mStrawberry- PSIV -YFP 
P2Ahis HistagYFPF HistagYFPR P426-GAL-mStrawberry-P2A-YFP 
E2Ahis HistagYFPF HistagYFPR P426-GAL-mStrawberry-E2A-YFP 
P2Av2 P2Av3YFPF P2Av3mStrawberryR P426-GAL-mStrawberry-P2A-
YFPhisx6 
P2Ad P2AdYFPF P2AdR P426-GAL-mStrawberry-P2A-
YFPhisx6 
Appendix Table A4-3: PCR products generated in this study 
Name Construction Fragment Figs used in 
P426-GAL-mStrawberry-P2A-YFP P2A 4-1 
P426-GAL-mStrawberry-T2A-YFP T2A 4-1 
P426-GAL-mStrawberry-E2A-YFP E2A 4-1 
P426-GAL-mStrawberry-P2A-YFPhisx6 P2Ahis 4-2,3 
P426-GAL-mStrawberry-E2A-YFPhisx6 E2Ahis 4-2 
P426-GAL-mStrawberry-P2Av2-YFPhisx6 P2Av2 4-3 
P426-GAL-mStrawberry-P2Ad-YFPhisx6 P2Ad 4-3 
Appendix Table A4-4: Plasmids generated in this study 
Appendix A5 














CrPV Vector Johnny 
HIPV Vector Johnny 
PSIV Vector Johnny 
SWSS Plasmid Ellington Lab 
CrTMV Plasmid Ellington Lab 
Gypsy Plasmid Ellington Lab 
Omega plasmid Jewett Lab 
G20 plasmid Jewett Lab 
G22 plasmid Jewett Lab 
G35 plasmid Jewett Lab 
G38 plasmid Jewett Lab 
G93 plasmid Jewett Lab 
G94 plasmid Jewett Lab 
OmegaT7 plasmid Jewett Lab 
G20T7 plasmid Jewett Lab 
G22T7 plasmid Jewett Lab 
G35T7 plasmid Jewett Lab 
G93T7 plasmid Jewett Lab 




Appendix Table A5-1: Plasmids used in this study 
Primer Name Sequence 
HIS3 Fwd gg-actagt-atgacagagcagaaagcc 





Ires Fwd g-gaattc-CGACTGCATAGGGTTACC 
Ires Rev2 gc-tctaga-GGTTGTGGCCATTATCATCG 




50N Fwd CGAACTGGTTGTGGgaattc 








































































































































Appendix Table A5-2: Primers used in this study (IDT) 
Name Primer 1 Primer 2 Template 
HIS3 HIS3 Fwd HIS3 Rev P413-GPD 
YFP MCS-Fwd-XbaI YFP-BamHI-REV P416-TEFmut7-YFP 
EMCV Ires Fwd Ires Rev2 pIRES-hrGFP 
EMCVlib Ires Fwd Ires Rev2 pIRES-hrGFP 
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IRESproms SacI IRES fwd Ires Rev2 Promising IRES Isolates 
50N 50N Fwd 50N Rev 50N 2 
M4lib Ires Fwd Ires Rev2 P416-GPD-HIS3-M4-
YFP 
IREShrlib IREShomFwd IREShomRev P416-GPD-HIS3-
EMCV-YFP 
IRESlcBBhr IRESBBFwd IRESBBRev P416-GPDMCSrev2 
50Nhr 50NFwd3 50NRev3 50N 3 
GPD-HIS3-EMCV-
YFP 
GPD fwd MCS-Rev-2 P416-GPD-HIS3-
EMCV-YFP 
IREShcBBhr IRESBBFwd IRESBBRev P426-GPD-HIS3-
EMCV-YFP 
Tadh SacITadhF TadhHindIIISpeIR Yeast genome 
CFP SpeIyECitrineF EcoRIyECitrineR pKT102 
GFP SpeIyECitrineF EcoRIyECitrineR pKT127 
Sapphire SpeIyECitrineF EcoRIyECitrineR pKT149 
mStrawberry SpeImStrawberryF EcoRImStrawberryR pmStrawberry 
Venus SpeIyECitrineF EcoRIyECitrineR pKT103 
YFPup SpeIyECitrineF EcoRIyECitrineR pKT120 
GPD GPDsacF GPDR P426-GPD-HIS3-
EMCV-YFP 
stem StemloopInsert None None 
CrPVhr1 CrPVshorthomF CrPVshorthomR CrPV Vector 
HiPVhr1 HiPVshorthomF HiPVshorthomR HIPV Vector 
PSIVhr1 PSIVshorthomF PSIVshorthomR PSIV Vector 
IREShcBBterm IRESBBFwd IRESBBRev P426-Tadh-HIS3-YFP 
EMCVhr IRESmutF IRESmutR  
CrPVhr2 IRESmutF IRESmutR P426-Tadh-HIS3-CrPV-
YFP 
HiPVhr2 IRESmutF IRESmutR P426-Tadh-HIS3-HIPV-
YFP 
PSIVhr2 IRESmutF IRESmutR P426-Tadh-HIS3-PSIV-
YFP 
50NB4hr IRESmutF IRESmutR IRES isolate from 
Library 4 
50ND7hr IRESmutF IRESmutR IRES isolate from 
Library 4 
50ND3hr IRESmutF IRESmutR IRES isolate from 
Library 4 
50NB8hr IRESmutF IRESmutR IRES isolate from 
Library 4 
IRESDFBBhrterm IRESBBFwd2 IRESBBRev2 P426-Tadh-
mStrawberry-YFP 
Stem-mStrawberry HindIII EcoRI P426-GPD-stem- 
mStrawberry-YFP 
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P150 p150F p150R Yeast genome 
YAP1 YAP1F YAP1R Yeast genome 
SWSS SWSSF SWSSR SWSS Plasmid 
CrTMV CrTMVF CrTMVR CrTMV Plasmid 
Gypsy gypsyF gypsyR Gypsy Plasmid 
IRESDFBBhr IRESBBFwd2 IRESBBRev2 P426-GPD-
mStrawberry-YFP 
Isolatehr IRESmutF IRESmutR IRES isolate 
GAL SacIGalF GALHindIIIR Yeast genome 
Omega OmegaWTF OmegaWTR Omega plasmid 
G20 OmegaG20F OmegaG20R G20 plasmid 
G22 OmegaG22F OmegaG22R G22 plasmid 
G35 OmegaG35F OmegaG35R G35 plasmid 
G38 OmegaG38F OmegaG38R G38 plasmid 
G93 OmegaG93F OmegaG93R G93 plasmid 
G94 OmegaG94F OmegaG94R G94 plasmid 
omegaT7 T7promF OmegaWTR OmegaT7 plasmid 
G20T7 T7promF OmegaG20R G20T7 plasmid 
G22T7 T7promF OmegaG22R G22T7 plasmid 
G35T7 T7promF OmegaG35R G35T7 plasmid 
G93T7 T7promF OmegaG93R G93T7 plasmid 
G101T7 T7promF OmegaG101R G101T7 plasmid 
URE2 URE2F URE2R Yeast genome 
GALBBhr IRESBBFwd2 IRESBBRev2 P426-GAL-
mStrawberry-IRES-YFP 
CrPVSD1 CrPV- Loop1F CrPV- Loop1R P426-GAL-
mStrawberry-CrPV-YFP
CrPVSD2 CrPV- PSF CrPV- PSR P426-GAL-
mStrawberry-CrPV-YFP
CrPVSD3 CrPV- connhp1F CrPV- connhp1R P426-GAL-
mStrawberry-CrPV-YFP
CrPVSD4 CrPV- connhp2F CrPV- connhp2R P426-GAL-
mStrawberry-CrPV-YFP
CrPVSD5 CrPV- conn3F CrPV- conn3R P426-GAL-
mStrawberry-CrPV-YFP
HIPVSD1 HIPV- Loop1F HIPV- Loop1R P426-GAL-
mStrawberry-HiPV-YFP
HIPVSD2 HIPV- PSF HIPV- PSR P426-GAL-
mStrawberry-HiPV-YFP
HIPVSD3 HIPV- connhp1F HIPV- connhp1R P426-GAL-
mStrawberry-HiPV-YFP
HIPVSD4 HIPV- connhp2F HIPV- connhp2R P426-GAL-
mStrawberry-HiPV-YFP
HIPVSD5 HIPV- conn3F HIPV- conn3R P426-GAL-
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mStrawberry-HiPV-YFP
PSIVSD1 PSIV- Loop1F PSIV- Loop1R P426-GAL-
mStrawberry-PSIV-YFP 
PSIVSD2 PSIV- PSF PSIV- PSR P426-GAL-
mStrawberry-PSIV-YFP 
PSIVSD3 PSIV- connhp1F PSIV- connhp1R P426-GAL-
mStrawberry-PSIV-YFP 
PSIVSD4 PSIV- connhp2F PSIV- connhp2R P426-GAL-
mStrawberry-PSIV-YFP 
PSIVSD5 PSIV- conn3F PSIV- conn3R P426-GAL-
mStrawberry-PSIV-YFP 
SUI2 SUI2SpeIF SUI2XhoIR Yeast genome 
SUI3 SUI3SpeIF SUI3XhoIR Yeast genome 
GCD1 GCD1SpeIF GCD1SpeIR Yeast genome 
Appendix Table A5-3: PCR products generated in this study 
Name Construction Fragments Figs Used in 
P416-GPD-HIS3-EMCVlib-YFP IRESlcBBhr, IREShrlib 5-10 
P416-GPD-HIS3-50N-YFP IRESlcBBhr, 50Nhr 5-10 
P426-GPD-HIS3-EMCVlib-YFP IREShcBBhr, IREShrlib 5-11,12 
P426-GPD-HIS3-50N-YFP IREShcBBhr, 50Nhr 5-11,12 
P426-Tadh-HIS3-CrPV-YFP CrPVhr1, IREShcBBterm  
P426-Tadh-HIS3-HIPV-YFP HIPVhr1, IREShcBBterm  
P426-Tadh-HIS3-PSIV-YFP PSIVhr1, IREShcBBterm  
P426-Tadh-mStrawberry-EMCV-YFP EMCVhr, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-CrPV-YFP CrPVhr2, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-HiPV-YFP HiPVhr2, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-PSIV-YFP PSIVhr2, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-50NB4-YFP 50NB4hr, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-50ND7-YFP 50ND7hr, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-50ND3-YFP 50ND3hr, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-50NB8-YFP 50NB8hr, IRESDFBBhrterm 5-16 
P426-Tadh-mStrawberry-P150-YFP P150, IRESDFBBhrterm 5-17 
P426-Tadh-mStrawberry-YAP1-YFP YAP1, IRESDFBBhrterm 5-17 
P426-Tadh-mStrawberry-SWSS-YFP SWSS, IRESDFBBhrterm 5-17 
P426-Tadh-mStrawberry-CrTMV-YFP CrTMV, IRESDFBBhrterm 5-17 
P426-Tadh-mStrawberry-gypsy-YFP Gypsy, IRESDFBBhrterm 5-17 
P426-GPD-mStrawberry-P150-YFP P150, IRESDFBBhr 5-17 
P426-GPD-mStrawberry-YAP1-YFP YAP1, IRESDFBBhr 5-17 
P426-GPD-mStrawberry-SWSS-YFP SWSS, IRESDFBBhr 5-17 
P426-GPD-mStrawberry-CrTMV-YFP CrTMV, IRESDFBBhr 5-17 
P426-GPD-mStrawberry-gypsy-YFP Gypsy, IRESDFBBhr 5-17 
P426-Tadh-mStrawberry-IRES-YFP Isolatehr, IRESDFBBhrterm 5-18 
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P426-GPD-mStrawberry-IRES-YFP Isolatehr, IRESDFBBhr 5-19 
P426-GAL-mStrawberry-URE2-YFP URE2, GALBBhr 5-22 
P426-GAL-mStrawberry-Omega-YFP Omega, GALBBhr 5-23 
P426-GAL-mStrawberry-G20-YFP G20, GALBBhr 5-23 
P426-GAL-mStrawberry-G22-YFP G22, GALBBhr 5-23 
P426-GAL-mStrawberry-G35-YFP G35, GALBBhr 5-23 
P426-GAL-mStrawberry-G38-YFP G38, GALBBhr 5-23 
P426-GAL-mStrawberry-G93-YFP G93, GALBBhr 5-23 
P426-GAL-mStrawberry-G94-YFP G94, GALBBhr 5-23 
P426-GAL-mStrawberry-omegaT7-YFP omegaT7, GALBBhr 5-23 
P426-GAL-mStrawberry-G20T7-YFP G20T7, GALBBhr 5-23 
P426-GAL-mStrawberry-G22T7-YFP G22T7, GALBBhr 5-23 
P426-GAL-mStrawberry-G35T7-YFP G35T7, GALBBhr 5-23 
P426-GAL-mStrawberry-G93T7-YFP G93T7, GALBBhr 5-23 
P426-GAL-mStrawberry-G101T7-YFP G101T7, GALBBhr 5-23 
Appendix Table A5-4: Plasmids generated through homolgous recombination 
Name Construction Fragments Figs used in 
P426-GAL-mStrawberry-CrPVSD1-YFP CrPVSD1 5-25 
P426-GAL-mStrawberry-CrPVSD2-YFP CrPVSD2 5-25 
P426-GAL-mStrawberry-CrPVSD3-YFP CrPVSD3 5-25 
P426-GAL-mStrawberry-CrPVSD4-YFP CrPVSD4 5-25 
P426-GAL-mStrawberry-CrPVSD5-YFP CrPVSD5 5-25 
P426-GAL-mStrawberry-HIPVSD1-YFP HIPVSD1 5-25 
P426-GAL-mStrawberry-HIPVSD2-YFP HIPVSD2 5-25 
P426-GAL-mStrawberry-HIPVSD3-YFP HIPVSD3 5-25 
P426-GAL-mStrawberry-HIPVSD4-YFP HIPVSD4 5-25 
P426-GAL-mStrawberry-HIPVSD5-YFP HIPVSD5 5-25 
P426-GAL-mStrawberry-PSIVSD1-YFP PSIVSD1 5-25 
P426-GAL-mStrawberry-PSIVSD2-YFP PSIVSD2 5-25 
P426-GAL-mStrawberry-PSIVSD3-YFP PSIVSD3 5-25 
P426-GAL-mStrawberry-PSIVSD4-YFP PSIVSD4 5-25 
P426-GAL-mStrawberry-PSIVSD5-YFP PSIVSD5 5-25 
Appendix Table A5-5: Plasmids generated through phosphorylation-ligation 
Name Insert Backbone RE1 RE2 Figs used in 
P416-GPD-HIS3 HIS3 P416-
GPDMCSrev2 

















XbaI EcoRI 5-1,2,4,5,8,9 















P426-GPD SacI XhoI 5-10 
P426-Tadh-HIS3-
IRES-YFP 
Tadh High Copy 
IRES Isolates 









































SpeI SacI  
P426-GPD-stem- 
mStrawberry-YFP 
Stem (4x) P426-GPD- 
mStrawberry-
YFP 































































































































































































SacI SpeI 5-20 
P423-GPD-SUI2 SUI2 P423-GPD SpeI XhoI 5-26,27 
P424-GPD-SUI3 SUI3 P424-GPD SpeI XhoI 5-26,27 
P425-GPD-GCD1 GCD1 P425-GPD SpeI XhoI 5-26,27 






































Appendix Table A5-7: Selected IRES mutants generated in this study 
Appendix A6 




































































































































































































































































































































































































































































































































































CEN6f ACGAAAGGGCCTCGTGATAC  
CEN6r AGGGCGACACGGAAATGTTG 
AfterOriF AGCACAGATGCTTCGTTCAG  























































































































Appendix Table A6-1: Oligonucleotides used in this study (IDT) 
PCR Fragment 
Name 




GALfrag1 S. cerevisiae BY4741 genome GalpF1 Gal1pFixR2 
  GALfrag2 GALfrag1 GalpF2 GalpR2 
Ty1frag1 S. cerevisiae BY4741 genome TyH3GenomeF TyH3Genom
eR 
  Ty1frag2 Ty1frag1 TyH3PCRF1 TyH3PCRR1 
    Ty1frag3 Ty1frag2 TyH3PCRF2 TyH3PCRR2 
      Ty1frag4 Ty1frag3 TyH3PCRF3 TyH3FlankR 
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HIVRTfrag1 Synthetic HIVRT (See Below) HIVnoATGF HIVRThomR 
URA3AIfrag1 S. cerevisiae BY4741 genome URA3F URA3AIR 
URA3frag1 S. cerevisiae BY4741 genome URA3R URA3AIF 
  URA3frag2 URA3frag1 URA3R AInoass2F 
    URA3frag3 URA3frag2 URA3R AInoass3F 
LTRfrag1 Synthetic Ty1 (See Below) LTRF1 LTRR1 
  LTRfrag2 LTRfrag1 PPTNotIF LTRflankR 
HIS3promfrag1 S. cerevisiae BY4741 genome HISpromF HISpromR 
P423frag1 P423-GPD (181) P416F P416R 
Ty1RTfrag1 Synthetic Ty1RT (See Below) Ty1RTHDF1 Ty1RTHDR1 
  Ty1RTfrag2 Ty1RTfrag1 Ty1RTHDF2 Ty1RTHDR2 
pGALmTy1frag1 pGALmTy1-HIV RTmutF RTmutR 
TYE1PCR S. cerevisiae BY4741 genome Tye1F Tye1R 
TEC1PCR S. cerevisiae BY4741 genome TEC1F TEC1R 
HSX1PCR S. cerevisiae BY4741 genome HSX1F HSX1R 
ELG1PCR S. cerevisiae BY4741 genome ELG1F ELG1R 
RTT101PCR S. cerevisiae BY4741 genome RTT101F RTT101R 
HIVPBS none TyHIVPBSF TyHIVPBSR 
HIVPPT none TyHIVPPTF TyHIVPPTR 
MidTy1-HIV pGALmTy1-HIV AftPBSF BefPPTR 
pGALmBackbone pGALmTy1-HIV 3'LTRF GALLTRR 
HH- pGALmTy1-HIV RTmutF TRnaseHcon
nR 
H-- pGALmTy1-HIV RTmutF TconnHpolR 
-T- pGALmTy1-Ty1 Ty1RTconnF Ty1RTconnR 
--T pGALmTy1-Ty1 TconnHRnaseF RTmutR 
--H pGALmTy1-HIV HconnTRnaseF RTmutR 
-TT pGALmTy1-Ty1 Ty1RTconnF RTmutR 
tHH pGALmTy1-HIV RTSpeIF tHIVRTXhoI
R 
tHT pGALmTy1-HTT RTSpeIF tTy1RTXhoI
R 
BYHIR35 S. cerevisiae BY4741 genome BYHIR35’F BYHIR35’R 
BYHIR33 S. cerevisiae BY4741 genome BYHIR33’F BYHIR33’R 
BYCAN15 S. cerevisiae BY4741 genome BYCAN15’F BYCAN15’R 
BYCAN13 S. cerevisiae BY4741 genome BYCAN13’F BYCAN13’R 
CPKCAN13 S. cerevisiae CEN.PK2 genome CPKCAN13’F BYCAN13’R 
CPKMRC15 S. cerevisiae CEN.PK2 genome CPKMRC15’F CPKMRC15’
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R 
CPKMRC13 S. cerevisiae CEN.PK2 genome CPKMRC13’F CPKMRC13’
R 
CPKCKB25 S. cerevisiae CEN.PK2 genome CPKCKB25’F CPKCKB25’
R 
CPKCKB23 S. cerevisiae CEN.PK2 genome CPKCKB23’F CPKCKB23’
R 
CAC25 S. cerevisiae BY4741 genome CAC25'F CAC25'R 
CAC23 S. cerevisiae BY4741 genome CAC23'F CAC23'R 
CAC35 S. cerevisiae BY4741 genome CAC35'F CAC35'R 
CAC33 S. cerevisiae BY4741 genome CAC33'F CAC33'R 
APL25 S. cerevisiae BY4741 genome APL25'F APL25'R 
APL23 S. cerevisiae BY4741 genome APL23'F APL23'R 
MRE115 S. cerevisiae BY4741 genome MRE115'F MRE115'R 
MRE113 S. cerevisiae BY4741 genome MRE113'F MRE113'R 












































ICE2 cassette S. cerevisiae BY4741 ΔICE2 
genome 
BefICE2F AftACE2R 





pGALmTy1-Ty1 HispromF HistermR 
pGALmTy1-HIV 
BB 
pGALmTy1-HIV HispromF HistermR 
CAN1 S. cerevisiae BY4741 genome HispromCANF HistermCAN
R 
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XylA-TEF1 cassette p416-TEF-YFP LTRTEFF2 XylAtefR 
XylA3-TEF1 
cassette 
p416-TEF-YFP LTRTEFF2 XylAtefR 
Spt15-TEF1 cassette p416-TEF-YFP LTRTEFF2 Spt15tefR 
Amp amplicon 1 p423-TART NGSAmp1F NGSAmp1R 
Amp amplicon 2 BY4741 Δrrm3-1 plasmid (glucose) NGSAmp2F NGSAmp2R 














































































































XylA pXylA HispromXylAF HistermXylA
R 
XylA3 pXylA3 HispromXylAF HistermXylA
3R 
Spt15 S. cerevisiae BY4741 genome HispromSPT15F HistermSPT1
5R 
CYC P416-CYC LTRCYCF2 URA3CYCR2
TEF P416-TEF LTRTEFF2 URA3TEFR2 
GPD P416-GPD LTRGPDF2 URA3GPDR2 
HIV-instop1 pGALmTy1-HIV Int1stopF Int1stopR 
HIV-instop2 pGALmTy1-HIV Int2stopF Int2stopR 
HIV-instop3 pGALmTy1-HIV Int3stopF Int3stopR 
HIV-instop4 pGALmTy1-HIV Int4stopF Int4stopR 
HIV-instop5 pGALmTy1-HIV Int5stopF Int5stopR 
HIV-intdel1 pGALmTy1-HIV Int1del1F Int1del1R 
HIV-intdel2 pGALmTy1-HIV Int1del2F Int1del2R 
HIV-intdel3 pGALmTy1-HIV Int1del3F Int1del3R 
HIV-intdel4 pGALmTy1-HIV Int1del4F Int1del4R 
HIV-intdel5 pGALmTy1-HIV Int1del5F Int1del5R 
HIV-intdel6 pGALmTy1-HIV Int1del6F Int1del6R 
TY1-instop1 pGALmTy1-Ty1 Int1stopF Int1stopR 
TY1-instop2 pGALmTy1-Ty1 Int2stopF Int2stopR 
TY1-instop3 pGALmTy1-Ty1 Int3stopF Int3stopR 
TY1-instop4 pGALmTy1-Ty1 Int4stopF Int4stopR 
TY1-instop5 pGALmTy1-Ty1 Int5stopF Int5stopR 
TY1-intdel1 pGALmTy1-Ty1 Int1del1F Int1del1R 
TY1-intdel2 pGALmTy1-Ty1 Int1del2F Int1del2R 
TY1-intdel3 pGALmTy1-Ty1 Int1del3F Int1del3R 
TY1-intdel4 pGALmTy1-Ty1 Int1del4F Int1del4R 
TY1-intdel5 pGALmTy1-Ty1 Int1del5F Int1del5R 
TY1-intdel6 pGALmTy1-Ty1 Int1del6F Int1del6R 




HIR3 cassette HIR3 40bp cassette BYHIRKO80A BYHIRKO80
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F OR 
PXKSmcs pGALmTy1-Ty1-XylA3-TEF1 PXKSmcsFor PXKSmcsRe
v 
MCS1 pGALmTy1-Ty1-XylA3-TEF1 MCS1For MCS1Rev 
MCS2 pGALmTy1-Ty1-XylA3-TEF1 MCS2For MCS2Rev 
XbaIXKS1XhoI pXKS1 XbaIXKS1 XKS1XhoI 
XmaIXylAXhoI pGALmTy1-Ty1-XylA XmaIXylAF XhoIXylAR 
NotI-XylA-TEF1-
EcoRI 





GRE3KO cassette p415-TEF-XKS GRE3KOleuF GRE3KOrev
new 
XKS1-Tkc6 1 pXKS1 SpeIXKSTkc6 XKSTkc6Rev




































SacI-Spt15-XhoI Spt15 plasmid or genomic DNA  TEF F XhoISpt15R 
TEF1 pGALmTy1-Ty1-XylA3-TEF1 NotITEFF XmaITEFR 
XylA pGALmTy1-Ty1-XylA XmaIXylA3F BamHIXylA
R 






GPD p416-GPD SacIIGPDF PacIGPDR 
XKS1 p413-TEF-XKS1 PacIXKS1F SbfIXKS1R 
Tkc6 Anneal SbfITKC6EcoRI EcoRITKC6S
bfI 
CEN6/ARSH p413-GPD CEN6f CEN6r 
NoOri pGALmTy1-Ty1 AfterOriF BeforeOriR 
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RT-URA3-BB pGALmTy1-Ty1 RT-URA3-BBf RT-URA3-
BBr 
Cargo-eGFP p423-GPD-eGFP RT-eGFPf RT-eGFPr 
Cargo-LacZ p423-GPD-LacZ RT-LacZf RT-LacZr 
Cargo-CAN1 pGALmTy1-Ty1-CAN1 RT-CAN1f RT-CAN1r 
NoOri-XylA pGALmTy1-Ty1-XylA-TEF1  AfterOriF BeforeOriR 
NoOri-Spt15 pGALmTy1-Ty1-Spt15-TEF1  AfterOriF BeforeOriR 
NoOri-XylA3 pGALmTy1-Ty1-XylA3-TEF1  AfterOriF BeforeOriR 
NoOri-Spt15-300 pGALmTy1-Ty1-Spt15-300-TEF1  AfterOriF BeforeOriR 
YFP-Ty1 p423-GPD-YFP YFPTARTfusF YFPfusR 
YFP-HIV p423-GPD-YFP YFPHARTfusF YFPfusR 
pGALmTy1-Ty1-
TEF 
pGALmTy1-Ty1-Spt15-TEF1 SPT300Vfor SPT300Vrev  























































SPT15lcintnoRT pGALmTy1-Ty1-Spt15intron-TEF1 His3AIgenomefl ARTR 
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GPD S. cerevisiae genome TKC8GPDF LADGPDR 
LAD p423-GPD-BM-LAD LADF TKC1LADR 
TEF S. cerevisiae genome TKC1TEFF LXRTEFR 
LXR p424-GPD-BM-LXR LXRF TKC5LXRR 








XK2 XK1 XKF RTTKC22R 
XDH2 XDH XDHF MCSTKC6R 
ENO2-2 S. cerevisiae genome TKC1ENO2F XDHENO2R 
HXT7-XR HXT7, XR LTREndF GPDTKC8R 
GPD-LAD GPD, LAD TKC8GPDF TEFTKC1R 
TEF-LXR TEF, LXR TKC1TEFF TKC5LXRR2
ENO2-XDH ENO2, XDH TKC5ENO2F PGITKC6R 
PGI-XK PGI, XK2 TKC6PGIF RTMCSR 
ENO2-XDH2 ENO2, XDH2 TKC5ENO2F RTMCSTCK
6R 
GPD-LAD2 GPD, LAD TKC8GPDF ENO2TKC1
R 
ENO2-2-XDH ENO2-2, XDH TKC1ENO2F PGITKC6R 
ENO2-2-XDH2 ENO2-2, XDH2 TKC1ENO2F RTMCSTCK
6R 
Cargo-eGFP p423-GPD-eGFP  RT-eGFPf RT-eGFPr 












Appendix Table A6-1: PCR fragments used to assemble the plasmids used in this 
study.   
Plasmid Name PCR Fragments Used For Assembly 
pGALmTy1H-HIV HIVPBS, HIVPPT, MidTy1-HIV, 
pGALmBackbone 
pGALmTy1-HHT RTmutBackbone, HH-, --T 
pGALmTy1-HTH RTmutBackbone, H--, -T-, --H 
pGALmTy1-HTT RTmutBackbone, H--, -TT 
pGALmTy1H-HHT RTmutBackboneH, HH-, --T 
pGALmTy1H-HTH RTmutBackboneH, H--, -T-, --H 
pGALmTy1H-HTT RTmutBackboneH, H--, -TT 
pGALmTy1-Ty1-CAN1 pGALmTy1-Ty1 BB, CAN1 
pGALmTy1-HIV-CAN1 pGALmTy1-HIV BB, CAN1 
pGALmTy1-Ty1-CYC pGALmTy1-Ty1, CYC 
pGALmTy1-Ty1-TEF pGALmTy1-Ty1, TEF 
pGALmTy1-Ty1-GPD pGALmTy1-Ty1, GPD 
pGALmTy1-HIV-CYC pGALmTy1-HIV, CYC 
pGALmTy1-HIV-TEF pGALmTy1-HIV, TEF 
pGALmTy1-HIV-GPD pGALmTy1-HIV, GPD 
pGALmTy1-Ty1-XylA pGALmTy1-Ty1, XylA 
pGALmTy1-Ty1-XylA3 pGALmTy1-Ty1, XylA3 
pGALmTy1-Ty1-Spt15 pGALmTy1-Ty1, Spt15 
pGALmTy1-HIV-XylA pGALmTy1-HIV, XylA 
pGALmTy1-HIV-XylA3 pGALmTy1-HIV, XylA3 
pGALmTy1-HIV-Spt15 pGALmTy1-HIV, Spt15 
pGALmTy1-Ty1-XylA-TEF1 pGALmTy1-Ty1-XylA, XylA-TEF1 cassette 
pGALmTy1-Ty1-XylA3-TEF1 pGALmTy1-Ty1-XylA3, XylA3-TEF1 cassette 
pGALmTy1-Ty1-Spt15-TEF1 pGALmTy1-Ty1-Spt15, Spt15-TEF1 cassette 
pGALmTy1-HIV-XylA-TEF1 pGALmTy1-HIV-XylA, XylA-TEF1 cassette 
pGALmTy1-HIV-XylA3-TEF1 pGALmTy1-HIV-XylA3, XylA3-TEF1 cassette 
























p415-TEF-XylA p415-TEF, XmaIXylAXhoI 
p415-TEF-XKS p415-TEF, XbaIXKS1XhoI 







p423-TEF-Spt15 p423-TEF, SacI-Spt15-XhoI 
pGALmTy1-Ty1-Spt15-300-TEF1 pGALmTy1-Ty1-TEF, Spt15-300 
pGALmTy1-Ty1-Tkc1-XylA-TEF1 pGALmTy1-Ty1-MCS, TEF1, XylA, Tkc1 
pGALmTy1-Ty1-Tkc1-XylA3-TEF1 pGALmTy1-Ty1-MCS, TEF1, XylA3, Tkc1 









pGALmTy1-Ty1 (low-copy) CEN6/ARSH, NoOri 
pGALmTy1-Ty1-Cargo1 RT-URA3-BB, Cargo-eGFP 
pGALmTy1-Ty1-Cargo2 RT-URA3-BB, Cargo-LacZ 
pGALmTy1-Ty1-Cargo3 RT-URA3-BB, Cargo-LacZ 












pGALmTy1-Ty1-YFP (no linker) Enzyme-digested pGALmTy1-Ty1, YFP-Ty1 
pGALmTy1-HIV-YFP (no linker) Enzyme-digested pGALmTy1-HIV, YFP-HIV 
pGALmTy1-Ty1-ara3gene pGALmTy1-Ty1-MCS BB, HXT7-XR, GPD-
LAD2, ENO2-2-XDH2 
pGALmTy1-Ty1-aranoLXR pGALmTy1-Ty1-MCS BB, HXT7-XR, GPD-
LAD2, ENO2-2-XDH, PGI-XK 
pGALmTy1-Ty1-aranoXKS pGALmTy1-Ty1-MCS BB, HXT7-XR, GPD-LAD, 
TEF-LXR, ENO2-XDH2 
pGALmTy1-Ty1-ara5gene pGALmTy1-Ty1-MCS BB, HXT7-XR, GPD-LAD, 
TEF-LXR, ENO2-XDH, PGI-XK 
pGALmTy1-Ty1-Cargo2 RT-URA3-BB, Cargo-CAN1 




Appendix Table A6-3: Plasmids generated through recombination cloning 
Strain Name Parent Strain Fragment Used for 
Construction 
BY4741 Δcac2 BY4741 CAC2 cassette 
BY4741 Δcac3 BY4741 CAC3 cassette 
BY4741 Δhir3 ΔAPL2 BY4741 Δhir3 APL2 cassette 
BY4741 Δhir3 Δmre11 BY4741 Δhir3 MRE11 cassette 
BY4741 ΔAPL2 Δmre11 BY4741 ΔAPL2 MRE11 cassette 
BY4741 Δhir3 Δcac2 BY4741 Δhir3 CAC2 cassette 
BY4741 Δhir3 Δcac3 BY4741 Δhir3 CAC3 cassette 
CEN.PK2 ΔCAN1 CEN.PK2 CPKCAN cassette 
CEN.PK2 Δcac2 CEN.PK2 CAC2 cassette 
CEN.PK2 Δcac3 CEN.PK2 CAC3 cassette 
CEN.PK2 ΔAPL2 CEN.PK2 APL2 cassette 
CEN.PK2 Δhir3 CEN.PK2 BYHIR cassette 
CEN.PK2 Δmre11 CEN.PK2 MRE11 cassette 
CEN.PK2 ΔICE2 CEN.PK2 ICE2 cassette 
CEN.PK2 Δrrm3 CEN.PK2 RRM3 cassette 
CEN.PK2 ΔMRC1 CEN.PK2 CPKMRC cassette 




Appendix Table A6-4: Strains generated in this study 
Fragment Name Template Enzyme I Enzyme II 
pGALmTy1-Ty1-
MCS BB 
pGALmTy1-Ty1-MCS (low copy) NotI SbfI 
Appendix Table A6-5: Restriction fragments used to assemble the plasmids used 
in this study.   
Appendix A7 














Appendix Table A7-1: Plasmids obtained for this study 
Strain  Genotype Source 
S. cerevisiae 
BY4741 











MATa; ura3-52; trp1-289; leu2-
3,112; his3Δ1; MAL2-8C; SUC2 
EUROSCARF 
S. cerevisiae Sigma 
10560-4A 
MATa; ura 3-52; trp1::hisG; 
leu2::hisG; his3::hisG 
Gerald R. Fink Laboratory 
S. cerevisiae 
BY4741 ∆ADE3 




































































































Appendix Table A7-3: Primers used in this study (IDT) 






Dicer pYES2.1-Dcr1 ScDcr1F ScDcr1R 
Ago2 pYES2.1-Ago1 ScAgo1F ScAgo1R 
YFPfrag100-F p416-GPD-YFP YFPfrag1SpeIF YFPfrag1EcoRIR 




YFPfrag200-F p416-GPD-YFP YFPfrag3SpeIF YFPfrag3EcoRIR 
Intron None SmallAIF SmallAIR 





YFPfrag240-F p416-GPD-YFP YFP-6SpeF YFP-6EcoRIR 
YFPfrag240-R p416-GPD-YFP YFP-6SalIF YFP-6XhoIR 
ADE3frag-F S. cerevisiae 
BY4741 genome 
ADE3-1SpeF ADE3-1EcoRIR 








p415-GPD TKC6-p4XXF GPD rev 
GPD-Dicer-
TKC1 
pYES2.1-Dcr1 GPDDicerF TKC1DicerR 
TKC1-TEF-
Ago2 
p416-TEF TKC1TEFF AgoTEFR 
TEF-Ago2-
TKC6 
pYES2.1-Ago1 TEFAgoF TKC6AgoR 
TRP-CYC-
YFP-TRP 
p416-CYC-YFP BefPromF AftMarkerR 
TRP-GPD-
YFP-TRP 
p416-GPD-YFP BefPromF AftMarkerR 
YFP p416-GPD-YFP MCS-Fwd-SpeI MCS-Rev-2 
Appendix Table A7-4: DNA fragments generated in this study 




p413-GPD-Dicer p413-GPD Dicer SpeI XhoI 



















p414-GPD-YFPhp200 p414-GPD YFPhp200 SpeI KpnI 













p414-GPD-ADE3frag p414-GPD ADE3frag-F SpeI EcoRI 
p414-GPD-
ADE3fragintron 
p414-GPD-ADE3frag Intron EcoRI SalI 
p414-GPD-ADE3hp p414-GPD-
ADE3fragintron 
ADE3frag-R SalI XhoI 
p414-TEF-ADE3hp p414-TEF ADE3hp SpeI KpnI 
p414-CYC-ADE3hp p414-CYC ADE3hp SpeI KpnI 
p413-GPD-YFP p413-GPD YFP SpeI XhoI 
p423-GPD-YFP p413-GPD YFP SpeI XhoI 
p41K-GPD-YFP p41K-GPD YFP Spe XhoI 
Appendix Table A7-5: Plasmids generated through restriction enzyme cloning 
Plasmid Name DNA Fragments 
p415-GPD-Dicer-TEF-
Ago2 
TKC6-p415-GPD, GPD-Dicer-TKC1, TKC1-TEF-Ago2, TEF-
Ago2-TKC6 
Appendix Table A7-6: Plasmids generated through homologous recombination 
cloning 
Strain Name Parent Strain PCR Fragment 
BY4741 TRP1::CYC-YFP S. cerevisiae BY4741 TRP-CYC-YFP-TRP 
BY4741 TRP1::GPD-YFP S. cerevisiae BY4741 TRP-GPD-YFP-TRP 












































































































































































































































































































































































































































































































































































































































































40 p413-GPD-YFP None None None BY4741 YSC -
His 




























































































Appendix Table A7-8: Strains generated through plasmid transformation 
Figure Category Series Strain 
No. 
7-2: Gene knockdowns attained by 






































 No Hairpin 13 
7-3: Growth Rate of Yeast 
Expressing the RNAi System 
No RNAi  42 
Dual RNAi Plasmid  43 
Dual RNAi Plasmid + 
YFPhp 
 44 
Single RNAi Plasmid  45 
Single RNAi Plasmid + 
YFPhp 
 46 
7-4A: Distribution of Knockdown Level in Strains Expressing 
Hairpins from High and Low Copy Plasmids 





7-4B: Variance in the Copy Number 
of High and Low Copy Plasmids 
High Copy Auxotrophic  40 
Low Copy Auxotrophic  41 
Low Copy Antibiotic  47 
7-5: Gene knockdown in alternate 
strains of yeast 
BY4741  14 
CEN.PK2  15 
Sigma 10560-4A  16 
Sham Hairpin  17 
7-6: Rapid Prototyping of gene 
knockdowns conferring increased 
itaconic acid (IA) production in 
multiple yeast strains 
 BY4741 ADE3 KO No Hairpin 18 
BY4741 Weak Hairpin No Hairpin 19 With Hairpin 20 
BY4741 Medium Hairpin No Hairpin 21 With Hairpin 22 
BY4741 Strong Hairpin No Hairpin 23 With Hairpin 24 
BY4741 Sham Hairpin No Hairpin 23 With Hairpin 25 
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CEN.PK Weak Hairpin No Hairpin 26 With Hairpin 27 
CEN.PK Medium Hairpin No Hairpin 28 With Hairpin 29 
CEN.PK Strong Hairpin No Hairpin 30 With Hairpin 31 
CEN.PK Sham Hairpin No Hairpin 30 With Hairpin 32 
Sigma Weak Hairpin No Hairpin 33 With Hairpin 34 
Sigma Medium Hairpin No Hairpin 35 With Hairpin 36 
Sigma Strong Hairpin No Hairpin 37 With Hairpin 38 
Sigma Sham Hairpin No Hairpin 37 With Hairpin 39 
7-7: Downregulation of ADE3 
mRNA 
BY4741 
No Hairpin 23 








No Hairpin 30 
Sham Hairpin 32 








No Hairpin 37 
















































































































































Appendix Table A7-10: Knockdown cassettes confirmed to improved the growth 
rate of BY4741 in 1-butanol an isobutanol. 
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APPENDIX B: SOFTWARE WRITTEN IN THIS WORK 
Appendix B1: Software Written for Chapter 2 
Readme for MATLAB scripts 
Table of Contents: 
1. The Purpose of the Scripts 
2. Contact Information 
3. List and Description of Scripts 




1.  The Purpose of the Scripts 
 
Computational redesign of native or synthetic promoters for altered nucleosome affinity. 
 
2.  Contact Information 
 
Hal Alper 
The University of Texas at Austin 
200 E. Dean Keeton Street, Stop C0400 
Austin, TX  78712-1589 
CPE 5.408 / phone: (512) 471-4417 / fax: (512) 471-7060 
E-mail: halper@che.utexas.edu 
 
3.  List and Description of Scripts 
 
affinity.m 
Takes a DNA sequence and computes nucleosome affinity values for each nucleotide. 
 
containsforbidden.m 




Computes the GC content of a sequence 
 
gcprofile.m 
Calculates the GC contents of each 100bp sliding window of input DNA sequence. 
 
maxprom.m 
This program will take a promoter and iteratively decrease predicted nucleosome occupancy in user-
defined basepair increments until the occupancy can no longer be decreased. 
 
nucleomin.m 
Nucleomin takes a sequence as input and searches all n-nucleotide variants of the starting sequence to find 
the one with the minimum predicted nucleosome affinity, with the requirement that the sequence is also 




Notes the positions of the input DNA sequence which contain particular DNA motifs and ranks them from 
lowest nucleotide to highest nucleotide. 
 
randprom.m 
Initializes a random DNA sequence for a synthetic promoter and generates a list of sequences within the 
promoter which must be conserved during the design process based on user specifications. 
 
randseq.m 
Makes a random DNA sequence of the length and GC content specified 
 
remforbidden.m 
Tries to remove as many matches to a set of DNA motifs as possible from an input sequence. Users may 
also specify the locations of bases which may not be changed during this process. 
 
seqarea.m 
Computes the cumulative affinity score for a DNA sequence. 
 
seqcheck.m 
The sole purpose of this program is to make sure that a sequence can be synthesized by IDT's gblocks.  It 




This function takes a general outline for a promoter and makes a synthetic nucleosome optimized promoter.  
 
4. Installation and Setup 
 Setup instructions provided for Windows systems.   
 1) Obtain a copy of MATLAB (tested on r2011b) with the bioinformatics toolbox (tested on 
r2013b) installed 
 2) Copy the scripts listed above into the MATLAB working directory 
 3) Download a copy of the FORTRAN code for NuPoP (as of 6/28/2013 it was located at 
http://nucleosome.stats.northwestern.edu/ as "NuPoP_F") 
 4) Edit the FORTRAN code for NuPoP_F as follows: 
   Replace the following in npred.f90: 
   
  REPLACE: 
 
    implicit none 
    !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
    integer i,lfn,mlL,rep,species,order; character*80 fileName; character*3 tpc 
    real*8  freqL1(4),tranL1(4,4),tranL2(16,4),tranL3(64,4),tranL4(256,4),Pd(500,11) 
    real*8  freqN4(64,4),tranN4((147-4)*256,4),freqN1(147,4),tranN1(584,4) 
    !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
    open(1,file='yourpath/NuPoP_F/profile/freqL.txt') 
    read(1,*) freqL1; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL.txt') 
    do i=1,4; read(1,*) tranL1(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL2.txt') 
    do i=1,16; read(1,*) tranL2(i,:); end do; close(1) 
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    open(1,file='yourpath/NuPoP_F/profile/tranL3.txt') 
    do i=1,64; read(1,*) tranL3(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL4.txt') 
    do i=1,256; read(1,*) tranL4(i,:); end do; close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/147freqN.txt') 
    do i=1,147; read(1,*) freqN1(i,:); end do 
    close(1) 
    open(1,file='yourpath/NuPoP_F/profile/147tranN.txt') 
    do i=1,584; read(1,*) tranN1(i,:); end do 
    close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/146-149freqN4.txt') 
    do i=1,64; read(1,*) freqN4(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/146-149tranN4.txt') 
    do i=1,(147-4)*256; read(1,*) tranN4(i,:); end do; close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/Pd.txt') 
    do i=1,500; read(1,*) Pd(i,1:11); end do; close(1) 
 
    write(*,'(a)') 'Please input' 
    write(*,'(a)',advance='no') '  File name of DNA sequence (FASTA)                  :  '; 
read*,fileName 
    mlL=500 
    write(*,'(a)',advance='no') '  Order of Markov model (1 or 4)                     :  '; read*,order 
    if(order/=1.and.order/=4) then; print*,'1 or 4 should be inputed! stop.'; stop; end if 
    rep=1 
    print*,' ' 
    write(*,'(a)') 'Select the species from the following list:'  
    print*,'1=Human          2=Mouse            3=Rat' 
    print*,'4=Zebrafish      5=D. melanogaster  6=C. elegans' 
    print*,'7=S. cerevisiae  8=C. albicans      9=S. pombe' 
    print*,'10=A. thaliana   11=Maize           0=Other' 
    print*,' ' 
    write(*,'(a)',advance='no') 'Input the lable of selected species                  :  '; 
read*,species 
    print*,' ' 
    write(*,'(a)') 'Predicting......' 
 
    lfn=len_trim(fileName) 
    if(order==1) then 
   call vtbfb(lfn,trim(fileName),freqL1,tranL1,freqN1,tranN1,mlL,rep,species,Pd) 
    else if(order==4) then 
   call 
vtbfbNL4(lfn,trim(fileName),freqL1,tranL1,tranL2,tranL3,tranL4,freqN4,tranN4,mlL,rep,species,Pd) 
    end if 
     
    write(*,'(a)') '                Done.' 
  end 
 
  WITH: 
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    implicit none 
    !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
    integer i,lfn,mlL,rep,species,order; character*80 fileName,stringorder,stringspecies; 
character*3 tpc 
    real*8  freqL1(4),tranL1(4,4),tranL2(16,4),tranL3(64,4),tranL4(256,4),Pd(500,11) 
    real*8  freqN4(64,4),tranN4((147-4)*256,4),freqN1(147,4),tranN1(584,4) 
    !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
    open(1,file='yourpath/NuPoP_F/profile/freqL.txt') 
    read(1,*) freqL1; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL.txt') 
    do i=1,4; read(1,*) tranL1(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL2.txt') 
    do i=1,16; read(1,*) tranL2(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL3.txt') 
    do i=1,64; read(1,*) tranL3(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/tranL4.txt') 
    do i=1,256; read(1,*) tranL4(i,:); end do; close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/147freqN.txt') 
    do i=1,147; read(1,*) freqN1(i,:); end do 
    close(1) 
    open(1,file='yourpath/NuPoP_F/profile/147tranN.txt') 
    do i=1,584; read(1,*) tranN1(i,:); end do 
    close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/146-149freqN4.txt') 
    do i=1,64; read(1,*) freqN4(i,:); end do; close(1) 
    open(1,file='yourpath/NuPoP_F/profile/146-149tranN4.txt') 
    do i=1,(147-4)*256; read(1,*) tranN4(i,:); end do; close(1) 
 
    open(1,file='yourpath/NuPoP_F/profile/Pd.txt') 
    do i=1,500; read(1,*) Pd(i,1:11); end do; close(1) 
 
    CALL GETARG(1,fileName) 
    CALL GETARG(2,stringorder) 
    CALL GETARG(3,stringspecies) 
 
    read(stringorder,*) order 
    read(stringspecies,*) species 
 
    mlL=500 
 
    if(order/=1.and.order/=4) then; print*,'1 or 4 should be inputed! stop.'; stop; end if 
    rep=1 
 
 
    lfn=len_trim(fileName) 
    if(order==1) then 
   call vtbfb(lfn,trim(fileName),freqL1,tranL1,freqN1,tranN1,mlL,rep,species,Pd) 
    else if(order==4) then 
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   call 
vtbfbNL4(lfn,trim(fileName),freqL1,tranL1,tranL2,tranL3,tranL4,freqN4,tranN4,mlL,rep,species,Pd) 
    end if 
 
  end 
  
 5) Replace the string "yourpath" with the directory in which NuPoP_F is located 
 6) Rename the file to "Npred2.f90" and compile Npred2.f90 as Npred2.exe using the instructions 
provided in the manual included with NuPoP_F.  See the NuPoP_F manual for more detailed information 
as to the installation of NuPoP. 
 7) Add the directory containing Npred2.exe to your system's path. 
 You're now ready to begin designing promoters! 
  
5.  Usage 
 1) Pick a promoter.  Promoters must be designed including 200bp upstream and 100bp 
downstream of its genomic or plasmid context.  This will ensure that the nucleosome affinity values 
calculated for promoter variants will be comparable to one another.  Note the nucleotide positions of the 
start and the end of the promoter. 
 2) Annotate the transcription factor binding sites and note the nucleotides covered by the binding 
sites. A particularly user-friendly repository is the Yeast Promoter Atlas http://ypa.ee.ncku.edu.tw/ 
 3) Annotate any sequences you would not want introduced into the designed promoter.  These 
sequences, if present in the wild-type promoter, will not be altered. 
 4) Build input files.  For the TEF promoter, we enter the DNA sequence of the promoter itself plus 














For its nucleotides covered by transcription factor binding sites, we enter: 
 
TEFforbidden=[281:291 334:343 377:383 443:484]; 
 
For the sequences which will not be introduced or removed from the designed promoter, make a cell array 
containing the relevant motifs.  We used the TF consensus list found at yeastract.com, in addition to the 
start codon and TATA box for our studies.  
 
These input files are included in Sample Data.mat 
  
 Example MATLAB Commands: 
 








For each command, the first output is a list of nucleosome-optimized promoters, starting from the wild-type 
(or seed) sequence, and proceeding in 1bp steps toward a variant with reduced predicted nucleosome 
affinity.  The second output is the corresponding cumulative affinity score for each promoter, and the third 
output is the nucleosome affinity curves used to compute the cumulative affinity score for each promoter.  
 
As the programs are running, they will periodically display a progress indicator which describes how far 
along the program is in computing the current mutation.  
 
6. Changelog 





%nucleomin takes a sequence as input and computes the n-nucleotide variant 
%with the minimum nucleosome affinity that is also synthesizable and also  
%does not have any additional or fewer transcription factor binding sites. n is user-defined.   
 
%input sequence must be uppercase strings 
 
%forbiddenseqs must be a cell array with each motif in the first row. 
%motifs specified in forbiddenseqs will neither be created or destroyed. 
%This is for things like TATA boxes or other general purpose transcription 
%factors which may be present.  Also ATGs if you like. 
 
%forbiddensites is a row vector of positions that you don't want the 
%program to mutate.  For example, things like transcription factor binding 
%sites. 
 
%numchanges tells the program how far to search from the parent sequence to 
%find an improved promoter.  numchanges=1 searches all single mutants, 
%numchanges=2 searches all double mutants, etc...  
 
%Prombeg and promend specify the positions of the beginning and end of the 




%IDT doesn't like these sequences, so we're making note of where they are. 








%We also save the locations of anything in forbiddenseqs.  For determining 




%generates a worklist for all the bases to mutate during the search 
%for an improved promoter.  For each entry in tomutate, basechanges is a 





%n and tic are just there if you are impatient and want to see the progress 
%of nucleomin in real time. Also initializing testarea. 
 
for i=1:size(tomutate,1) 
    %cycles through all the positions needing to be randomized 
     
    for j=1:size(basechanges,1) 
        %cycles through all possible bases at the randomized positions 
         
        badseq=0; 
        %badseq is 1 if sequence has an issue and should be thrown out, 
        %badseq is 0 otherwise. 
         
        testseq=sequence; 
        %this is the sequence we're going to be mutating 
         
        unicom=[tomutate(i,:)' basechanges(j,:)']; 
         
        if length(unique(tomutate(i,:)'))==size(unique(unicom,'rows'),1) 
            % the previous two lines are for making sure that for more than 
            % nbp mutations at a time (n>1), that the (<n)bp mutants are 
            % also computed and without unnecessary repetitions 
             
            for k=1:numchanges 
                %making the specified mutations to testseq 
                 
                 
                if sum(forbiddensites==tomutate(i,k))==0 
                    %makes sure we're not going to mutate anything in 
                    %forbiddensites 
                     
                    if basechanges(j,k)==0 
                        if sequence(tomutate(i,k))=='A' 
                            badseq=1; 
                            %prevents us from mutating to the same base, which 
                            %would eat up time. 
                        else 
                            testseq(tomutate(i,k))='A'; 
                            %make the mutation 
                        end 
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                    elseif basechanges(j,k)==1 
                        if sequence(tomutate(i,k))=='C' 
                            badseq=1; 
                        else 
                            testseq(tomutate(i,k))='C'; 
                        end 
                    elseif basechanges(j,k)==2 
                        if sequence(tomutate(i,k))=='T' 
                            badseq=1; 
                        else 
                            testseq(tomutate(i,k))='T'; 
                        end 
                    elseif basechanges(j,k)==3 
                        if sequence(tomutate(i,k))=='G' 
                            badseq=1; 
                        else 
                            testseq(tomutate(i,k))='G'; 
                        end 
                    end 
                else 
                    badseq=1; 
                end 
            end 
        else 
            badseq=1; 
        end 
        if badseq==0 
            testforbidden=containsforbidden(testseq,forbiddenseqs); 
            %looks for forbidden motifs in the mutated sequence 
             
            isok=seqcheck(testseq(prombeg:promend),sequence(prombeg:promend),runsstart); 
            %makes sure IDT can synthesize the mutated sequence. 
             
            if isequal(refforbidden,testforbidden)==0||isok==0 
                badseq=1; 
                %A sequence is bad if it contains a different number of 
                %forbidden motifs than the starting sequence or if it 
                %cannot be synthsized by IDT. 
            end 
        end 
        if badseq==0; 
            testaffinity=affinity(testseq); 
            testarea(n)=seqarea(learningcurve,testaffinity,prombeg-73,promend-73);          
            testseqs{n}=testseq; 
            %if the sequence is ok, this will compute the nucleosome 
            %affinity under the promoter and add this area to the list of 
            %mutants 
            n=n+1; 
           percentdone=((i-1)*size(basechanges,1)+j)/(size(tomutate,1)*size(basechanges,1))*100 
           timeleft=toc/(percentdone/100)-toc 
%   you can enable the previous two lines if you are impatient and want to 
%   see progress of nucleomin. 
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        end 









%This program will take a promoter and iteratively make improvements to it 
%in 'numchanges' increments until it can no longer be improved.  See the 
%functions this program calls for what each of the input arguments are. 
 
%Outputs the promoter, summed affinity area, and the affinity values along 


























    %continues to make improvements while we aren't stuck in a local 
    %minimum. 
    n 
    n=n+1; 
    [proms{n},~]=nucleomin(proms{n-1},prombeg,promend,numchanges,forbiddensites,forbiddenseqs); 
    testaffinity=affinity(proms{n}); 
    [areas(n),curves(n,:)]=seqarea(learningcurve,testaffinity,prombeg-73,promend-73); 
    %makes improvements 
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    areas 
    %things without semicolons are just so you can see how far along it is. 
    % Feel free to take these out if you're hardcore. 
     
    save('maxpromdata.mat') 
    % just in case your computer crashes you can start from where you left 




%makes an intial random sequence for the synthetic promoter and generates 





    if ischar(params{n})==1 
        a=length(sequence)+1; 
        sequence=strcat(sequence,params{n}); 
        b=length(sequence); 
        forbiddensites=[forbiddensites a:b]; 
    else 
        sequence=strcat(sequence,randseq(params{n},gc)); 




%Notes the positions of sequence containing a motif found in forbiddenseqs 




    if isempty(badsites{n})==0 
        problemsites=[problemsites badsites{n}]; 





%calculates GC contents in each 100bp sliding window of seq. 
len=length(seq); 
if len<100 
    GC=gccontent(seq); 
else 
    for n=1:len-99 
        GC(n)=gccontent(seq(n:n+99)); 





%This script looks for instances of motifs in forbiddenseqs in seq.  motifs 
%can include degenerate bases. 
 
for n=1:size(forbiddenseqs,2) 
    %cycles through everything in forbiddenseqs 
     
    forbiddenregexp1=seq2regexp(forbiddenseqs{1,n}(1),'Ambiguous',false); 
    forbiddenregexp2=seq2regexp(forbiddenseqs{1,n}(2:length(forbiddenseqs{1,n})),'Ambiguous',false); 
    forbiddensites{n}=regexp(sequence,strcat(forbiddenregexp1,'(?=',forbiddenregexp2,')')); 
    %regexp "consumes" a sequence as it checks for matches so I'm just 
    %taking the first nucleotide of the motif and looking ahead to see if 
    %it finds the rest after this basepair.  Then I save the positions or matches in 




%takes 'sequence' and computes nucleosome affinity values for each 
%nucleotide. 
 
%'sequence' is simply a string of nucleotides in uppercase. 
 
fastawrite('sequence.txt','sequence',sequence); 
%makes a FASTA-formatted text file containing the DNA sequence.  This 
%function is part of the bioinformatics toolbox 
 
system('Npred2 sequence.txt 4 7'); 
% system('Npred2 sequence.txt 4 1'); 
%Uses Npred2 to calculate the nucleosome affinities at each base.  This 
%MATLAB script forces a 4th-order Markov model and uses data for S. cerevisiae. 
%In this command, '4' designates the order of the Markov model and '7' designates the 
%organism (in this case, yeast).  Other organisms are found in the manual for NuPoP_F. 
 
%Note that Npred2 must be added to the system path for this script to run. 
%If it is not, simply edit the above system command to point to the right 
%directory. 
 
%Npred2 is nearly equivalent to the script 'Npred' published in the below reference, 
%the only difference being the ability to accept variables from the command 
%line.  See the attached Readme 
 
%Xi, L., Fondufe-Mittendor, Y., Xia, L., Flatow, J., Widom, J. and Wang, J.-P.,  
%Predicting nucleosome positioning using a duration Hidden Markov Model,  




%deletes temp input file 
 
fid=fopen('sequence.txt_Prediction4.txt'); 
data=textscan(fid,'%s %s %s %s %s'); 
fclose(fid); 
system('del "sequence.txt_Prediction4.txt"'); 
%gets data from temp output file and deletes the file 
 
affin=str2double(data{1,5}(2:length(data{1,5}),1)); 
%makes a vector of affinities from extracted data 
 
affinities=affin(~isnan(affin)); 
%removes NaNs from affinity 
gccontent.m (MATLAB) 
function GC=gccontent(seq) 
%computes the gc content of seq 
numSeq = double(nt2int(seq)); 
baseNum = [sum(numSeq == 1) sum(numSeq == 2) sum(numSeq == 3) sum(numSeq == 4)]; 
GC = 100 * ((baseNum(2) + baseNum(3)) / length(numSeq)); 
randseq.m (MATLAB) 
function sequence=randseq(n,gc) 
%makes a random sequence of the length specified by n and with an average 
%gc content of gc 
randnum=randi(100,[1,n]); 
for i=1:n 
    if randnum(i)>=1&&randnum(i)<gc/2 
        sequence(i)='C'; 
    elseif randnum(i)>=gc/2&&randnum(i)<gc 
        sequence(i)='G'; 
    elseif randnum(i)>=gc&&randnum(i)<(gc+(100-gc)/2) 
        sequence(i)='T'; 
    else 
        sequence(i)='A'; 




%this function takes a general outline for a promoter (specified in params) 
%and makes a synthetic nucleosome optimized promoter.  All variables are 
%the same for nucleomin except for params.  Params is a cell array whose 
%contents are either numbers or DNA sequences.  numbers represent length of 
%random (nucleosome optimizable) unspecified DNA sequences, and DNA 
%sequences are TFBSs or anything else you want to keep constant during the 
%optimization.  Put each segement in the order you want it to appear. 
 




%GC content of randomly generated portions of the promoter.  Yeast is 








%removes anything in forbiddenseqs (like TFBSs) randomly generated in sequence, unless 
%they're contained in forbiddensites. 
 
[proms,areas,curves]=maxprom(sequencefix,prombeg,promend,numchanges,forbiddensites,forbiddenseqs); 
%Takes the initialized sequence and performs a nucleosome optimiztion. 
remforbidden.m (MATLAB) 
function sequencefix=remforbidden(sequence,forbiddensites,forbiddenseqs) 
%Tries to remove as many motifs found in forbiddenseqs as possible from 





    problemsites=problemrank(sequence,forbiddenseqs); 
    %notes which bases contain motifs in forbiddenseqs 
    isbetter=0; 
    for i=problemsites 
        %iterates through the problem bases 
        for j=0:3 
            %iterates through all basepair changes 
            if isbetter==0; 
                % if we haven't removed a motif yet 
                badseq=0; 
                testseq=sequence; 
                if sum(forbiddensites==i)==0 
                    %makes sure we aren't mutating a forbidden site 
                    if j==0 
                        if testseq(i)=='A' 
                            badseq=1; 
                        else 
                            testseq(i)='A'; 
                        end 
                    elseif j==1 
                        if testseq(i)=='C' 
                            badseq=1; 
                        else 
                            testseq(i)='C'; 
                        end 
                    elseif j==2 
                        if testseq(i)=='T' 
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                            badseq=1; 
                        else 
                            testseq(i)='T'; 
                        end 
                    elseif j==3 
                        if testseq(i)=='G' 
                            badseq=1; 
                        else 
                            testseq(i)='G'; 
                        end 
                    end 
                else 
                    badseq=1; 
                end 
                if badseq==0 
                    testsites=problemrank(testseq,forbiddenseqs); 
                    %counts the forbidden motifs in the new sequence 
                    if length(testsites)<length(problemsites) 
                        isbetter=1; 
                        sequence=testseq; 
                        %if the new sequence contains less motifs than the 
                        %original, discard the parent and save the good one 
                        %for the next round 
                    end 
                end 
            end 
        end 
    end 
end 
sequencefix=sequence; 
%this sequence should contain the minimum number of forbidden motifs given 




%The sole purpose of this program is to make sure that a sequence can be 
%synthesized by IDT's gblocks.  It was sufficient at the time of writing but some 














    isok=0; 
end 
 
%check GC content every 100bp 
if isok==1 
    GC=gcprofile(seq); 
    if max(GC)>80||min(GC)<24 %checks if GC content is not within acceptable range 
        if min(GC)<min(GCstart) %is minimum GC content of new sequence lower than parent? 
            isok=0; 
        elseif min(GC)==min(GCstart) %is minimum GC content of new sequence equal to parent? 
            if sum(GC==min(GC))>=sum(GCstart==min(GCstart)) %is there not less of the minimum GC 
value than for the parent? 
                isok=0; 
            end 
        end 
    end 
end 
 
%Check for homopolymers which are too long 
if isok==1     
    seqforbidden=containsforbidden(seq,forbiddenruns); 
    if 
isempty(seqforbidden{1})==0||isempty(seqforbidden{2})==0||isempty(seqforbidden{3})==0||isempty(seqf
orbidden{4})==0 %Are there runs? 
        for n=1:4 
            if isempty(seqforbidden{n})==1 
                moreruns(n)=0; 
            else 
                moreruns(n)=(sum(seqforbidden{n})<sum(runsstart{n})); 
            end 
        end 
        if sum(moreruns)==0 % Are there equal or more runs in the new sequence than the parent sequence? 
            isok=0; 
        end 
    end 
end 
             
 
% check for hairpins 
if isok==1 
    %create the dot matrix and rotate it 
    for n=1:len 
        hpdot(n,:)=complement==seq(n); 
    end 
    hpdot=rot90(hpdot); 
    %search through all the diagonals for runs of "dots" of a certain 
    %length.  higher than 8bp hairpin is bad if GC content is greater than 
    %80%, higher than 11bp hairpin is always bad 
    for n=-length(seq)+1:length(seq)-1 
        if isok==1; 
            a=diag(hpdot,n); 
            dia=a(1:ceil(length(a)/2)); 
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            hpsmall=strfind(dia',ones(1,9)); 
            hpbig=strfind(dia',ones(1,12)); 
            if size(hpbig)~=0 
                isok=0; 
            elseif size(hpsmall)~=0 
                for m=1:size(hpsmall) 
                    if n<=0 
                        GC=gccontent(seq(hpsmall(m):hpsmall(m)+6)); 
                    else 
                        GC=gccontent(seq(len-hpsmall(m)-5:len-hpsmall(m)+1)); 
                    end 
                    if GC>80 
                        isok=0; 
                    end 
                end 
            end 
        end 
    end 
end 
 
%check for repeats or inverted repeats in each 100bp subsequence 
done=0; 
if isok==1 
    %create the dot matrices 
    for m=1:len 
        repdot(m,:)=seq==seq(m); 
    end 
    %straighten out the diagonals for only those nucleotides within a 100bp 
    %window of one another 
    for m=1:95 
        repdiags(:,m)=padarray(diag(repdot,m),length(diag(repdot,1))-length(diag(repdot,m)),'post'); 
    end 
    %iterate through all relevant repeat lengths 
    for l=4:50 
        reps=zeros(100-l,len); 
        if isok==1&&done==0 
            %look for the relevant repeat length within a 100bp window and 
            %save all instances of the repeat to reps as its location (if 
            %the repeat would extend beyond a 100bp window then it isn't 
            %counted, hence the 100-l) 
            for m=1:100-2*l 
                occur=strfind(repdiags(:,m+l-1)',ones(1,l)); 
                if size(occur,1)>0 
                    reps(m,:)=padarray(occur,[0 len-length(occur)],'post'); 
                end 
            end 
            %and filter out any repeats which occur within l bp of one 
            %another 
            if sum(sum(reps))>0 
                filteredreps=reps; 
                for n=1:100-2*l+1 
                    a=~ismember(filteredreps(n+1:n+l-1,:),filteredreps(n,:)); 
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                    filteredreps(n+1:n+l-1,:)=a.*filteredreps(n+1:n+l-1,:); 
                end 
                res = [(1:len)' histc(filteredreps(:), 1:len)]; 
                sortedres = sortrows(res, -2); 
                %check if the repeats cover more than 30bp (ie 30% of the 100bp 
                %window) 
                if (sortedres(1,2)+1)*l>=30&&sortedres(1,2)>0 
                    isok=0; 
                end 
            else 
                done=1; 
                %stops calculation early if it can be. 
            end 
        end 




%scales an input affinity curve so that it is comparable to another 
%affinity curve, specified by 'learningcurve' 
 
%Npred does this weird thing where it scales its affinity output depending 
%on the max and min affinities.  This becomes a problem when promoter 
%modifications change the extrema of the affinity curve.  This program 
%effectively "unscales" this affinity curve and "rescales" it to the same 
%scale as a reference curve.  To do so, it does a simple linear regression 
%between the first 25 affinity values of each curve.  In order for this to 
%be valid, the first 25bp of each generating seqence must be the same.  We 
%recommend putting 200bp of context before and 100bp of context after each 
%promoter, as detailed in "Notes for MATLAB".  prombeg and promend specify 
%the locations of the first and last nucleotide of the promoter of interest 




%Performs regression between learningcurve and affinities 
 
affinitiesscaled=affinities.*m+b; 
%Uses regression to scale affinities 
 
area=sum(affinitiesscaled(prombeg:promend)); 
%computes nucleosome area under promoter region. 
Appendix B2: Software Written for Chapter 7 
transmutratefit.m (MATLAB script) 
function [ft,rm]=transmutratefit(f1m,f2m,f3m,L1,L2,fi1,fi2) 
    function a=fun(x) 
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        a=(f2m-(x(1)*(1+(1-fi1)*x(2)-x(2))^L1*(1+(1-fi2)*x(2)-x(2))^L2))^2+(f1m-(1-x(1)+x(1)*(1-(1+(1-
fi1)*x(2)-x(2))^L1)*(1-(1+(1-fi2)*x(2)-x(2))^L2)))^2; 





calceverything.sh (shell script) 
#!/bin/bash 
 
# first argument is forward read, second is reverse, third is a space-delimited list of barcodes and output 
files 





echo "Unzipping first file..." 
gunzip -c $1 > fwdread.fastq 
echo "Unzipping second file..." 
gunzip -c $2 > revread.fastq 
 
pandaseq -f fwdread.fastq -r revread.fastq -d bfsmrk -L 256 -l 244 -t 0.9 -N > align.fasta 
 
rm -f fwdread.fastq 
rm -f revread.fastq 
 
echo "demultiplexing reads..." 
 
perl Fakefastq.pl align.fasta align.fastq 
 
rm -f align.fasta 
 
sabre se -m 0 -f align.fastq -b $3 -u failed.fastq 
 
rm -f failed.fastq 






while read line 
do 
 filename=$(echo "$line" | awk '{print $2}') 
 noext="${filename%.*}" 
 last=${noext: -1:1} 
 base="${noext%?}" 
 mkdir tempalign 
 mv $filename tempalign/input.fastq 
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 rm -f $filename 
 cp $3 tempalign/barcodeinfo.txt 
 cd tempalign 
 fastx_reverse_complement -i input.fastq -o inputrc.fastq 
 rm -f input.fastq 
 sabre se -m 0 -f inputrc.fastq -b barcodeinfo.txt -u turbofailed.fastq 
 if [ "$last" == "$F" ] 
 then 
  cp $base$rsuffix ../$base$fsuffix 
 else 
  cp $base$fsuffix ../$base$rsuffix 
 fi 
 cd .. 
 rm -r tempalign 
done < $3    
 
echo "Preparing Templates..." 
 
ls *.fasta > templateout 
 
while read line 
do 
 filename=$(basename "$line") 
 extension="${filename##*.}" 
 filename="${filename%.*}" 
 ssaha2Build -solexa -save "$filename" "$line" 







while read line 
do 
 filename=$(echo "$line" | awk '{print $1}') 
 templatestring=$(echo "$line" | grep -o "\S\+.fasta") 





 #cat $filenamef$trim > $filename 
 cat $filenamef $filenamer > $filename 
 rm -f $filenamef 
 rm -f $filenamer 
 echo "preparing template for qiime" 
 bash fastqtofna.sh "$filename" "qiime_inputs/$filename$qiimeext" 
 echo "aligning a read to its template" 
 ssaha2 -solexa -disk 1 -align 1 -save "$templatename" "$filename" > $filename$align 
 rm -f "$filename" 
 echo "counting mutations" 
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 bash spectrumcalc.sh $filename$align $5 
 rm -f $filename$align 
done < $4 
 
echo "Analyzing Phylogenetic Groups" 
cat qiime_inputs/* >> $5/qiimeseqs.fna 
pick_de_novo_otus.py -i $5/qiimeseqs.fna -p parameters.txt -o $5/taxonomies099 
 
echo "cleaning stuff up..." 
 
rm -r qiime_inputs 








while read line 
do 
 filename=$(basename "$line") 
 extension="${filename##*.}" 
 filename="${filename%.*}" 
 rm -f $filename$base 
 rm -f $filename$body 
 rm -f $filename$head 
 rm -f $filename$name 
 rm -f $filename$size 
done < templateout 
 
rm -f templateout 
 
echo "Making Phylogenetic Groups look Pretty" 
cd $5/taxonomies099 
plot_rank_abundance_graph.py -i otu_table.biom -s '*' -o otu_graph.pdf 




ELAPSED=$((END - START)) 
echo "Elapsed Time is" 
echo "$ELAPSED" 
echo "Seconds" 
echo "Job Done!  Hooray!" 
trimquals.sh (shell script) 
#!/bin/bash 
 
#first argument is input file, second argument is output file 
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while read line 
do 
 m=$(( ($n-2) % 4 )) 
 if [ $m = 0 ]; 
 then 
  seqnum=$(( (n-2)/4 )) 
  echo $prevline >> $2 
  echo $line >> $2 
 fi 
 n=$(($n + 1)) 
 prevline=$line 
done < $1 
fastqtofna.sh (shell script) 
#!/bin/bash 
 
#first argument is input file, second argument is output file 
 





other="orig_bc=ATACGA new_bc=ATACGA bc_diffs=0" 
n=1 
 
while read line 
do 
 m=$(( ($n-2) % 4 )) 
 if [ $m = 0 ]; 
 then 
  seqnum=$(( (n-2)/4 )) 
  echo $carat$1$underscore$seqnum$space$prevline$space$other >> $2 
  echo $line >> $2 
 fi 
 n=$(($n + 1)) 
 prevline=$line 
done < $1 
spectrumalc.sh (shell script) 
#!/bin/bash 
#first argument is input, second is output folder 
grep -o "Sbjct[[:space:]]\{2,\}[[:digit:]]\+[[:space:]][GCAT-]\+" $1 > "$1sbjct" 
grep -o "Query[[:space:]]\{2,\}[[:digit:]]\+[[:space:]][GCAT-]\+" $1 > "$1query" 
 
python seqcat.py "$1sbjct" "$1sbjctcat" 
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python seqcat.py "$1query" "$1querycat" 
python mutspectrum.py "$1sbjctcat" "$1querycat" $2/$1spectrum 
rm -f "$1sbjct" 
rm -f "$1query" 
rm -f "$1sbjctcat" 
rm -f "$1querycat" 
seqcat.py (Python) 





















subjectfile = open(sys.argv[1],"rb") 
queryfile = open(sys.argv[2],"rb") 
 
from collections import defaultdict 
 
spectrum={'match':0, 'cta':0, 'tta':0, 'gta':0, 'atc':0, 'ttc':0, 'gtc':0, 'att':0, 'ctt':0, 'gtt':0, 'atg':0, 'ctg':0, 'ttg':0, 
'ains':0, 'cins':0, 'tins':0, 'gins':0, 'adel':0, 'cdel':0, 'tdel':0, 'gdel':0} 
 
for qline,sline in zip(queryfile, subjectfile): 
 for qnuc,snuc in zip(qline,sline): 
  if qnuc==snuc: 
   spectrum['match']=spectrum['match']+1 
  elif qnuc=='A' and snuc=='C': 
   spectrum['cta']=spectrum['cta']+1 
  elif qnuc=='A' and snuc=='T': 
   spectrum['tta']=spectrum['tta']+1 
  elif qnuc=='A' and snuc=='G': 
   spectrum['gta']=spectrum['gta']+1 
  elif qnuc=='A' and snuc=='-': 
   spectrum['ains']=spectrum['ains']+1 
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  elif qnuc=='C' and snuc=='A': 
   spectrum['atc']=spectrum['atc']+1 
  elif qnuc=='C' and snuc=='T': 
   spectrum['ttc']=spectrum['ttc']+1 
  elif qnuc=='C' and snuc=='G': 
   spectrum['gtc']=spectrum['gtc']+1 
  elif qnuc=='C' and snuc=='-': 
   spectrum['cins']=spectrum['cins']+1 
  elif qnuc=='T' and snuc=='A': 
   spectrum['att']=spectrum['att']+1 
  elif qnuc=='T' and snuc=='C': 
   spectrum['ctt']=spectrum['ctt']+1 
  elif qnuc=='T' and snuc=='G': 
   spectrum['gtt']=spectrum['gtt']+1 
  elif qnuc=='T' and snuc=='-': 
   spectrum['tins']=spectrum['tins']+1 
  elif qnuc=='G' and snuc=='A': 
   spectrum['atg']=spectrum['atg']+1 
  elif qnuc=='G' and snuc=='C': 
   spectrum['ctg']=spectrum['ctg']+1 
  elif qnuc=='G' and snuc=='T': 
   spectrum['ttg']=spectrum['ttg']+1 
  elif qnuc=='G' and snuc=='-': 
   spectrum['tins']=spectrum['tins']+1 
  elif qnuc=='-' and snuc=='A': 
   spectrum['adel']=spectrum['adel']+1 
  elif qnuc=='-' and snuc=='C': 
   spectrum['cdel']=spectrum['cdel']+1 
  elif qnuc=='-' and snuc=='T': 
   spectrum['tdel']=spectrum['tdel']+1 
  elif qnuc=='-' and snuc=='G': 







for key, value in spectrum.iteritems(): 
 outfile.write('%s\t%s\n' % (key,str(value))) 
Nt_Count.py (python) 
# 1st arg is input, 2nd is output file 
from collections import defaultdict 
from collections import Counter 
import sys 
 
d = defaultdict() 
 




 for line in file: #addressing each line 
  n = line.rstrip() 
  i = 0 
  for x in n: # for each letter in the line 
   i += 1 
   if not d.has_key(i): 
    d[i] = {} 
   if not d[i].has_key(x): 
    d[i][x] = 1 
   elif d[i].has_key(x): 








for key, value in d.iteritems(): 
 for subkey, subvalue in value.iteritems(): 
























































































1. Curran, K.A. and Alper, H.S. (2012) Expanding the chemical palate of cells by 
combining systems biology and metabolic engineering. Metabolic Engineering, 
14, 289-297. 
2. Nevoigt, E. (2008) Progress in metabolic engineering of Saccharomyces 
cerevisiae. Microbiol. Mol. Biol. Rev., 72, 379-412. 
3. Purnick, P.E.M. and Weiss, R. (2009) The second wave of synthetic biology: 
from modules to systems. Nature Reviews Molecular Cell Biology, 10, 410-422. 
4. Ro, D.K., Paradise, E.M., Ouellet, M., Fisher, K.J., Newman, K.L., Ndungu, J.M., 
Ho, K.A., Eachus, R.A., Ham, T.S., Kirby, J. et al. (2006) Production of the 
antimalarial drug precursor artemisinic acid in engineered yeast. Nature, 440, 
940-943. 
5. Verwaal, R., Wang, J., Meijnen, J.P., Visser, H., Sandmann, G., van den Berg, 
J.A. and van Ooyen, A.J. (2007) High-level production of beta-carotene in 
Saccharomyces cerevisiae by successive transformation with carotenogenic genes 
from Xanthophyllomyces dendrorhous. Applied and environmental microbiology, 
73, 4342-4350. 
6. Curran, K.A., Leavitt, J.M., Karim, A.S. and Alper, H.S. (2013) Metabolic 
engineering of muconic acid production in Saccharomyces cerevisiae. Metabolic 
Engineering, 15, 55-66. 
7. Lee, S.M., Jellison, T. and Alper, H.S. (2012) Directed evolution of xylose 
isomerase for improved xylose catabolism and fermentation in the yeast 
Saccharomyces cerevisiae. Applied and environmental microbiology, 78, 5708-
5716. 
8. Westfall, P.J., Pitera, D.J., Lenihan, J.R., Eng, D., Woolard, F.X., Regentin, R., 
Horning, T., Tsuruta, H., Melis, D.J., Owens, A. et al. (2012) Production of 
amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to 
the antimalarial agent artemisinin. Proceedings of the National Academy of 
Sciences. 
9. Elowitz, M.B. and Leibler, S. (2000) A synthetic oscillatory network of 
transcriptional regulators. Nature, 403, 335-338. 
10. Gardner, T.S., Cantor, C.R. and Collins, J.J. (2000) Construction of a genetic 
toggle switch in Escherichia coli. Nature, 403, 339-342. 
11. Friedland, A.E., Lu, T.K., Wang, X., Shi, D., Church, G. and Collins, J.J. (2009) 
Synthetic Gene Networks That Count. Science, 324, 1199-1202. 
12. Tan, C., Marguet, P. and You, L. (2009) Emergent bistability by a growth-
modulating positive feedback circuit. Nature Chemical Biology, 5, 842-848. 
13. Blazeck, J. and Alper, H.S. (2012) Promoter engineering: Recent advances in 
controlling transcription at the most fundamental level. Biotechnology Journal, 
Accepted/In Press. 
14. Gama-Castro, S., Jimenez-Jacinto, V., Peralta-Gil, M., Santos-Zavaleta, A., 
Penaloza-Spinola, M.I., Contreras-Moreira, B., Segura-Salazar, J., Muniz-
 315
Rascado, L., Martinez-Flores, I., Salgado, H. et al. (2008) RegulonDB (version 
6.0): gene regulation model of Escherichia coli K-12 beyond transcription, active 
(experimental) annotated promoters and Textpresso navigation. Nucleic Acids 
Research, 36, D120-124. 
15. Gupta, R., Bhattacharyya, A., Agosto-Perez, F.J., Wickramasinghe, P. and 
Davuluri, R.V. (2010) MPromDb update 2010: an integrated resource for 
annotation and visualization of mammalian gene promoters and ChIP-seq 
experimental data. Nucleic Acids Research. 
16. Yamamoto, Y.Y. and Obokata, J. (2008) ppdb: a plant promoter database. Nucleic 
Acids Research, 36, D977-981. 
17. Zhu, J. and Zhang, M.Q. (1999) SCPD: a promoter database of the yeast 
Saccharomyces cerevisiae. Bioinformatics, 15, 607-611. 
18. Portales-Casamar, E., Thongjuea, S., Kwon, A.T., Arenillas, D., Zhao, X., Valen, 
E., Yusuf, D., Lenhard, B., Wasserman, W.W. and Sandelin, A. (2010) JASPAR 
2010: the greatly expanded open-access database of transcription factor binding 
profiles. Nucleic Acids Research, 38, D105-110. 
19. Blazeck, J., Liu, L., Redden, H. and Alper, H. (2011) Tuning Gene Expression in 
Yarrowia lipolytica by a Hybrid Promoter Approach. Applied and Environmental 
Microbiology, 77, 7905-7914. 
20. Blazeck, J., Garg, R., Reed, B. and Alper, H.S. (2012) Controlling promoter 
strength and regulation in Saccharomyces cerevisiae using synthetic hybrid 
promoters. Biotechnology and Bioengineering. 
21. Blazeck, J., Reed, B., Garg, R., Gerstner, R., Pan, A., Agarwala, V. and Alper, H. 
(2012) Generalizing a hybrid synthetic promoter approach in Yarrowia lipolytica. 
Applied Microbiology and Biotechnology, 1-16. 
22. Amit, R., Garcia, Hernan G., Phillips, R. and Fraser, Scott E. (2011) Building 
Enhancers from the Ground Up: A Synthetic Biology Approach. Cell, 146, 105-
118. 
23. Lam, F.H., Steger, D.J. and O'Shea, E.K. (2008) Chromatin decouples promoter 
threshold from dynamic range. Nature, 453, 246-250. 
24. Sharon, E., Kalma, Y., Sharp, A., Raveh-Sadka, T., Levo, M., Zeevi, D., Keren, 
L., Yakhini, Z., Weinberger, A. and Segal, E. (2012) Inferring gene regulatory 
logic from high-throughput measurements of thousands of systematically 
designed promoters. Nature Biotechnology, 30, 521-530. 
25. Sun, J., Shao, Z., Zhao, H., Nair, N., Wen, F., Xu, J.-H. and Zhao, H. (2012) 
Cloning and characterization of a panel of constitutive promoters for applications 
in pathway engineering in Saccharomyces cerevisiae. Biotechnology and 
Bioengineering, 109, 2082-2092. 
26. Alper, H., Fischer, C., Nevoigt, E. and Stephanopoulos, G. (2005) Tuning genetic 
control through promoter engineering. Proc Natl Acad Sci U S A, 102, 12678-
12683. 
27. Nevoigt, E., Kohnke, J., Fischer, C.R., Alper, H., Stahl, U. and Stephanopoulos, 
G. (2006) Engineering of promoter replacement cassettes for fine-tuning of gene 
 316
expression in Saccharomyces cerevisiae. Applied and environmental 
microbiology, 72, 5266-5273. 
28. Peccoud, J., Blauvelt, M.F., Cai, Y., Cooper, K.L., Crasta, O., DeLalla, E.C., 
Evans, C., Folkerts, O., Lyons, B.M., Mane, S.P. et al. (2008) Targeted 
Development of Registries of Biological Parts. PLoS ONE, 3, e2671. 
29. Mathews, D.H., Sabina, J., Zuker, M. and Turner, D.H. (1999) Expanded 
sequence dependence of thermodynamic parameters improves prediction of RNA 
secondary structure. Journal of Molecular Biology, 288, 911-940. 
30. Gruber, A.R., Lorenz, R., Bernhart, S.H., Neubock, R. and Hofacker, I.L. (2008) 
The Vienna RNA websuite. Nucleic Acids Research, 36, W70-74. 
31. Zadeh, J.N., Steenberg, C.D., Bois, J.S., Wolfe, B.R., Pierce, M.B., Khan, A.R., 
Dirks, R.M. and Pierce, N.A. (2011) NUPACK: Analysis and design of nucleic 
acid systems. Journal of Computational Chemistry, 32, 170-173. 
32. Win, M.N., Liang, J.C. and Smolke, C.D. (2009) Frameworks for Programming 
Biological Function through RNA Parts and Devices. Chemistry & Biology, 16, 
298-310. 
33. Isaacs, F.J., Dwyer, D.J., Ding, C., Pervouchine, D.D., Cantor, C.R. and Collins, 
J.J. (2004) Engineered riboregulators enable post-transcriptional control of gene 
expression. Nature Biotechnology, 22, 841-847. 
34. Zuker, M. (2003) Mfold web server for nucleic acid folding and hybridization 
prediction. Nucleic Acids Res., 31, 3406-3415. 
35. Salis, H.M., Mirsky, E.A. and Voigt, C.A. (2009) Automated design of synthetic 
ribosome binding sites to control protein expression. Nature Biotechnology, 27, 
946-950. 
36. Na, D. and Lee, D. (2010) RBSDesigner: software for designing synthetic 
ribosome binding sites that yields a desired level of protein expression. 
Bioinformatics, 26, 2633-2634. 
37. Crook, N.C., Freeman, E.S. and Alper, H.S. (2011) Re-engineering multicloning 
sites for function and convenience. Nucleic Acids Research, 39, e92. 
38. Goldfless, S.J., Belmont, B.J., de Paz, A.M., Liu, J.F. and Niles, J.C. (2012) 
Direct and specific chemical control of eukaryotic translation with a synthetic 
RNA–protein interaction. Nucleic Acids Research. 
39. Win, M.N. and Smolke, C.D. (2007) A modular and extensible RNA-based gene-
regulatory platform for engineering cellular function. Proceedings of the National 
Academy of Sciences, 104, 14283-14288. 
40. Win, M.N. and Smolke, C.D. (2008) Higher-Order Cellular Information 
Processing with Synthetic RNA Devices. Science, 322, 456-460. 
41. Carothers, J.M., Goler, J.A., Juminaga, D. and Keasling, J.D. (2011) Model-
Driven Engineering of RNA Devices to Quantitatively Program Gene Expression. 
Science, 334, 1716-1719. 
42. Kim, J.H., Lee, S.R., Li, L.H., Park, H.J., Park, J.H., Lee, K.Y., Kim, M.K., Shin, 
B.A. and Choi, S.Y. (2011) High cleavage efficiency of a 2A peptide derived 
 317
from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One, 6, 
e18556. 
43. Donnelly, M.L., Luke, G., Mehrotra, A., Li, X., Hughes, L.E., Gani, D. and Ryan, 
M.D. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism 
indicates not a proteolytic reaction, but a novel translational effect: a putative 
ribosomal 'skip'. The Journal of general virology, 82, 1013-1025. 
44. de Felipe, P., Hughes, L.E., Ryan, M.D. and Brown, J.D. (2003) Co-translational, 
intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A 
peptide. J Biol Chem, 278, 11441-11448. 
45. Niepmann, M. (2009) Internal translation initiation of picornaviruses and hepatitis 
C virus. Biochim Biophys Acta, 1789, 529-541. 
46. Paz, I., Abramovitz, L. and Choder, M. (1999) Starved Saccharomyces cerevisiae 
cells have the capacity to support internal initiation of translation. J Biol Chem, 
274, 21741-21745. 
47. Witherell, G.W., Schultz-Witherell, C.S. and Wimmer, E. (1995) Cis-acting 
elements of the encephalomyocarditis virus internal ribosomal entry site. 
Virology, 214, 660-663. 
48. Hoffman, M.A. and Palmenberg, A.C. (1995) Mutational analysis of the J-K 
stem-loop region of the encephalomyocarditis virus IRES. Journal of virology, 
69, 4399-4406. 
49. Van Der Velden, A., Kaminski, A., Jackson, R.J. and Belsham, G.J. (1995) 
Defective point mutants of the encephalomyocarditis virus internal ribosome 
entry site can be complemented in trans. Virology, 214, 82-90. 
50. Nakashima, N. and Uchiumi, T. (2009) Functional analysis of structural motifs in 
dicistroviruses. Virus research, 139, 137-147. 
51. Benton, B.M., Eng, W.K., Dunn, J.J., Studier, F.W., Sternglanz, R. and Fisher, 
P.A. (1990) Signal-mediated import of bacteriophage T7 RNA polymerase into 
the Saccharomyces cerevisiae nucleus and specific transcription of target genes. 
Molecular and cellular biology, 10, 353-360. 
52. Das, S., Ott, M., Yamane, A., Tsai, W., Gromeier, M., Lahser, F., Gupta, S. and 
Dasgupta, A. (1998) A Small Yeast RNA Blocks Hepatitis C Virus Internal 
Ribosome Entry Site (HCV IRES)-Mediated Translation and Inhibits Replication 
of a Chimeric Poliovirus under Translational Control of the HCV IRES Element. 
J. Virol., 72, 5638-5647. 
53. Hertz, M.I. and Thompson, S.R. (2011) In vivo functional analysis of the 
Dicistroviridae intergenic region internal ribosome entry sites. Nucleic Acids 
Research. 
54. Lippow, S.M. and Tidor, B. (2007) Progress in computational protein design. 
Current Opinion in Biotechnology, 18, 305-311. 
55. Kortemme, T. and Baker, D. (2004) Computational design of protein-protein 
interactions. Current Opinion in Chemical Biology, 8, 91-97. 
 318
56. Samish, I., MacDermaid, C.M., Perez-Aguilar, J.M. and Saven, J.G. (2011) 
Theoretical and Computational Protein Design. Annual Review of Physical 
Chemistry, 62, 129-149. 
57. Leaver-Fay, A., Tyka, M., Lewis, S.M., Lange, O.F., Thompson, J., Jacak, R., 
Kaufman, K., Renfrew, P.D., Smith, C.A., Sheffler, W. et al. (2011) ROSETTA3: 
an object-oriented software suite for the simulation and design of 
macromolecules. Methods in Enzymology, 487, 545-574. 
58. Siegel, J.B., Zanghellini, A., Lovick, H.M., Kiss, G., Lambert, A.R., St Clair, J.L., 
Gallaher, J.L., Hilvert, D., Gelb, M.H., Stoddard, B.L. et al. (2010) 
Computational design of an enzyme catalyst for a stereoselective bimolecular 
Diels-Alder reaction. Science, 329, 309-313. 
59. Nannemann, D.P., Kaufmann, K.W., Meiler, J. and Bachmann, B.O. (2010) 
Design and directed evolution of a dideoxy purine nucleoside phosphorylase. 
Protein Eng Des Sel, 23, 607-616. 
60. Fleishman, S.J., Whitehead, T.A., Ekiert, D.C., Dreyfus, C., Corn, J.E., Strauch, 
E.M., Wilson, I.A. and Baker, D. (2011) Computational design of proteins 
targeting the conserved stem region of influenza hemagglutinin. Science, 332, 
816-821. 
61. Cooper, S., Khatib, F., Treuille, A., Barbero, J., Lee, J., Beenen, M., Leaver-Fay, 
A., Baker, D., Popovic, Z. and players, F. (2010) Predicting protein structures 
with a multiplayer online game. Nature, 466, 756-760. 
62. Eiben, C.B., Siegel, J.B., Bale, J.B., Cooper, S., Khatib, F., Shen, B.W., Players, 
F., Stoddard, B.L., Popovic, Z. and Baker, D. (2012) Increased Diels-Alderase 
activity through backbone remodeling guided by Foldit players. Nat Biotech, 30, 
190-192. 
63. Looger, L.L., Dwyer, M.A., Smith, J.J. and Hellinga, H.W. (2003) Computational 
design of receptor and sensor proteins with novel functions. Nature, 423, 185-
190. 
64. Kaplan, J. and DeGrado, W.F. (2004) De novo design of catalytic proteins. 
Proceedings of the National Academy of Sciences, 101, 11566-11570. 
65. Jiang, L., Althoff, E.A., Clemente, F.R., Doyle, L., Röthlisberger, D., Zanghellini, 
A., Gallaher, J.L., Betker, J.L., Tanaka, F., Barbas, C.F. et al. (2008) De Novo 
Computational Design of Retro-Aldol Enzymes. Science, 319, 1387-1391. 
66. Rothlisberger, D., Khersonsky, O., Wollacott, A.M., Jiang, L., DeChancie, J., 
Betker, J., Gallaher, J.L., Althoff, E.A., Zanghellini, A., Dym, O. et al. (2008) 
Kemp elimination catalysts by computational enzyme design. Nature, 453, 190-
195. 
67. Zastrow, M.L., PeacockAnna, F.A., Stuckey, J.A. and Pecoraro, V.L. (2012) 
Hydrolytic catalysis and structural stabilization in a designed metalloprotein. 
Nature Chemistry, 4, 118-123. 
68. Rohl, C.A., Strauss, C.E., Misura, K.M. and Baker, D. (2004) Protein structure 
prediction using Rosetta. Methods Enzymol, 383, 66-93. 
 319
69. Song, L.S. and Poulter, C.D. (1994) YEAST FARNESYL-DIPHOSPHATE 
SYNTHASE - SITE-DIRECTED MUTAGENESIS OF RESIDUES IN HIGHLY 
CONSERVED PRENYLTRANSFERASE DOMAIN-I AND DOMAIN-II. Proc. 
Natl. Acad. Sci. U. S. A., 91, 3044-3048. 
70. Fasan, R., Chen, M.M., Crook, N.C. and Arnold, F.H. (2007) Engineered alkane-
hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. 
Angew. Chem.-Int. Edit., 46, 8414-8418. 
71. Liang, J.C., Bloom, R.J. and Smolke, C.D. (2011) Engineering Biological 
Systems with Synthetic RNA Molecules. Mol. Cell, 43, 915-926. 
72. Ellington, A.D. and Szostak, J.W. (1990) In vitro selection of RNA molecules that 
bind specific ligands. Nature, 346, 818-822. 
73. Crameri, A., Raillard, S.A., Bermudez, E. and Stemmer, W.P.C. (1998) DNA 
shuffling of a family of genes from diverse species accelerates directed evolution. 
Nature, 391, 288-291. 
74. Crameri, A., Whitehorn, E.A., Tate, E. and Stemmer, W.P.C. (1996) Improved 
green fluorescent protein by molecular evolution using DNA shuffling. Nat. 
Biotechnol., 14, 315-319. 
75. Stemmer, W.P.C. (1994) RAPID EVOLUTION OF A PROTEIN IN-VITRO BY 
DNA SHUFFLING. Nature, 370, 389-391. 
76. Arnold, F.H. and Volkov, A.A. (1999) Directed evolution of biocatalysts. Current 
Opinion in Chemical Biology, 3, 54-59. 
77. Fasan, R., Meharenna, Y.T., Snow, C.D., Poulos, T.L. and Arnold, F.H. (2008) 
Evolutionary History of a Specialized P450 Propane Monooxygenase. J. Mol. 
Biol., 383, 1069-1080. 
78. Alper, H., Moxley, J., Nevoigt, E., Fink, G.R. and Stephanopoulos, G. (2006) 
Engineering yeast transcription machinery for improved ethanol tolerance and 
production. Science, 314, 1565-1568. 
79. Alper, H., Fischer, C., Nevoigt, E. and Stephanopoulos, G. (2005) Tuning genetic 
control through promoter engineering. Proceedings of the National Academy of 
Sciences of the United States of America, 102, 12678-12683. 
80. Esvelt, K.M., Carlson, J.C. and Liu, D.R. (2011) A system for the continuous 
directed evolution of biomolecules. Nature, 472, 499-U550. 
81. Savinell, J.M. and Palsson, B.O. (1992) Network analysis of intermediary 
metabolism using linear optimization. I. Development of mathematical formalism. 
Journal of Theoretical Biology, 154, 421-454. 
82. Segrè, D., Vitkup, D. and Church, G.M. (2002) Analysis of optimality in natural 
and perturbed metabolic networks. Proceedings of the National Academy of 
Sciences, 99, 15112-15117. 
83. Curran, K.A., Crook, N.C. and Alper, H.S. (2012) Using flux balance analysis to 
guide microbial metabolic engineering. Methods in Molecular Biology, 834, 197-
216. 
84. Henry, C.S., Broadbelt, L.J. and Hatzimanikatis, V. (2007) Thermodynamics-
based metabolic flux analysis. Biophys J, 92, 1792-1805. 
 320
85. Beard, D.A., Babson, E., Curtis, E. and Qian, H. (2004) Thermodynamic 
constraints for biochemical networks. Journal of Theoretical Biology, 228, 327-
333. 
86. Mavrovouniotis, M.L. (1990) Group contributions for estimating standard gibbs 
energies of formation of biochemical compounds in aqueous solution. 
Biotechnology and Bioengineering, 36, 1070-1082. 
87. Fischer, E., Zamboni, N. and Sauer, U. (2004) High-throughput metabolic flux 
analysis based on gas chromatography-mass spectrometry derived C-13 
constraints. Anal. Biochem., 325, 308-316. 
88. Antoniewicz, M.R., Kelleher, J.K. and Stephanopoulos, G. (2007) Elementary 
metabolite units (EMU): A novel framework for modeling isotopic distributions. 
Metabolic Engineering, 9, 68-86. 
89. Antoniewicz, M.R., Kelleher, J.K. and Stephanopoulos, G. (2006) Determination 
of confidence intervals of metabolic fluxes estimated from stable isotope 
measurements. Metabolic Engineering, 8, 324-337. 
90. Jamshidi, N. and Palsson, B.Ø. (2010) Mass Action Stoichiometric Simulation 
Models: Incorporating Kinetics and Regulation into Stoichiometric Models. 
Biophysical journal, 98, 175-185. 
91. Canelas, A.B., Ras, C., ten Pierick, A., van Gulik, W.M. and Heijnen, J.J. (2011) 
An in vivo data-driven framework for classification and quantification of enzyme 
kinetics and determination of apparent thermodynamic data. Metabolic 
Engineering, 13, 294-306. 
92. Nolan, R.P. and Lee, K. (2011) Dynamic model of CHO cell metabolism. 
Metabolic Engineering, 13, 108-124. 
93. Smallbone, K., Simeonidis, E., Swainston, N. and Mendes, P. (2010) Towards a 
genome-scale kinetic model of cellular metabolism. BMC Systems Biology, 4, 6. 
94. Dugar, D. and Stephanopoulos, G. (2011) Relative potential of biosynthetic 
pathways for biofuels and bio-based products. Nature Biotechnology, 29, 1074-
1078. 
95. Karr, Jonathan R., Sanghvi, Jayodita C., Macklin, Derek N., Gutschow, 
Miriam V., Jacobs, Jared M., Bolival, B., Assad-Garcia, N., Glass, John I. and 
Covert, Markus W. (2012) A Whole-Cell Computational Model Predicts 
Phenotype from Genotype. Cell, 150, 389-401. 
96. Pramanik, J. and Keasling, J.D. (1997) Stoichiometric model of Escherichia coli 
metabolism: Incorporation of growth-rate dependent biomass composition and 
mechanistic energy requirements. Biotechnology and Bioengineering, 56, 398-
421. 
97. Förster, J., Famili, I., Fu, P., Palsson, B.Ø. and Nielsen, J. (2003) Genome-Scale 
Reconstruction of the Saccharomyces cerevisiae Metabolic Network. Genome 
Research, 13, 244-253. 
98. Schilling, C.H., Covert, M.W., Famili, I., Church, G.M., Edwards, J.S. and 
Palsson, B.O. (2002) Genome-Scale Metabolic Model of Helicobacter pylori 
26695. Journal of Bacteriology, 184, 4582-4593. 
 321
99. Edwards, J.S. and Palsson, B.O. (1999) Systems Properties of the Haemophilus 
influenzae Rd Metabolic Genotype. Journal of Biological Chemistry, 274, 17410-
17416. 
100. Feist, A.M., Henry, C.S., Reed, J.L., Krummenacker, M., Joyce, A.R., Karp, P.D., 
Broadbelt, L.J., Hatzimanikatis, V. and Palsson, B.O. (2007) A genome-scale 
metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 
1260 ORFs and thermodynamic information. Molecular Systems Biology, 3. 
101. Dobson, P.D., Smallbone, K., Jameson, D., Simeonidis, E., Lanthaler, K., Pir, P., 
Lu, C., Swainston, N., Dunn, W.B., Fisher, P. et al. (2010) Further developments 
towards a genome-scale metabolic model of yeast. BMC Systems Biology, 4, 145. 
102. Henry, C.S., DeJongh, M., Best, A.A., Frybarger, P.M., Linsay, B. and Stevens, 
R.L. (2010) High-throughput generation, optimization and analysis of genome-
scale metabolic models. Nature Biotechnology, 28, 977-U922. 
103. Karp, P.D., Paley, S. and Romero, P. (2002) The Pathway Tools software. 
Bioinformatics, 18 Suppl 1, S225-232. 
104. Kumar, V.S. and Maranas, C.D. (2009) GrowMatch: An Automated Method for 
Reconciling in Silico/in Vivo Growth Predictions. PLoS Computational Biology, 
5, e1000308. 
105. Hucka, M., Finney, A., Sauro, H.M., Bolouri, H., Doyle, J.C., Kitano, H., Forum:, 
a.t.r.o.t.S., Arkin, A.P., Bornstein, B.J., Bray, D. et al. (2003) The systems 
biology markup language (SBML): a medium for representation and exchange of 
biochemical network models. Bioinformatics, 19, 524-531. 
106. Alper, H., Jin, Y.-S., Moxley, J.F. and Stephanopoulos, G. (2005) Identifying 
gene targets for the metabolic engineering of lycopene biosynthesis in 
Escherichia coli. Metabolic Engineering, 7, 155-164. 
107. Kennedy, C.J., Boyle, P.M., Waks, Z. and Silver, P.A. (2009) Systems-level 
Engineering of Non-fermentative Metabolism in Yeast. Genetics. 
108. Burgard, A.P., Pharkya, P. and Maranas, C.D. (2003) Optknock: A bilevel 
programming framework for identifying gene knockout strategies for microbial 
strain optimization. Biotechnology and Bioengineering, 84, 647-657. 
109. Fong, S.S., Burgard, A.P., Herring, C.D., Knight, E.M., Blattner, F.R., Maranas, 
C.D. and Palsson, B.O. (2005) In silico design and adaptive evolution of 
Escherichia coli for production of lactic acid. Biotechnology and Bioengineering, 
91, 643-648. 
110. Ng, C.Y., Jung, M.Y., Lee, J. and Oh, M.K. (2012) Production of 2,3-butanediol 
in Saccharomyces cerevisiae by in silico aided metabolic engineering. Microbial 
Cell Factories, 11, 68. 
111. Caspi, R., Foerster, H., Fulcher, C.A., Hopkinson, R., Ingraham, J., Kaipa, P., 
Krummenacker, M., Paley, S., Pick, J., Rhee, S.Y. et al. MetaCyc: a 
multiorganism database of metabolic pathways and enzymes. Nucleic Acids 
Research, 34, D511-D516. 
112. Caspi, R., Altman, T., Dale, J.M., Dreher, K., Fulcher, C.A., Gilham, F., Kaipa, 
P., Karthikeyan, A.S., Kothari, A., Krummenacker, M. et al. (2010) The MetaCyc 
 322
database of metabolic pathways and enzymes and the BioCyc collection of 
pathway/genome databases. Nucleic Acids Research, 38, D473-479. 
113. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. and Tanabe, M. (2012) KEGG 
for integration and interpretation of large-scale molecular data sets. Nucleic Acids 
Research, 40, D109-114. 
114. Scheer, M., Grote, A., Chang, A., Schomburg, I., Munaretto, C., Rother, M., 
Sohngen, C., Stelzer, M., Thiele, J. and Schomburg, D. (2011) BRENDA, the 
enzyme information system in 2011. Nucleic Acids Research, 39, D670-676. 
115. Schellenberger, J., Park, J.O., Conrad, T.M. and Palsson, B.O. (2010) BiGG: a 
Biochemical Genetic and Genomic knowledgebase of large scale metabolic 
reconstructions. BMC Bioinformatics, 11, 213. 
116. Henry, C.S., Broadbelt, L.J. and Hatzimanikatis, V. (2010) Discovery and 
analysis of novel metabolic pathways for the biosynthesis of industrial chemicals: 
3-hydroxypropanoate. Biotechnology and Bioengineering, 106, 462-473. 
117. Yim, H., Haselbeck, R., Niu, W., Pujol-Baxley, C., Burgard, A., Boldt, J., 
Khandurina, J., Trawick, J.D., Osterhout, R.E., Stephen, R. et al. (2011) 
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. 
Nature Chemical Biology, 7, 445-452. 
118. Cho, A., Yun, H., Park, J.H., Lee, S.Y. and Park, S. (2010) Prediction of novel 
synthetic pathways for the production of desired chemicals. BMC Systems 
Biology, 4, 35. 
119. Yousofshahi, M., Lee, K. and Hassoun, S. (2011) Probabilistic pathway 
construction. Metabolic Engineering, 13, 435-444. 
120. Carbonell, P., Planson, A.G., Fichera, D. and Faulon, J.L. (2011) A retrosynthetic 
biology approach to metabolic pathway design for therapeutic production. BMC 
Systems Biology, 5, 122. 
121. Schellenberger, J., Que, R., Fleming, R.M.T., Thiele, I., Orth, J.D., Feist, A.M., 
Zielinski, D.C., Bordbar, A., Lewis, N.E., Rahmanian, S. et al. (2011) 
Quantitative prediction of cellular metabolism with constraint-based models: the 
COBRA Toolbox v2.0. Nature Protocols, 6, 1290-1307. 
122. Lewis, N.E., Nagarajan, H. and Palsson, B.O. (2012) Constraining the metabolic 
genotype-phenotype relationship using a phylogeny of in silico methods. Nature 
Reviews Microbiology, 10, 291-305. 
123. Patil, K.R., Rocha, I., Forster, J. and Nielsen, J. (2005) Evolutionary 
programming as a platform for in silico metabolic engineering. BMC 
Bioinformatics, 6, 308. 
124. Brochado, A.R., Matos, C., Moller, B.L., Hansen, J., Mortensen, U.H. and Patil, 
K.R. (2010) Improved vanillin production in baker's yeast through in silico 
design. Microbial Cell Factories, 9, 84. 
125. Asadollahi, M.A., Maury, J., Patil, K.R., Schalk, M., Clark, A. and Nielsen, J. 
(2009) Enhancing sesquiterpene production in Saccharomyces cerevisiae through 
in silico driven metabolic engineering. Metabolic Engineering, 11, 328-334. 
 323
126. Cvijovic, M., Olivares-Hernandez, R., Agren, R., Dahr, N., Vongsangnak, W., 
Nookaew, I., Patil, K.R. and Nielsen, J. (2010) BioMet Toolbox: genome-wide 
analysis of metabolism. Nucleic Acids Research, 38, W144-149. 
127. Le Fèvre, F., Smidtas, S., Combe, C., Durot, M., d'Alché-Buc, F. and Schachter, 
V. (2009) CycSim - an online tool for exploring and experimenting with genome-
scale metabolic models. Bioinformatics. 
128. Yamada, T., Letunic, I., Okuda, S., Kanehisa, M. and Bork, P. (2011) iPath2.0: 
interactive pathway explorer. Nucleic Acids Research, 39, W412-415. 
129. Bates, J.T., Chivian, D. and Arkin, A.P. (2011) GLAMM: Genome-Linked 
Application for Metabolic Maps. Nucleic Acids Research, 39, W400-405. 
130. Alper, H., Miyaoku, K. and Stephanopoulos, G. (2005) Construction of lycopene-
overproducing E. coli strains by combining systematic and combinatorial gene 
knockout targets. Nature biotechnology, 23, 612-616. 
131. Yim, H., Haselbeck, R., Niu, W., Pujol-Baxley, C., Burgard, A., Boldt, J., 
Khandurina, J., Trawick, J.D., Osterhout, R.E., Stephen, R. et al. (2011) 
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. 
Nat Chem Biol, 7, 445-452. 
132. Atsumi, S., Cann, A.F., Connor, M.R., Shen, C.R., Smith, K.M., Brynildsen, 
M.P., Chou, K.J., Hanai, T. and Liao, J.C. (2008) Metabolic engineering of 
Escherichia coli for 1-butanol production. Metab Eng, 10, 305-311. 
133. Liu, L., Redden, H. and Alper, H.S. Frontiers of yeast metabolic engineering: 
diversifying beyond ethanol and Saccharomyces. Current Opinion in 
Biotechnology. 
134. Na, D., Yoo, S.M., Chung, H., Park, H., Park, J.H. and Lee, S.Y. (2013) 
Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. 
Nature biotechnology, 31, 170-174. 
135. Tomari, Y. and Zamore, P.D. (2005) Perspective: machines for RNAi. Genes & 
Development, 19, 517-529. 
136. Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., 
Elbashir, S., Geick, A., Hadwiger, P., Harborth, J. et al. (2004) Therapeutic 
silencing of an endogenous gene by systemic administration of modified siRNAs. 
Nature, 432, 173-178. 
137. Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, 
B., Kinsey, K., Oppel, S., Scheiblauer, S. et al. (2007) A genome-wide transgenic 
RNAi library for conditional gene inactivation in Drosophila. Nature, 448, 151-
U151. 
138. Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, 
A., Le Bot, N., Moreno, S., Sohrmann, M. et al. (2003) Systematic functional 
analysis of the Caenorhabditis elegans genome using RNAi. Nature, 421, 231-
237. 
139. Chuang, C.F. and Meyerowitz, E.M. (2000) Specific and heritable genetic 
interference by double-stranded RNA in Arabidopsis thaliana. Proc. Natl. Acad. 
Sci. U. S. A., 97, 4985-4990. 
 324
140. Mansoor, S., Amin, I., Hussain, M., Zafar, Y. and Briddon, R.W. (2006) 
Engineering novel traits in plants through RNA interference. Trends in plant 
science, 11, 559-565. 
141. Drinnenberg, I.A., Weinberg, D.E., Xie, K.T., Mower, J.P., Wolfe, K.H., Fink, 
G.R. and Bartel, D.P. (2009) RNAi in Budding Yeast. Science, 326, 544-550. 
142. Crook, N. and Alper, H.S. (2013) Model-based design of synthetic, biological 
systems. Chem. Eng. Sci., 103, 2-11. 
143. Khalil, Ahmad S., Lu, Timothy K., Bashor, Caleb J., Ramirez, Cherie L., 
Pyenson, Nora C., Joung, J.K. and Collins, James J. (2012) A Synthetic Biology 
Framework for Programming Eukaryotic Transcription Functions. Cell, 150, 647-
658. 
144. Zaslaver, A., Bren, A., Ronen, M., Itzkovitz, S., Kikoin, I., Shavit, S., 
Liebermeister, W., Surette, M.G. and Alon, U. (2006) A comprehensive library of 
fluorescent transcriptional reporters for Escherichia coli. Nature methods, 3, 623-
628. 
145. Du, J., Yuan, Y., Si, T., Lian, J. and Zhao, H. (2012) Customized optimization of 
metabolic pathways by combinatorial transcriptional engineering. Nucleic acids 
research, 40, e142. 
146. Xi, L., Fondufe-Mittendorf, Y., Xia, L., Flatow, J., Widom, J. and Wang, J.P. 
(2010) Predicting nucleosome positioning using a duration Hidden Markov 
Model. BMC Bioinformatics, 11, 346. 
147. Chang, D.T., Huang, C.Y., Wu, C.Y. and Wu, W.S. (2011) YPA: an integrated 
repository of promoter features in Saccharomyces cerevisiae. Nucleic acids 
research, 39, D647-652. 
148. Abdulrehman, D., Monteiro, P.T., Teixeira, M.C., Mira, N.P., Lourenco, A.B., 
dos Santos, S.C., Cabrito, T.R., Francisco, A.P., Madeira, S.C., Aires, R.S. et al. 
(2011) YEASTRACT: providing a programmatic access to curated transcriptional 
regulatory associations in Saccharomyces cerevisiae through a web services 
interface. Nucleic acids research, 39, D136-140. 
149. Flagfeldt, D.B., Siewers, V., Huang, L. and Nielsen, J. (2009) Characterization of 
chromosomal integration sites for heterologous gene expression in 
Saccharomyces cerevisiae. Yeast (Chichester, England), 26, 545-551. 
150. McIsaac, R.S., Oakes, B.L., Wang, X., Dummit, K.A., Botstein, D. and Noyes, 
M.B. (2013) Synthetic gene expression perturbation systems with rapid, tunable, 
single-gene specificity in yeast. Nucleic acids research, 41, e57. 
151. Blount, B.A., Weenink, T., Vasylechko, S. and Ellis, T. (2012) Rational 
Diversification of a Promoter Providing Fine-Tuned Expression and Orthogonal 
Regulation for Synthetic Biology. PLoS ONE, 7, e33279. 
152. Jeppsson, M., Johansson, B., Jensen, P.R., Hahn-Hagerdal, B. and Gorwa-
Grauslund, M.F. (2003) The level of glucose-6-phosphate dehydrogenase activity 
strongly influences xylose fermentation and inhibitor sensitivity in recombinant 
Saccharomyces cerevisiae strains. Yeast (Chichester, England), 20, 1263-1272. 
 325
153. Holstege, F.C., Jennings, E.G., Wyrick, J.J., Lee, T.I., Hengartner, C.J., Green, 
M.R., Golub, T.R., Lander, E.S. and Young, R.A. (1998) Dissecting the 
regulatory circuitry of a eukaryotic genome. Cell, 95, 717-728. 
154. Swamy, K.B., Chu, W.Y., Wang, C.Y., Tsai, H.K. and Wang, D. (2011) Evidence 
of association between nucleosome occupancy and the evolution of transcription 
factor binding sites in yeast. BMC evolutionary biology, 11, 150. 
155. Lanza, A.M., Blazeck, J.J., Crook, N.C. and Alper, H.S. (2012) Linking Yeast 
Gcn5p Catalytic Function and Gene Regulation Using a Quantitative, Graded 
Dominant Mutant Approach. PLoS ONE, 7, e36193. 
156. Keasling, J.D. (1999) Gene-expression tools for the metabolic engineering of 
bacteria. Trends Biotechnol., 17, 452-460. 
157. Christianson, T.W., Sikorski, R.S., Dante, M., Shero, J.H. and Hieter, P. (1992) 
Multifunctional Yeast High-Copy-Number Shuttle Vectors. Gene, 110, 119-122. 
158. Gustafsson, C., Govindarajan, S. and Minshull, J. (2004) Codon bias and 
heterologous protein expression. Trends Biotechnol., 22, 346-353. 
159. Blake, W.J., Kaern, M., Cantor, C.R. and Collins, J.J. (2003) Noise in eukaryotic 
gene expression. Nature, 422, 633-637. 
160. Salis, H.M., Mirsky, E.A. and Voigt, C.A. (2009) Automated design of synthetic 
ribosome binding sites to control protein expression. Nat. Biotechnol., 27, 946-
U112. 
161. Kudla, G., Murray, A.W., Tollervey, D. and Plotkin, J.B. (2009) Coding-
Sequence Determinants of Gene Expression in Escherichia coli. Science, 324, 
255-258. 
162. Paik, S.Y., Ra, K.S., Cho, H.S., Koo, K.B., Baik, H.S., Lee, M.C., Yun, J.W. and 
Choi, J.W. (2006) The influence of the nucleotide sequences of random Shine-
Dalgarno and spacer region on bovine growth hormone gene expression. J. 
Microbiol., 44, 64-71. 
163. Pickering, B.M. and Willis, A.E. (2005) The implications of structured 5 ' 
untranslated regions on translation and disease. Semin. Cell Dev. Biol., 16, 39-47. 
164. McCarthy, J.E.G. (1998) Posttranscriptional control of gene expression in yeast. 
Microbiol. Mol. Biol. Rev., 62, 1492-1553. 
165. Kozak, M. (2005) Regulation of translation via mRNA structure in prokaryotes 
and eukaryotes. Gene, 361, 13-37. 
166. Baim, S.B. and Sherman, F. (1988) Messenger-RNA Structures Influencing 
Translation in the Yeast Saccharomyces cerevisiae. Mol. Cell. Biol., 8, 1591-
1601. 
167. Ringner, M. and Krogh, M. (2005) Folding free energies of 5'-UTRs impact post-
transcriptional regulation on a genomic scale in yeast. PLoS Comput. Biol., 1, 
585-592. 
168. Kapp, L.D. and Lorsch, J.R. (2004) The molecular mechanics of eukaryotic 
translation. Annu. Rev. Biochem., 73, 657-704. 
 326
169. Partow, S., Siewers, V., Bjorn, S., Nielsen, J. and Maury, J. (2010) 
Characterization of different promoters for designing a new expression vector in 
Saccharomyces cerevisiae. Yeast, 27, 955-964. 
170. Muller, S., Sandal, T., Kamp-Hansen, P. and Dalboge, H. (1998) Comparison of 
expression systems in the yeasts Saccharomyces cerevisiae, Hansenula 
polymorpha, Klyveromyces lactis, Schizosaccharomyces pombe and Yarrowia 
lipolytica. Cloning of two novel promoters from Yarrowia lipolytica. Yeast, 14, 
1267-1283. 
171. Kozak, M. (1989) Circumstances and mechanisms of inhibition of translation by 
secondary structure in eukaryotic messenger-RNAs. Mol. Cell. Biol., 9, 5134-
5142. 
172. Wang, L.J. and Wessler, S.R. (2001) Role of mRNA secondary structure in 
translational repression of the maize transcriptional activates L-C. Plant Physiol., 
125, 1380-1387. 
173. Short, J.D. and Pfarr, C.M. (2002) Translational regulation of the JunD messenger 
RNA. J. Biol. Chem., 277, 32697-32705. 
174. van der Velden, A.W., van Nierop, K., Voorma, H.O. and Thomas, A.A.M. 
(2002) Ribosomal scanning on the highly structured insulin-like growth factor II-
leader 1. Int. J. Biochem. Cell Biol., 34, 286-297. 
175. Hoover, D.S., Wingett, D.G., Zhang, J., Reeves, R. and Magnuson, N.S. (1997) 
Pim-1 protein expression is regulated by its 5 '-untranslated region and translation 
initiation factor eIF-4E. Cell Growth Differ., 8, 1371-1380. 
176. Dirks, R.M., Bois, J.S., Schaeffer, J.M., Winfree, E. and Pierce, N.A. (2007) 
Thermodynamic analysis of interacting nucleic acid strands. SIAM Rev., 49, 65-
88. 
177. Hofacker, I.L. (2003) Vienna RNA secondary structure server. Nucleic Acids 
Res., 31, 3429-3431. 
178. Serra, M.J. and Turner, D.H. (1995), Energetics of Biological Macromolecules. 
Academic Press Inc, San Diego, Vol. 259, pp. 242-261. 
179. Mathews, D.H., Disney, M.D., Childs, J.L., Schroeder, S.J., Zuker, M. and 
Turner, D.H. (2004) Incorporating chemical modification constraints into a 
dynamic programming algorithm for prediction of RNA secondary structure. 
Proc. Natl. Acad. Sci. U. S. A., 101, 7287-7292. 
180. Sikorski, R.S. and Hieter, P. (1989) A System of Shuttle Vectors and Yeast Host 
Strains Designed for Efficient Manipulation of DNA in Saccharomyces 
cerevisiae. Genetics, 122, 19-27. 
181. Mumberg, D., Muller, R. and Funk, M. (1995) Yeast vectors for the controlled 
expression of heterologous proteins in different genetic backgrounds. Gene, 156, 
119-122. 
182. Sheff, M.A. and Thorn, K.S. (2004) Optimized cassettes for fluorescent protein 
tagging in Saccharomyces cerevisiae. Yeast (Chichester, England), 21, 661-670. 
 327
183. Teste, M.A., Duquenne, M., Francois, J.M. and Parrou, J.L. (2009) Validation of 
reference genes for quantitative expression analysis by real-time RT-PCR in 
Saccharomyces cerevisiae. BMC Mol. Biol., 10. 
184. Nevoigt, E., Kohnke, J., Fischer, C.R., Alper, H., Stahl, U. and Stephanopoulos, 
G. (2006) Engineering of promoter replacement cassettes for fine-tuning of gene 
expression in Saccharomyces cerevisiae. Appl. Environ. Microbiol., 72, 5266-
5273. 
185. Andersen, J.B., Sternberg, C., Poulsen, L.K., Bjorn, S.P., Givskov, M. and Molin, 
S. (1998) New unstable variants of green fluorescent protein for studies of 
transient gene expression in bacteria. Appl. Environ. Microbiol., 64, 2240-2246. 
186. Sharp, P.M. and Li, W.H. (1987) The codon adaptation index  - a measure of 
directinal synonymous codon usage bias, and its potential applications. Nucleic 
Acids Res., 15, 1281-1295. 
187. Grote, A., Hiller, K., Scheer, M., Munch, R., Nortemann, B., Hempel, D.C. and 
Jahn, D. (2005) JCat: a novel tool to adapt codon usage of a target gene to its 
potential expression host. Nucleic Acids Res., 33, W526-W531. 
188. Ellis, T., Wang, X. and Collins, J.J. (2009) Diversity-based, model-guided 
construction of synthetic gene networks with predicted functions. Nat. 
Biotechnol., 27, 465-471. 
189. Dueber, J.E., Wu, G.C., Malmirchegini, G.R., Moon, T.S., Petzold, C.J., Ullal, 
A.V., Prather, K.L.J. and Keasling, J.D. (2009) Synthetic protein scaffolds 
provide modular control over metabolic flux. Nat Biotech, 27, 753-759. 
190. Beekwilder, J., van Rossum, H.M., Koopman, F., Sonntag, F., Buchhaupt, M., 
Schrader, J., Hall, R.D., Bosch, D., Pronk, J.T., van Maris, A.J. et al. (2014) 
Polycistronic expression of a beta-carotene biosynthetic pathway in 
Saccharomyces cerevisiae coupled to beta-ionone production. J Biotechnol. 
191. Lanza, A., Curran, K., Rey, L. and Alper, H. (2014) A Condition-Specific Codon 
Optimization Approach for Improved Heterologous Gene Expression in 
Saccharomyces cerevisiae. BMC Systems Biology. 
192. Donnelly, M.L., Hughes, L.E., Luke, G., Mendoza, H., ten Dam, E., Gani, D. and 
Ryan, M.D. (2001) The 'cleavage' activities of foot-and-mouth disease virus 2A 
site-directed mutants and naturally occurring '2A-like' sequences. The Journal of 
general virology, 82, 1027-1041. 
193. Zhu, J., Musco, M.L. and Grace, M.J. (1999) Three-color flow cytometry analysis 
of tricistronic expression of eBFP, eGFP, and eYFP using EMCV-IRES linkages. 
Cytometry, 37, 51-59. 
194. Zhou, W., Edelman, G.M. and Mauro, V.P. (2003) Isolation and identification of 
short nucleotide sequences that affect translation initiation in Saccharomyces 
cerevisiae. Proc Natl Acad Sci U S A, 100, 4457-4462. 
195. Zhou, W., Edelman, G.M. and Mauro, V.P. (2001) Transcript leader regions of 
two Saccharomyces cerevisiae mRNAs contain internal ribosome entry sites that 
function in living cells. Proc Natl Acad Sci U S A, 98, 1531-1536. 
 328
196. Han, F. and Zhang, X. (2006) Internal initiation of mRNA translation in insect 
cell mediated by an internal ribosome entry site (IRES) from shrimp white spot 
syndrome virus (WSSV). Biochem Biophys Res Commun, 344, 893-899. 
197. Marom, L., Hen-Avivi, S., Pinchasi, D., Chekanova, J.A., Belostotsky, D.A. and 
Elroy-Stein, O. (2009) Diverse poly(A) binding proteins mediate internal 
translational initiation by a plant viral IRES. RNA biology, 6, 446-454. 
198. Ronfort, C., De Breyne, S., Sandrin, V., Darlix, J.L. and Ohlmann, T. (2004) 
Characterization of two distinct RNA domains that regulate translation of the 
Drosophila gypsy retroelement. RNA (New York, N.Y.), 10, 504-515. 
199. Komar, A.A., Lesnik, T., Cullin, C., Merrick, W.C., Trachsel, H. and Altmann, 
M. (2003) Internal initiation drives the synthesis of Ure2 protein lacking the prion 
domain and affects [URE3] propagation in yeast cells. EMBO J, 22, 1199-1209. 
200. Reineke, L.C., Cao, Y., Baus, D., Hossain, N.M. and Merrick, W.C. (2011) 
Insights into the role of yeast eIF2A in IRES-mediated translation. PLoS One, 6, 
e24492. 
201. Komar, A.A., Gross, S.R., Barth-Baus, D., Strachan, R., Hensold, J.O., Goss 
Kinzy, T. and Merrick, W.C. (2005) Novel characteristics of the biological 
properties of the yeast Saccharomyces cerevisiae eukaryotic initiation factor 2A. J 
Biol Chem, 280, 15601-15611. 
202. Davies, M.V. and Kaufman, R.J. (1992) The sequence context of the initiation 
codon in the encephalomyocarditis virus leader modulates efficiency of internal 
translation initiation. Journal of virology, 66, 1924-1932. 
203. Hennecke, M., Kwissa, M., Metzger, K., Oumard, A., Kroger, A., Schirmbeck, 
R., Reimann, J. and Hauser, H. (2001) Composition and arrangement of genes 
define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic 
acids research, 29, 3327-3334. 
204. Wilhelm, F.X., Wilhelm, M. and Gabriel, A. (2005) Reverse transcriptase and 
integrase of the Saccharomyces cerevisiae Ty1 element. Cytogenet. Genome Res., 
110, 269-287. 
205. Wilhelm, F.X., Wilhelm, M. and Gabriel, A. (2005) Reverse transcriptase and 
integrase of the Saccharomyces cerevisiae Ty1 element. Cytogenet Genome Res, 
110, 269-287. 
206. Boeke, J.D., Garfinkel, D.J., Styles, C.A. and Fink, G.R. (1985) Ty elements 
transpose through an RNA intermediate. Cell, 40, 491-500. 
207. Bolton, E.C., Coombes, C., Eby, Y., Cardell, M. and Boeke, J.D. (2005) 
Identification and characterization of critical cis-acting sequences within the yeast 
Ty1 retrotransposon. RNA-Publ. RNA Soc., 11, 308-322. 
208. Boutabout, M., Wilhelm, M. and Wilhelm, F.-X. (2001) DNA synthesis fidelity 
by the reverse transcriptase of the yeast retrotransposon Ty1. Nucleic Acids 
Research, 29, 2217-2222. 
209. Sharon, G., Burkett, T.J. and Garfinkel, D.J. (1994) EFFICIENT 
HOMOLOGOUS RECOMBINATION OF TY1 ELEMENT CDNA WHEN 
INTEGRATION IS BLOCKED. Molecular and Cellular Biology, 14, 6540-6551. 
 329
210. Nissley, D.V., Garfinkel, D.J. and Strathern, J.N. (1996) HIV reverse transcription 
in yeast. Nature, 380, 30-30. 
211. Curcio, M.J. and Garfinkel, D.J. (1991) SINGLE-STEP SELECTION FOR TY1 
ELEMENT RETROTRANSPOSITION. Proc. Natl. Acad. Sci. U. S. A., 88, 936-
940. 
212. Boutabout, M., Wilhelm, M. and Wilhelm, F.X. (2001) DNA synthesis fidelity by 
the reverse transcriptase of the yeast retrotransposon Ty1. Nucleic Acids Res., 29, 
2217-2222. 
213. Bryk, M., Briggs, S.D., Strahl, B.D., Curcio, M.J., Allis, C.D. and Winston, F. 
(2002) Evidence that SET1, a factor required for methylation of histone H3, 
regulates rDNA silencing in S-cerevisiae by a sir2-independent mechanism. Curr. 
Biol., 12, 165-170. 
214. Radford, S.J., Boyle, M.L., Sheely, C.J., Graham, J., Haeusser, D.P., Zimmerman, 
L. and Keeney, J.B. (2004) Increase in Tyl cDNA recombination in yeast sir4 
mutant strains at high temperature. Genetics, 168, 89-101. 
215. Lee, B.S., Lichtenstein, C.P., Faiola, B., Rinckel, L.A., Wysock, W., Curcio, M.J. 
and Garfinkel, D.J. (1998) Posttranslational inhibition of Ty1 retrotransposition 
by nucleotide excision repair transcription factor TFIIH subunits Ss12p and 
Rad3p. Genetics, 148, 1743-1761. 
216. Conte, D. and Curcio, M.J. (2000) Fus3 controls Ty1 transpositional dormancy 
through the invasive growth MAPK pathway. Molecular microbiology, 35, 415-
427. 
217. Scholes, D.T., Banerjee, M., Bowen, B. and Curcio, M.J. (2001) Multiple 
regulators of Tyl transposition in Saccharomyces cerevisiae have conserved roles 
in genome maintenance. Genetics, 159, 1449-1465. 
218. Chan, J.E. and Kolodner, R.D. (2011) A Genetic and Structural Study of Genome 
Rearrangements Mediated by High Copy Repeat Ty1 Elements. PLoS genetics, 7. 
219. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steitz, T.A. (1992) 
CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 
REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR. Science, 
256, 1783-1790. 
220. de Oliveira, T., Engelbrecht, S., van Rensburg, E.J., Gordon, M., Bishop, K., zur 
Megede, J., Barnett, S.W. and Cassol, S. (2003) Variability at human 
immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of 
viral fitness? J. Virol., 77, 9422-9430. 
221. Merkulov, G.V., Lawler, J.F., Eby, Y. and Boeke, J.D. (2001) Ty1 proteolytic 
cleavage sites are required for transposition: All sites are not created equal. J. 
Virol., 75, 638-644. 
222. Wilhelm, M., Boutabout, M. and Wilhelm, F.X. (2000) Expression of an active 
form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion 
protein containing the C-terminal region of the Ty1 integrase linked to the reverse 
transcriptase-RNase H domain exhibits polymerase and RNase H activities. 
Biochem. J., 348, 337-342. 
 330
223. Servant, G., Pinson, B., Tchalikian-Cosson, A., Coulpier, F., Lemoine, S., 
Pennetier, C., Bridier-Nahmias, A., Todeschini, A.L., Fayol, H., Daignan-Fornier, 
B. et al. (2012) Tye7 regulates yeast Ty1 retrotransposon sense and antisense 
transcription in response to adenylic nucleotides stress. Nucleic Acids Research, 
40, 5271-5282. 
224. Kawakami, K., Pande, S., Faiola, B., Moore, D.P., Boeke, J.D., Farabaugh, P.J., 
Strathern, J.N., Nakamura, Y. and Garfinkel, D.J. (1993) A RARE TRANSFER 
RNA-ARG(CCU) THAT REGULATES TY1 ELEMENT RIBOSOMAL 
FRAMESHIFTING IS ESSENTIAL FOR TY1 RETROTRANSPOSITION IN 
SACCHAROMYCES-CEREVISIAE. Genetics, 135, 309-320. 
225. Curcio, M.J., Kenny, A.E., Moore, S., Garfinkel, D.J., Weintraub, M., Gamache, 
E.R. and Scholes, D.T. (2007) S-phase checkpoint pathways stimulate the 
mobility of the retrovirus-like transposon Ty1. Molecular and Cellular Biology, 
27, 8874-8885. 
226. Belcourt, M.F. and Farabaugh, P.J. (1990) Ribosomal frameshifting in the yeast 
retrotransposon Ty: tRNAs induce slippage on a 7 nucleotide minimal site. Cell, 
62, 339-352. 
227. Patrick, W.M., Firth, A.E. and Blackburn, J.M. (2003) User-friendly algorithms 
for estimating completeness and diversity in randomized protein-encoding 
libraries. Protein Eng., 16, 451-457. 
228. Stumpp, S.N., Heyn, B. and Brakmann, S. (2010) Activity-based selection of 
HIV-1 reverse transcriptase variants with decreased polymerization fidelity. 
Biological chemistry, 391, 665-674. 
229. Kaushik, N., Chowdhury, K., Pandey, V.N. and Modak, M.J. (2000) Valine of the 
YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the 
fidelity of DNA synthesis. Biochemistry, 39, 5155-5165. 
230. Kaushik, N., Singh, K., Alluru, I. and Modak, M.J. (1999) Tyrosine 222, a 
member of the YXDD motif of MuLV RT, is catalytically essential and is a major 
component of the fidelity center. Biochemistry, 38, 2617-2627. 
231. Halvas, E.K., Svarovskaia, E.S. and Pathak, V.K. (2000) Development of an in 
vivo assay to identify structural determinants in murine leukemia virus reverse 
transcriptase important for fidelity. Journal of virology, 74, 312-319. 
232. Halvas, E.K., Svarovskaia, E.S. and Pathak, V.K. (2000) Role of murine leukemia 
virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in 
retroviral replication and in vivo fidelity. Journal of virology, 74, 10349-10358. 
233. Dapp, M.J., Heineman, R.H. and Mansky, L.M. (2013) Interrelationship between 
HIV-1 fitness and mutation rate. Journal of molecular biology, 425, 41-53. 
234. Shah, F.S., Curr, K.A., Hamburgh, M.E., Parniak, M., Mitsuya, H., Arnez, J.G. 
and Prasad, V.R. (2000) Differential influence of nucleoside analog-resistance 
mutations K65R and L74V on the overall mutation rate and error specificity of 
human immunodeficiency virus type 1 reverse transcriptase. The Journal of 
biological chemistry, 275, 27037-27044. 
 331
235. Lwatula, C., Garforth, S.J. and Prasad, V.R. (2012) Lys66 residue as a 
determinant of high mismatch extension and misinsertion rates of HIV-1 reverse 
transcriptase. The FEBS journal, 279, 4010-4024. 
236. Youngren, S.D., Boeke, J.D., Sanders, N.J. and Garfinkel, D.J. (1988) Functional 
organization of the retrotransposon Ty from Saccharomyces cerevisiae: Ty 
protease is required for transposition. Molecular and cellular biology, 8, 1421-
1431. 
237. Wilhelm, M. and Wilhelm, F.X. (2005) Role of integrase in reverse transcription 
of the Saccharomyces cerevisiae retrotransposon Ty1. Eukaryotic cell, 4, 1057-
1065. 
238. Lee, S.-M., Jellison, T. and Alper, H.S. (2012) Directed Evolution of Xylose 
Isomerase for Improved Xylose Catabolism and Fermentation in the Yeast 
Saccharomyces cerevisiae. Appl. Environ. Microbiol., 78, 5708-5716. 
239. Karim, A.S., Curran, K.A. and Alper, H.S. (2013) Characterization of plasmid 
burden and copy number in Saccharomyces cerevisiae for optimization of 
metabolic engineering applications. FEMS Yeast Res., 13, 107-116. 
240. Garfinkel, D.J., Boeke, J.D. and Fink, G.R. (1985) Ty element transposition: 
reverse transcriptase and virus-like particles. Cell, 42, 507-517. 
241. T. Werpy, G.P. (2004) Top Value Added Chemicals from Biomass. 
242. Hegemann, J.H. and Heick, S.B. (2011) Delete and repeat: a comprehensive 
toolkit for sequential gene knockout in the budding yeast Saccharomyces 
cerevisiae. Methods in molecular biology (Clifton, N.J.), 765, 189-206. 
243. Hooshangi, S., Thiberge, S. and Weiss, R. (2005) Ultrasensitivity and noise 
propagation in a synthetic transcriptional cascade. Proc. Natl. Acad. Sci. U. S. A., 
102, 3581-3586. 
244. Friedland, A.E., Lu, T.K., Wang, X., Shi, D., Church, G. and Collins, J.J. (2009) 
Synthetic gene networks that count. Science, 324, 1199-1202. 
245. Shirane, D., Sugao, K., Namiki, S., Tanabe, M., Iino, M. and Hirose, K. (2004) 
Enzymatic production of RNAi libraries from cDNAs. Nat Genet, 36, 190-196. 
246. Johnson, E. and Srivastava, R. (2013) Volatility in mRNA secondary structure as 
a design principle for antisense. Nucleic acids research, 41, e43. 
247. Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. and Williams, B.R.G. 
(2003) Activation of the interferon system by short-interfering RNAs. Nature Cell 
Biology, 5, 834-839. 
248. Huang, L., Jin, J., Deighan, P., Kiner, E., McReynolds, L. and Lieberman, J. 
(2013) Efficient and specific gene knockdown by small interfering RNAs 
produced in bacteria. Nat Biotech, 31, 350-356. 
249. Voineagu, I., Narayanan, V., Lobachev, K.S. and Mirkin, S.M. (2008) Replication 
stalling at unstable inverted repeats: Interplay between DNA hairpins and fork 
stabilizing proteins. Proceedings of the National Academy of Sciences, 105, 9936-
9941. 
250. Yoshimatsu, T. and Nagawa, F. (1989) Control of gene expression by artificial 
introns in Saccharomyces cerevisiae. Science, 244, 1346-1348. 
 332
251. Blazeck, J., Miller, J., Pan, A., Gengler, J., Holden, C., Jamoussi, M. and Alper, 
H.S. (2013) Metabolic Engineering of Saccharomyces cerevisiae for itaconic acid 
production. Submitted/Under Review. 
252. Troutt, A.B., McHeyzer-Williams, M.G., Pulendran, B. and Nossal, G.J. (1992) 
Ligation-anchored PCR: a simple amplification technique with single-sided 
specificity. Proceedings of the National Academy of Sciences, 89, 9823-9825. 
253. Si, T., Luo, Y., Xiao, H. and Zhao, H. (2014) Utilizing an endogenous pathway 
for 1-butanol production in Saccharomyces cerevisiae. Metabolic Engineering, 
22, 60-68. 
254. Bukau, B. and Horwich, A.L. (1998) The Hsp70 and Hsp60 chaperone machines. 
Cell, 92, 351-366. 
255. Planta, R.J. and Mager, W.H. (1998) The list of cytoplasmic ribosomal proteins of 
Saccharomyces cerevisiae. Yeast (Chichester, England), 14, 471-477. 
256. Bermingham-McDonogh, O., Gralla, E.B. and Valentine, J.S. (1988) The copper, 
zinc-superoxide dismutase gene of Saccharomyces cerevisiae: cloning, 
sequencing, and biological activity. Proc Natl Acad Sci U S A, 85, 4789-4793. 
257. Elowitz, M.B. and Leibler, S. (2000) A synthetic oscillatory network of 
transcriptional regulators. Nature, 403, 335-338. 
258. Kozak, M. (2005) A second look at cellular mRNA sequences said to function as 
internal ribosome entry sites. Nucleic Acids Research, 33, 6593-6602. 
259. Sambrook, J. and Russell, D.W. (2001) Molecular cloning: a laboratory manual. 
3 ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 
260. Shivaswamy, S., Bhinge, A., Zhao, Y., Jones, S., Hirst, M. and Iyer, V.R. (2008) 
Dynamic remodeling of individual nucleosomes across a eukaryotic genome in 
response to transcriptional perturbation. PLoS Biol, 6, e65. 
261. Li, W.-Z. and Sherman, F. (1991) Two Types of TATA Elements for the CYC1 
Gene of the Yeast Saccharomyces Cerevisiae. Mol. Cell. Biol., 11, 666-676. 
262. Hahn, S., Hoar, E.T. and Guarente, L. (1985) Each of 3 TATA Elements Specifies 
a Subset of the Transcription Initiation Sites at the CYC-1 Promoter of 
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A., 82, 8562-8566. 
263. Nagashima, K., Kasai, M., Nagata, S. and Kaziro, Y. (1986) Structure of the 2 
genes coding for polypeptide chain elongation factor 1-alpha (EF-1-alpha) from 
Saccharomyces cerevisiae. Gene, 45, 265-273. 
264. Zhang, Z.H. and Dietrich, F.S. (2005) Mapping of transcription start sites in 
Saccharomyces cerevisiae using 5 ' SAGE. Nucleic Acids Res., 33, 2838-2851. 
265. Lamprecht, M.R., Sabatini, D.M. and Carpenter, A.E. (2007) CellProfiler(TM): 
free, versatile software for automated biological image analysis. BioTechniques, 
42, 71-75. 
266. Hall, B.M., Ma, C.X., Liang, P. and Singh, K.K. (2009) Fluctuation AnaLysis 
CalculatOR: a web tool for the determination of mutation rate using Luria-
Delbruck fluctuation analysis. Bioinformatics, 25, 1564-1565. 
 333
267. Ma, W.T., Sandri, G.V. and Sarkar, S. (1992) Analysis of the Luria-Delbrück 
Distribution Using Discrete Convolution Powers. Journal of Applied Probability, 
29, 255-267. 
268. Lamprecht, M.R., Sabatini, D.M. and Carpenter, A.E. (2007) CellProfiler: free, 
versatile software for automated biological image analysis. BioTechniques, 42, 
71-75. 
269. Masella, A.P., Bartram, A.K., Truszkowski, J.M., Brown, D.G. and Neufeld, J.D. 
(2012) PANDAseq: paired-end assembler for illumina sequences. BMC 
Bioinformatics, 13, 31. 
270. Patel, R.K. and Jain, M. (2012) NGS QC Toolkit: A Toolkit for Quality Control 
of Next Generation Sequencing Data. PLoS ONE, 7, e30619. 
271. Ning, Z., Cox, A.J. and Mullikin, J.C. (2001) SSAHA: a fast search method for 
large DNA databases. Genome research, 11, 1725-1729. 
272. CLOPPER, C.J. and PEARSON, E.S. (1934) THE USE OF CONFIDENCE OR 
FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL. 
Biometrika, 26, 404-413. 
273. Guldener, U., Heck, S., Fielder, T., Beinhauer, J. and Hegemann, J.H. (1996) A 
new efficient gene disruption cassette for repeated use in budding yeast. Nucleic 
acids research, 24, 2519-2524. 
274. Shao, Z., Zhao, H. and Zhao, H. (2009) DNA assembler, an in vivo genetic 
method for rapid construction of biochemical pathways. Nucleic Acids Research, 
37, e16. 
275. Lanza, A.M., Kim, D.S. and Alper, H.S. (2013) Evaluating the influence of 
selection markers on obtaining selected pools and stable cell lines in human cells. 
Biotechnology Journal, 8, 811-821. 
 
 
